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ABSTRACT 
The zinc ion is an important emerging signaling molecule for biological processes. In 
this work we engineered improved zinc sensors based on our previously developed 
fluorescent sensor GZnP1 to provide sensors with a higher fluorescent readout, faster 
kinetics, and a superior sensitivity to zinc. We utilized these zinc sensors and further 
developed the sensors to answer questions pertaining to biological zinc. We showed the 
labile zinc concentration in the mitochondrial matrix was less than 1 pM while the labile 
zinc concentration in the cytosol and mitochondrial IMS were comparable (~100 pM) 
across four different cell lines. Using these zinc sensors we found that exposure to high 
labile zinc only overloaded the cytosol and the mitochondrial IMS with zinc while the 
mitochondrial matrix did not sequester excess labile zinc. We highlighted the importance 
of mitochondrial labile zinc dynamics and concentrations across different mitochondrial 
locations and distinguished the mitochondria as not being a storage site for zinc. 
In this work we revealed, for the first time, a novel vital role zinc plays in the 
regulation of cellular trafficking. High load of zinc can arrest the motility of 
mitochondria, lysosomes and vesicles in both HeLa cells and neurons. The zinc-
microtubule interaction was found to prevent motor proteins from landing on 
microtubules obstructing microtubule-based motility. Zinc was identified as interacting 
with two histidine residues on the α-tubulin monomer of microtubules. This finding 
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resolved the long lasting controversy regarding the signaling roles of labile zinc and 
provided solid, direct and strong evidence confirming that zinc act as a significant 
intracellular signaling molecule. In addition to zinc, polyamines were investigated as a 
potential specific regulator of mitochondrial microtubule-based trafficking.  
We found a correlation between mitochondrial microtubule-based trafficking and 
abnormal polyamine concentrations resulting from Alzheimer’s disease (AD) in a Down 
syndrome (DS) cell model. Decreased mitochondrial motility was found in primary 
cultured rat hippocampal neurons as well as in the DS mouse hippocampal neuron model 
with increased polyamines. Polyamine production can be blocked using 
difuoromethylornithine (DFMO) a drug that inhibits ornithine decarboxylase (ODC) 
preventing the production of polyamines. DFMO restored mitochondrial motility in the 
DS mouse model. Mitochondrial motility in relation to polyamines has never been 
connected prior to these results indicating a novel pathway for the pathology of AD in DS 
brains. Two new regulatory mechanisms for axonal motility and exposure of previously 
unknown zinc mitochondrial relationships were discovered which has magnified our 
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1 
CHAPTER ONE:  INTRODUCTION of ZINC BIOLOGY 
1.1 BIOLOGICAL ROLE OF ZINC 
Zinc biology is a new and exciting upcoming field that scientists are quickly realizing 
is an integral part of numerous cellular processes. Zinc is the second most abundant 
heavy metal within cells and has been bioinformatically linked to over 2800 proteins, yet 
our understanding of how the interaction between zinc and these proteins modulate 
various cellular functions is still in its infancy [1]. Emerging studies have shown that zinc 
affects a multitude of cellular processes including: the alteration of enzymatic function 
[2], regulation of mitochondrial function [3], [4], [5], modulation of cell division [6], and 
facilitation of apoptosis [6]. The breadth of cellular processes that require zinc has 
defined zinc as a necessary trace element or micronutrient for all plants and higher 
animals such as humans [7]. Zinc was found to be an essential micronutrient in plants in 
1869, in animals in 1934, and humans in 1961 [8]. Many of the human organ systems 
require zinc such as the epidermal, gastrointestinal, central nervous, immune, skeletal, 
and reproductive systems [9]. Unlike other biological metals such as iron where the metal 
is concentrated into certain tissues or locations within cells zinc is found ubiquitously 
throughout the body. Deficiency in zinc cause impaired growth [10], increase risk for 
infections [11], slow wound healing, and diarrhea [12]. Overabundance of ingested zinc 
can cause nausea, vomiting, headaches, or in the scenario of ischemic events can act as a 
potent neurotoxin [13]. The brain as a whole relies on zinc although specific regions are
2 
more dependent on zinc such as the hippocampal neurons where zinc can impact 
learning, neurogenesis, memory, and neuronal survival [14] [15]. For this reason dietary 
zinc has been found to influence proper brain development in an age-dependent manner 
[16]. One of the reasons for breast milk containing high concentrations of zinc is for the 
proper neural development of the child. Zinc deficiencies are more prevalent in youth, 
pregnant, and lactating women [8]. Deficiency in serum zinc has been linked to 
neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease [17, 18] while 
overabundance of zinc causes excitotoxic neuronal damage as observed in head trauma, 
ischemia, and seizures [19, 20]. 
Specific regions of the brain have higher concentrations of zinc and hence rely 
heavily on zinc to properly function as described above for the hippocampus region. The 
neurons that contain the majority of brain zinc are glutamatergic/gluzinergic neurons or 
neurons that package zinc in vesicles and release both zinc and glutamate [21]. These 
gluzinergic neurons are mainly present in the cerebral cortex and limbic system 
(hippocampus, amygdala, thalamus, etc.) [22, 23]. Either the zinc in these zinc-vesicles 
[24] or other intracellular stores of zinc [25] can modulate neurons by regulating key 
neuronal receptors such as N-methyl-d-aspartate (NMDA) receptors, alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors, and gamma-
aminobutyric acid (GABA) [22, 26].  
The NMDAR's contain two binding sites for the extracellular zinc allowing the zinc 
to bind according to the concentrations present and affect the receptor. The NMDAR's 
can sense zinc from nano molar levels to micro molar levels affecting the receptor 
dramatically, from lower concentrations causing inhibition of the pore to becoming a 
3 
pore blocker at higher levels of zinc [27]. The GABAA receptor or type A receptor at the 
synaptic terminal where an alpha and beta subunit act as a zinc binding site which when 
bound inhibits the GABAR from transporting GABA across the membrane [28]. This is 
thought to occur from spill over from nearby synapses containing zinc that then inhibit 
the GABA from another synaptic region from transporting across the cell membrane of 
the postsynaptic terminal. This is believed to be necessary for long term potentiation of 
the neurons involved in auditory fear conditioning [29]. How this is accomplished is 
neurons that contain vesicular zinc to be released are nearby GABA and GABAR's 
thereby permanently being present juxtaposed to each other allowing zinc to be released 
and to have spillover into the nearby neuron inhibiting the GABA receptors. This will 
allow for a permanent long lasting effect where the receptor is inhibited via the zinc and 
allow the LTP to be maintained [29, 30]. AMPA receptors can also be modulated by zinc 
upon zinc release into the synaptic cleft. AMPA receptors have been linked to nearly all 
aspects of brain development, neural plasticity, and function making a modulator such as 
zinc extremely important in proper neural development and function. Zinc will interact 
with AMPA receptors and inhibit them when contacting the channel [31]. Due to these 
important neural channels being regulated by zinc many have decided zinc is essential in 
proper excitatory and inhibitory synaptic transmission [32, 33]. Zinc under physiological 
conditions has been shown to be highly important for brain development although 
pathologies such as Alzheimer’s disease have been linked to zinc in the brain. 
Alzheimer’s disease is characterized by oligomerization of amyloid-β plaques as well 
as intracellular accumulation of a protein named Tau. These Aβ deposits are localized at 
synapses and are not ubiquitous within the brain in all regions [34]. One of the reasons 
4 
for this localization of the Aβ deposits is believed to be in the metallochemistry 
associated with the protein. When zinc binds to the Aβ deposit oligomerization occurs 
between the proteins and the oligomer formed is resistant to tryptic cleavage at the 
synapse where the zinc is released [35]. This results in aggregates of the protein at 
synapses where zinc is released and the aggregates cannot be degraded by the cells. The 
zinc ion is the major ion responsible for these aggregates at physiological pH (7.4) at 
slightly lower pH copper and iron can bind to the Aβ proteins and cause the aggregates 
[36, 37]. The reuptake of the zinc from the synapse is an energy dependent process 
meaning it requires mitochondria to produce ATP to reuptake the zinc. As the 
mitochondria have reduced efficiencies seen in older patients which is commonly the 
case with Alzheimer’s disease zinc will dwell in the synaptic space longer allowing 
longer times for the zinc to interact with the Aβ protein and further form plaques of 
insoluble protein oligomers. Therapies utilizing zinc chelators such as Clioquinol have 
been employed although with little success to treat Alzheimer’s disease [38]. Parkinson’s 
disease is another example of zinc impacting the pathology. 
Parkinson’s disease has been linked to zinc through mitophagy in a study performed 
on Drosophila Melanogaster flies exhibiting Parkinson’s disease where the flies were 
supplemented with zinc and the symptoms associated with Parkinson’s disease were 
reduced [39]. A specific type of Parkinson’s disease called Kufor-Rakeb Parkinson’s 
disease where there is a defect in a protein, ATP13A2, responsible for segregating zinc 
within the lysosomes of cells [40]. In ATP13A2 deficient cells (form of Parkinson’s 
disease) the mitochondria are quickly overwhelmed with zinc due to excess zinc not 
being properly sequestered into the lysosomes [41]. Due to the excess zinc the 
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mitochondrial membrane potential decreases thereby decreasing the ATP production 
without a strong proton gradient present to produce the ATP via the electron transport 
chain [3-5, 42-45]. This causes mitochondria fragmentation, increased ROS production, 
reduced energy production, and eventual cell death [3-5, 42, 45]. In these PARK9 
deficient patients there is a reorganization of the ZnT's and ZIP proteins to accommodate 
for the lack of sequestration of zinc in the lysosomes [41], although by removing one of 
the main storage sites for zinc the cells can are more susceptible to zinc toxicity causing 
mitochondrial dysfunction leading to Parkinson’s disease. Another event that hinges on 
zinc are excitotoxic events such as brain trauma, ischemia, and seizures. 
Insults to the brain such as direct mechanical damage i.e. concussion or ischemic 
events depriving the cells of proper blood and nutrients results in excitotoxicity. These 
neurological conditions currently lack adequate intervention once the damage has 
occurred and can result from a variety of etiologies [46, 47]. Following ischemia or brain 
damage the damaged neurons spill glutamate and zinc into the extracellular fluid flooding 
nearby neurons with the neurotransmitters such as zinc [48] over stimulating nearby 
neurons resulting in cell death. Previously it has been shown that following ischemic 
stroke large influxes of labile zinc are present in the neuronal cells which may be the 
central source of their demise [13]. It has been shown that while calcium levels increase 
in parallel with zinc the increase in calcium appears to be a result of the zinc ions 
increasing making zinc the more potent mediator [49, 50]. Studies have investigated 
treating stroke victims by reducing zinc as a potential treatment to alleviate the damage 
incurred following a stroke with mixed success [51]. Zinc plays a central role in proper 
brain functioning, development, plasticity, and maintenance although there are other 
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secretory tissues that have unusual zinc requirements that set them apart from other cells 
such as prostate, pancreas, and mammary gland tissues. 
The pancreas is an organ with multiple roles within the body involving glucose 
regulation and digestion. Zinc has a critical role in pancreatic cells assisting with 
secretion and signaling of glucagon and insulin packaging [52].  Zinc serves a crucial role 
in α-cells glucagon secretion [53]. ZIP-1, ZIP-10, and ZIP-14 channels are all expressed 
on the plasma membrane of the α-cells serving as a mechanism to bring zinc into the 
cytoplasm of the cell [54]. What can occur is zinc when imported into the cell via these 
ZIP channels can then bind to the ATP-K+ channel activating the channel allowing the 
efflux of zinc and potassium. The zinc blocks depolarization (hyperpolarizing the cell) 
preventing voltage gated calcium channels from opening and releasing glucagon [54, 55]. 
The zinc can inhibit the release of glucagon consequently affecting glucose metabolism. 
The zinc acts as a signaling molecule in this system being released from β-cells which 
also are heavily dependent on zinc too. β-cells will import zinc through the ZIP-4 channel 
on the plasma membrane and condense the zinc into vesicles containing insulin using the 
ZnT8 zinc transporter [56]. Zinc is imported into the insulin vesicles because zinc is a 
required structural component of insulin granules. Two zinc ions will bind to two insulin 
dimers which will then be combined with an additional insulin dimer forming a 
hexameric unit requiring zinc as a structural component [57]. Once these insulin 
containing vesicles release the insulin hexamers in response to glucose the zinc can 
dissociate from the insulin hexamer as the hexamer breaks apart into individual insulin 
subunits allowing zinc to be imported into the α-cells preventing glucagon secretion [52]. 
Zinc has a fundamental role in pancreatic cells being required for the biogenesis of 
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insulin as a structural component of insulin, in addition zinc is of paramount importance 
as a signaling molecule in the regulation of blood glucose levels by monitoring glucagon 
release (increasing blood glucose) and insulin formation (decreasing blood glucose). 
While zinc is essential for maintenance of proper blood glucose the soft tissue with 
the highest zinc concentration is the prostate tissue, containing more than 3 times higher 
zinc than any other tissue [52, 58]. The prostate cells are unique unlike any other cells 
where zinc is typically sequestered into compartments, prostate cells have over 35% of 
their total zinc in the cytosol [52]. The zinc remains loosely bound to small molecules 
mainly citrate leaving the zinc still biologically active (available to bind zinc sites) [58]. 
How the prostate cells accomplish maintaining high concentrations of cytosolic zinc is by 
inhibiting the Krebs cycle enzyme m-aconitase responsible for the oxidation of citrate in 
the Kreb’s cycle [59]. This promotes the accumulation of cytosolic citrate allowing 
citrate to be available to coordinate free zinc ions. The justification for the prostate 
containing high concentrations of zinc is to maintain sperm motility [60] and release [61], 
and zincs antimicrobial ability [62]. Zincs importance in prostate cells is so pronounced 
that lowered zinc concentrations lead to decreased fertility [63] and prostate cancer [52]. 
Zinc concentrations in the prostate tend to decrease with age which result in lower 
fertility rates of men [63] a result of decreased sperm motility. The decreased zinc also 
tends towards higher likelihood of prostate cancer [52]. The production of prostate cancer 
results from the decreased zinc no longer inhibiting the aconitase enzyme boosting the 
mitochondrial metabolism in these cells [42]. Increased mitochondrial function increases 
reactive oxygen species contributing to oxidative stress damaging DNA which increases 
the probability of a cancerous mutation [64, 65]. Zinc is the central component for 
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functioning prostate cells, a tissue that is imperative for reproduction a process universal 
to all living organisms. 
While zinc is required for the male reproductive system, zinc is also required for 
mammary gland function in the female reproductive system. Zinc is imperative for 
mammary gland function and tissue remodeling during pregnancy and lactation. The 
mammary gland is a dynamic secretory tissue that remodels both structurally and 
functionally depending largely on zinc signals [52]. The mammary gland is comprised of 
a network of branched structures terminating into acini. The cells lining the acini are 
mammary epithelial cells (MEC) which are the cells responsible for the transfer of 
nutrients into breast milk [52]. MEC can be argued to be the most important cells in 
lactation and uncontested as the most dynamic cells in the mammary gland. The control 
of MEC proliferation, differentiation, and function is essential for functional mammary 
glands. The mammary gland utilizes transcription factor IIIA for proliferation of MEC’s, 
transcription factor IIIA is a protein with a 9 repeat zinc finger domain responsible for all 
cellular RNA transcription [66]. Transcription factor IIIA requires zinc bound to the zinc 
fingers to properly regulate RNA transcription in the cell and can be regulated by changes 
in zinc concentrations [67]. Additional proteins are dependent on zinc interaction for 
proper proliferation of MEC’s such as Zfp289 [68], differentiation LIM-ONLY [69], and 
GATA3 [70]. Expansion of the MEC is highly important in mammary glands during 
lactation to accommodate the production of breast milk for the offspring. Expansion is 
accomplished by the zinc dependent proteins metalloproteinases changing their 
expression in response to lactation or cessation of lactation [71, 72]. All of these proteins 
are sensitive to changes in MEC zinc concentrations where deficient zinc can lead to 
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breast cancer [73] and dysfunctional mammary gland expansion/development or low 
concentrations of zinc in breast milk [74]. As mentioned previously low zinc in youth can 
affect their brain development as well as cause diarrhea and skin conditions [12]. 
Mammary gland tissue is another example of an extremely zinc sensitive tissue. 
There are numerous examples of how zinc is emerging as an important regulator, 
signaling molecule, or structural component for not only cellular processes but 
physiological systems. All of these discoveries hinge on techniques to analyze zinc which 
have improved dramatically over just the last decade. Throughout this manuscript we 
show the importance of developing accurate and sensitive zinc sensors to solve questions 
pertinent to zinc biology. Zinc biology similar to all science is constantly evolving 
revealing the complex interlaced workings of the cell. In this work we discovered zinc 
was not sequestered in the mitochondria if cytosolic zinc concentrations increase to 
potentially deadly concentrations despite previous studies claiming the mitochondria to 
be a sink for unbound zinc. This changes our view how zinc homeostasis is maintained 
evolving our understanding of zinc biology. We furthered our understanding of zinc 
biology upon discovering zinc biology also regulates microtubule-based trafficking a 
mechanism previously thought to be independent of zinc. These discoveries in zinc 
biology would not have been possible without the development of novel zinc sensors 
designed in this work. All of these discoveries have added momentum to the importance 
of zinc being a key component of cell biology. Further details of how zinc is regulated 
and characteristics of biological zinc will be discussed for clarity while discussing zinc 
throughout this work. 
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1.2 ZINC HOMEOSTASIS IN MAMMALIAN CELLS 
The importance of maintaining zinc homeostasis is vital for cell survival as is the case 
with all nutrients, although labile zinc concentrations unlike many other biological metal 
species are extremely small. Despite being the second most abundant heavy metal (after 
iron) in the body, labile zinc concentrations are maintained in the pico molar to low nano 
molar concentrations because the majority of zinc is bound and unavailable to the zinc 
effectors within the cell. The “total zinc” or ZnTotal include both the bound and labile zinc. 
The total zinc concentration has been determined using x-ray fluorescence spectroscopy 
(XRF), atomic absorption spectroscopy (AAS), and inductively coupled plasma mass 
spectroscopy (ICP-MS) to be between 50 and 730 µM [75] while unbound zinc is 
typically ~100 pM in the cell [76-78]. The vast majority of zinc is coordinated to proteins 
within the cell and therefore inaccessible within the cell. Despite the small concentrations 
of unbound zinc, this active form of zinc is affecting a plethora of cellular processes vital 
for life. Total zinc in the cell is estimated to range from 1-300 µM [75, 79, 80] while 
serum concentrations of zinc range from 1-15 µM [81-83]. The concentration of total 
zinc in the cell is approximately 10-100 times more concentrated than the zinc 
concentration outside the cell. There are exceptions such as pancreatic, prostate, and 
mammary gland cells which concentrate zinc into vesicles [52] regardless this shows all 
cells require substantial amounts of zinc. Zinc is buffered to such low concentrations via 
a variety of mechanisms requiring numerous channels, buffering proteins, and 
compartments for the sequestration of zinc. Unbound zinc being at such low 
concentrations was a major contributor to why zinc was originally interpreted to not be as 
biologically significant as other ions i.e. calcium. Although this logic was only a 
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consequence of lacking the techniques and tools necessary to accurately measure zinc 
ions at such low concentrations. To drive the progression and understanding of zinc 
biology sensitive and accurate tools are essential to monitor zinc at such low 
concentrations, without these tools the field of zinc biology will be unable to advance.  
Maintaining proper zinc concentrations in the cell is a complex endeavor with 
numerous proteins responsible for the maintenance of zinc concentrations. Zinc in the 
cytoplasm is present at very minute concentrations typically on the order of pico molar 
(10-12 M) concentrations [76, 77, 84], although due to elaborate mechanisms the cells can 
raise the concentration of zinc to the hundreds of micro molar (10-6) concentrations for 
example in zinc vesicles at the synapses and when released into the synaptic cleft [85, 
86]. These vast concentration differences in zinc are observable in different 
compartments of the cell by FluoZin-3 AM staining showing punctate structures 
containing high zinc for example in insulin secretory granules and hippocampal and 
cortical neurons synaptic vesicles [87]. These reservoirs of zinc are also found in 
organelles such as the lysosomes [88] reported as having significantly higher zinc 
concentrations than cytosolic concentrations.  
Besides the above mentioned transporters of zinc there are proteins that store zinc 
called metallothionien proteins. There are four isoforms of metallothionien in the body 
MT-I and MT-II are expressed in a multitude of tissues throughout the body, MT-III is 
found exclusively in the brain [89], and MT-IV is found exclusively in stratified 
squamous epithelium [90]. MT-III is specifically found in neurons that sequester zinc 
into zinc vesicles. Metallothionien proteins bind up to seven zinc ions through sulfur 
bonds from cysteine's [91] with a high affinity (kd = 1.4 x 10
-13 M) [92]. Metallothioniens 
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act as reservoirs of zinc for the cells that can buffer zinc concentrations by releasing or 
storing excess zinc. These proteins release zinc through oxidation of cysteines creating a 
disulfide bridge which releases the coordinated zinc. Zinc is released by oxidation due to 
the high affinity cysteine has for binding zinc ions. Oxidation is facilitated by glutathione 
which can oxidize the metallothionien cysteines and release zinc [92]. The 
metallothioniens perform the function of an intracellular zinc pool gathering up excess 
zinc to prevent zinc neurotoxicity while also releasing zinc when necessary. 
Metallothionien have been shown to regulate zinc concentrations through redox 
environments. If exposed to an oxidizing environment the metallothionien will release 
zinc and vice-versa if exposed to a reducing environment. Metallothioniens can 
dramatically affect the concentration and thus the homeostasis of zinc within the cells.  
 While metallothionien proteins provide a buffering system for zinc another 
mechanism the cell has to regulate zinc homeostasis is through sequestration of zinc. Zinc 
is sequestered into compartments with high zinc for example lysosomes or vesicles to 
expel zinc from the cell to the extracellular environment. Sequestration of zinc affords the 
cell a mechanism to maintain zinc homeostasis when zinc concentrations exceed zinc 
buffering capabilities. The major group of proteins responsible for zinc homeostasis in 
the cells are zinc transporters split into two families solute carrier 30 (SLC30, ZnT, Zinc 
Transporters) proteins and solute carrier 39A (SLC39A, ZIP, Zinc-Iron Permease) 
proteins. There are other proteins that are believed to transport zinc however these 
proteins are less studied and not well understood. ZnT and ZIP proteins are found in all 
mammalian cells and have been found to be expressed or redistributed based on stimuli 
(i.e. changes in zinc concentrations) to maintain zinc homeostasis. 
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ZnT’s function is the efflux of zinc out of the cell cytoplasm to the extracellular 
environment or into intracellular compartments (i.e. lysosomes, vesicles). There are 10 
ZnT’s that are encoded in the human genome localizing on specific organelles. The ZnT's 
have been found to be a zinc proton exchanger stabilizing the pH of the cells. The zinc 
import proteins are coupled to proton or carbonate ion gradients contributing to both pH 
and zinc homeostasis. Following excitotoxicity or increased levels of nitric oxide a 
known second messenger to release zinc ZnT expression was increased, suggesting the 
protein may be shuttling zinc away from the neuron to decrease cell injury [93]. The 
structure of mammalian ZnT has been determined although the exact mechanism of zinc 
transport is still not understood. Mammalian ZnT proteins typically have 6 
transmembrane domains with the N and C termini on the cytosolic side of the membrane. 
The loop in between the fourth and fifth transmembrane domain is rich in serine and 
histidine residues and believed to be the location where zinc interacts and can be 
transported through the channel. The C-terminal tail is also a potential zinc interaction 
site where it also could potentially act as a site for dimerization. No mammalian ZnT 
protein structures have been determined although an E. Coli Yiip protein was published 
in 2007 clearly showing zinc interacts on the cytosolic interface and the transmembrane 
domains [94]. 
ZIP proteins perform the opposite function of ZnT proteins by allowing the influx 
zinc into the cytosol of the cell from the extracellular fluid or from vesicles [95]. There 
are 14 ZIPs encoded in the human genome. These zinc transporters are found within the 
cell membrane and throughout the organelles. These transport proteins are responsible for 
the majority of the zinc buffering occurring within the cell by sequestering zinc or 
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increasing the zinc concentrations. ZIP protein structures have been determined but again 
the exact mechanism of how zinc is transported through the channel and the channel 
regulation are still not known. ZIP proteins have 8 transmembrane domains with the N 
and C termini on the non-cytosolic side of the channel. The loop between the 
transmembrane domains 3 and 4 is rich in histidine residues and is believed to be the 
interaction site for zinc. ZIPs function by a symport mechanism Zn2+-(HCO3)2 that is 
independent of ATP and driven by the concentration gradients of the ions [96]. 
These two families of zinc transporters, ZIP’s and ZnT’s, are responsible for the 
transport of zinc into or out of the cell to maintain zinc homeostasis if the zinc buffering 
mechanisms are overloaded. Other channels contribute to zinc homeostasis although 
these two families are the most extensively studied and show the most robust response to 
maintain zinc homeostasis. There are many routes found for zinc to enter or exit the cells 
to buffer the cellular concentration of zinc such as NMDA (N-methyl-D-aspartate) [97], 
voltage gated calcium channels (VGCC) [54], GluR2-lacking AMPA(Alpha-amino-3-
hydroxy-5-methyl-4-isoxazole propionoic acid receptors (AMPARCa-Zn) channels [98], 
and ZIP or zinc importing proteins, and Zinc transporters (ZnT's) [99]. NMDA, VGCC, 
and AMPA receptors will be discussed in further detail in chapter 3. Zinc buffering 
proteins such as metallothionien buffer intracellular unbound zinc by several orders of 
magnitude compared to total zinc concentration. The cell utilizes a variety of proteins to 
maintain labile zinc within a tight concentration range. 
Aside from buffering zinc with metallothionien proteins and the sequestration of zinc 
through the use of ZIP and ZnT channels the majority of cellular zinc is bound to 
proteins. This bound zinc has been shown to be a structural component to thousands of 
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proteins and a cofactor for hundreds of proteins. Zinc fingers are a common structure in 
cells typically containing 20-40 amino acids stabilized by a zinc ion. These structures are 
required for many sequence specific binding of transcription factors to DNA, protein-
RNA, and protein-protein interactions. Our understanding of zinc required structures is 
expanding rapidly but still not well understood and many of our presumptions about zinc 
binding are based on previously known zinc binding sites perhaps eliminating novel zinc 
binding sites. Many of these proteins can be present at high concentrations such as 
carbonic anhydrase in red blood cells being in the micro molar range and requiring zinc 
to act as a Lewis acid to catalyze the conversion of carbon dioxide to bicarbonate [100]. 
Zinc also binds other amino acids such as cysteines and glutathione as previously 
mentioned which are present in mili molar concentrations in cells likely meaning almost 
all zinc will be bound to protein. This provides adequate binding sites for all the zinc in 
the cell to be bound, leading to changes in unbound zinc through changes in the 
occupancy of bound zinc. Detecting these zinc dynamics in the cells is pivotal to the 
advancement of zinc biology to understand how zinc is changing and coordinating 
cellular functions. An in depth description of biological zinc is necessary to understand 
the zinc biology discussed further in this work. 
1.3 BIOLOGICAL INORGANIC CHEMISTRY OF LABILE ZINC 
Understanding what exactly biological zinc is at a chemical level is key to understand 
how zinc functions in biology. When we discuss unbound zinc this is misleading and not 
necessarily true. Zinc in a biological environment will always be “bound” by ligands 
even if not coordinated by proteins (i.e. water, hydroxide, chloride, etc.) although our 
interpretation is if the zinc is free to interact with protein ligands the zinc is “unbound”. 
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Semantics such as these will be teased out in further detail in this section. We will focus 
on elucidating the chemistry of biological zinc. 
Biological zinc can be coordinated with oxygen, nitrogen, or sulfur donors which are 
the side chains of the amino acids cysteine, aspartate, glutamate, and histidine. Common 
zinc binding domains include Cys4, Cys2His2 for zinc fingers [1] one of the most 
common zinc binding domains. Figure 1A shows the zinc coordination site for ZAP1 
transcription factor utilizing the Cys2His2 for zinc coordination (Figure 1C) [101]. Figure 
1B shows another common coordination of zinc ions for zinc fingers, Cys4 (Figure 1D), 
from a RNA regulator DksA zinc finger [102]. Many other examples exist although zinc 
fingers are among the best studied zinc coordination sites and will serve a large role later 
in this work. Any protein with these amino acids (Nitrogen, Sulfur, or Oxygen) has the 
potential to coordinate zinc via 3-6 coordination sites on zinc. Although these amino 
acids must be structurally close to be able to coordinate the zinc ion. In addition small 
perturbations in the protein environment can alter the ability of amino acids such as 
cysteine with a pKa close to physiological pH from coordinating zinc [103, 104]. When 
cysteine’s thiol group is protonated the thiol group will not coordinate zinc although once 
the pH exceeds pKa of the thiol group (~8) the sulfur loses the proton and the electrons 
can then coordinate zinc. The large flexibility of coordination geometries (3-6 




Figure 1: Zinc Finger Coordination of Zinc Ions. (A) ZAP1 transcription factor 
coordination of zinc ions. Two zinc fingers coordinating two zinc ions using two 
histidine’s and two cysteines. Structure derived from PDB 1ZW8 [101]. (B) Zinc finger 
from RNA regulator DksA utilizing four cysteines to coordinate a zinc ion [102]. (C) 
Cys2His2 zinc coordination site. (D) Cys4 zinc coordination site. 
The lack of ligand field stabilization allows biological zinc to flexibly coordinate 
using multiple geometries to permit zinc to coordinate a diverse range of coordination 
sites [80]. The d-block of zinc in the 2+ oxidation state is completely full preventing 
changes in the degenerate barycenter electrons (i.e. being more stable than other 
degeneracies) produced when anion ligands coordinate with the d-orbitals. As a ligand 
approaches the metal ion (Zn2+), the electrons from the ligand will be closer to some of 
the d-orbitals and farther away from others, causing a loss of degeneracy. This can be 
observed in Figure 2 where the free zinc ion energy state is the most stable and as the 
ligands coordinate zinc the energy is increased to the “barycenter” higher energy state. 
The electrons in the d-orbitals and those in the ligand repel each other due to repulsion 
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between like charges.  Thus the d-electrons closer to the ligands will have a higher energy 
than those further away which results in the d-orbitals splitting in energy. Coordination of 
ligands will change the degenerate electrons energy state depending on the most stable 
coordination for the electrons. This is accomplished by placing the majority of the 
electrons into lower energy states compared to the barycenter which will stabilize the 
electrons when coordinated with ligands (i.e. t2g and t2 energy states, Figure 2). Although 
in the case of zinc the full d shell is never stabilized further than the barycenter no matter 
which coordination geometry (number) is used, see Figure 2 for example comparison 
between octahedral and tetrahedral coordination states. The eg and t2g orbitals will always 
cancel each other out regardless of the coordination number dissolving any stabilization 
different coordination geometries may offer making the barycenter energy state the most 
stable, see the crystal field stabilization energy equation in Figure 2 [105, 106]. This 
increases the catalytic prowess of biological zinc for proteins due to the variety of 
coordination geometries that can stabilize the zinc ion. Zinc-ligand bonds utilize the 4s 
electron shell with the full d-orbital which causes the zinc ion to become sterochemically 
inactive promoting flexibility in coordination number unlike other biological transition 
metals. This combined with the fast kinetics for ligand exchange are characteristics that 
make zinc well suited for signaling on biological time scales and to serve as a second 
messenger in biological systems in response to external stimuli. 
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Figure 2: Ligand Field Stabilization Energy. Two examples of ligand field 
stabilization energy diagrams are shown for tetrahedral and octahedral geometry. 
Although the same stabilization is observed for all geometries for zinc in the 2+ oxidation 
state. 
Another unique characteristic of biological zinc is that it remains in the 2+ oxidation 
state for all biological redox potentials and pH changes unlike any other metal in the cell. 
This can be viewed from a Pourbaix diagram of the speciation of zinc under biological 
redox (-670-820 mV) and pH conditions (0-9) [80]. The inert nature of biological zinc 
enables zinc to have a flexible coordination number by restricting zinc to the 2+ oxidation 
state. Whenever referring to zinc it will be zinc in the 2+ oxidation state not Zn (s) with 
no oxidation state as is the common jargon with chemists. 
Although the O, N, or S atoms coordinate directly with the zinc ion and are 
commonly considered the major zinc binding sites there are always secondary 
coordination spheres created by hydrogen bonding of ligands such as water. Secondary 
coordination spheres create pockets of variable dielectric constants which contribute to 
zinc binding sometimes more than the atoms forming the first coordination sphere for 
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example with zinc hooks where the zinc affinity is increased to femto molar affinity 
[107]. Hydrogen bonds, electrostatic and hydrophobic interactions all contribute to the 
exchange kinetics of bound zinc ions which has been documented in zinc fingers [108]. 
These secondary coordination spheres are not always obvious and many times they occur 
from intra and inter molecular interactions causing changes in the zinc binding site 
affinity. The biological coordination of zinc has been catalogued extensively although is 
still not well explored. 
Unbound zinc is what the focus of this dissertation will be. Unbound zinc is also 
referred to as labile zinc or free zinc or mobile zinc or fast-exchange zinc, this form of 
zinc is the zinc that can interact with macromolecules. Free zinc is an ion that is buffered 
to low pico molar concentrations in the cell and available to interact. The different 
mechanisms have been presented for buffering free zinc in the cell although how 
precisely do these proteins buffer zinc? Zinc buffering is due to the zinc binding 
sites/proteins having dissociation constants for zinc in the nano molar and pico molar 
range which bind up any available zinc forcing the concentrations in the range of these 
dissociation constants. The buffering system will prevent the zinc from increasing or 
decreasing outside this range in the same fashion pH buffers perform this function on 
hydronium and hydroxide ions. The Henderson-Hasselbalch equation can be used 
analogously with the conjugate base and acid being replaced with the protein and zinc 
bound protein respectively. Zinc coordinates to proteins better than any other divalent 
cation with the exception of copper following the Irving-Williams series (Cu(I) > Zn(II) 
> Ni(II) > Co(II) > Fe(II) > Mn(II) > Mg(II) > Ca(II)) [109]. This is due to lack of 
specificity for metals at binding sites. The lack of metal specificity at binding sites would 
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cause copper and zinc to dominate all the metal binding sites outcompeting any other 
metal, although this issue is overcome by buffering the different metals to different 
concentrations [110]. For example total zinc concentrations are approximately 200 µM 
while free zinc is around 100 pM. That is 6 orders of magnitude lower or only 0.00005% 
of zinc is in the free form. The equilibrium of zinc ions and a zinc binding protein lies 
almost entirely to the left with zinc bound to protein shown in equation 1 below. 
ZnP        P + [Zn2+]  (1) 
The concentrations of the metals within the cell are opposite the binding affinity with 
zinc having very low concentrations within the cell (10-12 M) and magnesium having 
higher concentrations (10-3 M) allowing the magnesium to bind to “magnesium binding 
sites” and zinc to bind to “zinc binding sites” [110]. This balance is phenomenal in that 
all zinc enzymes must be bound to zinc while not allowing labile zinc concentrations to 
exceed pico molar concentrations causing toxicity. Furthermore labile zinc is often 
interpreted as a zinc ion with no ligands bound or all coordination’s are water forming an 
aquo complex. Although zinc is not always bound to all water ligands there are numerous 
light molecular weight (LMW) ligands both organic and inorganic anions present zinc is 
bound to many different LMW ligands. These LMW ligands can be displaced by other 
macromolecules that have higher binding affinities for zinc such as the amino acids 
cysteine, glutamate, aspartate, and histidine [80]. When referring to free zinc this zinc ion 
is actually bound to a variety of LMW ligands with multiple different coordination 
geometries. These different zinc species become important when trying to understand the 
zinc dynamics occurring in cells by designing zinc probes that are free zinc sensing and 
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not being selective to some free zinc ions that contain or do not contain certain LMW 
ligands. 
Measurements of free zinc is at the heart of this work using reporters called 
fluorescent sensors. Free zinc concentrations have been recorded since 1971 [111] 
although many improvements have been made producing far more accurate zinc 
measurements since then with the advent of acetoxymethyl (AM) esters being 
incorporated into small molecule probes in 1981 [112] to the advancement of genetically 
encoded zinc sensors taking off in the last decade. Fluorescent sensors can bind free zinc 
offering a quantitative measurement of free zinc. Although many techniques can be 
utilized to analyze free zinc, fluorescent probes and fluorescent microscopy is the most 
heavily utilized method. Throughout the entirety of this work “zinc” will be referring to 
the free/labile/exchangeable form of zinc ions in the 2+ oxidation state. Further work 




CHAPTER TWO:  ZINC SENSOR DESIGN AND OPTIMIZATION 
2.1 INTRODUCTION 
Zinc biology is rapidly becoming an integral part of numerous cellular processes upon 
each new discovery although each discovery requires the proper tools to study biological 
zinc. The scientific communities’ recent desire to further elucidate the role of zinc in 
these essential cellular functions has driven the development of fluorescent zinc sensors 
in the past decade. Zinc sensors are still in their infancy especially when compared to 
calcium sensors which have been developed for over 50 years. Small molecule probes 
such as Quin2 developed by Roger Tsien [113] and genetically encoded sensors such as 
GCaMP[114] and GGECO[115] sensors have been improved and optimized for decades. 
Calcium has been a focal point of biological metal research for decades while zinc has 
been dismissed mainly due to the extremely small physiological concentrations of zinc 
relative to other biological metals. Low concentrations of zinc made zinc effectively 
invisible to early researchers who focused on calcium. Labile zinc concentrations in the 
cytosol of the cell are ~100 pM [84] compared to cytosolic calcium concentrations of 100 
nM [116], a 1000 fold difference between the concentrations of these two ions. This 
creates a challenge when designing a sensor to be sensitive enough to detect low 
concentrations of zinc while also remaining specific for zinc. This opened the door to 
focus on creating zinc sensors that are sensitive enough to pick up zinc dynamics 
occurring at physiological concentrations both spatially and temporally.
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Two different approaches for metal sensor development have resulted in the 
establishment of small molecule probes and genetically encoded sensors. While both 
sensors have their distinct advantages, genetically expressed zinc sensors demonstrate 
advantages in studying the physiological functions of zinc in living cells due to the ability 
to control the spatial expression of sensors within specific cellular compartments using 
various molecular tags. These molecular tags offer a plethora of ways to tag a fluorescent 
protein to any location within a cell, refer to Figure 3 for examples of the multitude of 
subcellular localizations possible. Genetically encoded sensors are composed of proteins 
which the cell will assemble after receiving the DNA sequence via transfection. This 
allows the cell to make the genetically encoded sensor and localize the sensor using the 
same machinery the cell uses to localize any protein to a location within the cell. Small 
molecule probes however cannot be localized to specific locations with nearly the 
specificity or breadth of locations genetically encoded sensors are capable of. One 
method small molecule probes rely on is utilizing organelles with a charge potential such 
as the mitochondria and designing the probe to be oppositely charged creating an 
electrostatic attraction localizing the majority of small molecule probes to this location 
for example the mitochondrial probes tetramethyl rhodamine methyl ester (TMRM) [117] 
and tetramethyl rhodamine ethyl ester (TMRE) [118] and the small molecule zinc probe 
Rhodzin-3 [119]. Small molecule probes are limited in the mechanisms to localize them 
to specific locations within a cell making it difficult to analyze specific locations within 
cells. In addition small molecule probes that are designed to localize to a specific 
subcellular location still suffer from high background noise due to non-localized small 
molecule probes. Besides the issue of localizing small molecule probes these probes 
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suffer from loading the small molecule probe into the cell causing the sensor to bind free 
metal ions. This rapid chelation of metal ions alters the physiological concentrations of 
metal ions believed to create artifacts when studying physiological metal dynamics [120, 
121]. These two issues can be overcome by using a genetically encoded sensor. 
Genetically encoded zinc sensors are designed using various metal sensing domains for 
zinc including zinc finger 1 (ZF1) and zinc finger 2 (ZF2) from the Zap1 transcription 
factor of S. cerevisiae for the ZapCY, ZapCmR and GZnP sensors [78, 122-124], Atox1 
and the fourth domain of ATP7B (WD4) for the eCALWY sensors [125, 126], and 
simple metal coordinating amino acids (Cysteine and Histidine) introduced at the 
dimerization interface between the two chromophores in eZinCh sensors [127, 128]. One 
characteristic that should always be considered when using genetically encoded sensors is 
their susceptibility to pH changes. These sensors are extremely sensitive to pH changes 
because the amino acids that compose the sensor are susceptible to pH changes. Changes 
in pH can quickly quench or increase fluorescence signals which must be accounted for 
to prevent misinterpretations of the sensor signal. 
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Figure 3: Subcellular targeting of genetically encoded zinc sensors. (A) Nucleus 
localization of NLS-ZapCY1 in HeLa cell. (B) ER localization of ER-ZapCY in HeLa 
Cells. (C) Mitochondrial localization of mito-GZnP1 in HeLa Cells. (D) Cytosol 
localization in NES-ZapCV2 in HeLa Cells. (E) Interior localization to plasma membrane 
using lck-GZnP1 in HeLa Cells. (F) Exterior localization to plasma membrane using 
pDisplayGZnP1 in Ins-1 Cells. (G) Post synaptic localization of PSD95-GZnP1 in 
primary hippocampal neurons. (H) Pre synaptic localization of synaphysin-GZnP1 
(unpublished) primary hippocampal neurons. 
Two types of genetically encoded sensors have been developed using this concept of 
metal sensing domains: FRET based (ratiometric) and single fluorescent protein based 
(intensiometric) sensors. The FRET (Förster Resonance Energy Transfer) based sensor 
relies on fluorescent resonance energy transfer between two different fluorescent proteins 
(FP) to indicate if the sensor is bound or unbound to the metal ion. The two different FP 
chromophores are both specific and unique to each other based on their emission and 
excitation wavelengths. The donor will be excited then the donor emission fluorescence 
needs to closely match the excitation wavelength of the acceptor chromophore. In 
addition the acceptor will only be excited if the donor chromophore is close to each other 
physically (1-10 nm) allowing the emission light to act as excitation light on the acceptor 
chromophore. The zinc induced conformational changes in ZF1 and ZF2 can bring the 
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donor and acceptor fluorescent proteins closer to each other, resulting in increased FRET 
(Figure 4A). One pro to using FRET sensors is they do not depend on the sensor 
concentration or thickness of the sample due to the spectral shift in wavelengths allowing 
these sensors to be normalized for quantification of free metal ions. The total number of 
FRET sensors will be known in the sample by measuring both the donor and acceptor 
fluorescence. Some of the limitations to a FRET based sensor is the need for the 
combination of two different excitation and emission filters for image acquisition, 
spectral bleed through if using other sensors, and smaller dynamic ranges correlating to 
lower sensitivity to the metal ion of interest. FRET sensors are typically better for the 
quantification of metal ions due to their indifference of cell expression and thickness. 
 
Figure 4: Sensor design for ratiometric and intensiometric sensors. (A) Schematic of a 
FRET sensor design. The FRET/ratiometric sensor is composed of two separate 
fluorescent proteins bound via ZF1and ZF2.  Upon binding zinc, the conformation 
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changes of ZF1 and ZF2 brought the donor and acceptor fluorescent protein close 
together. (B) Schematic of a single fluorescent protein sensor design.  The intensiometric 
sensor is designed by attaching a pair of zinc fingers to circularly permuted GFP 
(cpGFP). Zinc induced conformational change protects the cpGFP fluorophore from 
solvent attack, resulting in increased fluorescence. 
The following is the structural and mechanistic description of the Green Zinc Probe 
(GZnP) [78], the sensor optimized and developed for the remainder of this chapter refer 
to Figure 5. GZnP is a single fluorescent protein based zinc sensor that utilizes one 
chromophore and detects changes in the metal ion concentrations based on changes in the 
fluorescent sensor intensity (AKA an intensiometric sensor). This chapter focuses on the 
optimization and design of genetically encoded zinc sensors designed using zinc fingers 
derived from the Zap1 transcription factor of Saccharomyces Cerevisiae (Residues 575 to 
643) [78] linked to the N and C termini of circularly permuted GFP. The first two zinc 
fingers from transcription factor Zap1 (ZF1 and ZF2) have been shown to confer major 
conformational changes in response to zinc. Prior to binding zinc, the ZF1 and ZF2 
domains are un-structured linear strings of protein, after binding zinc there is a 
conformation change in the zinc fingers, resulting in a finger-finger interaction complex 
and the linear strings of amino acids form into structured alpha helices [129]. The ZAP1 
transcription factor ZF1 & 2 was found to exhibit a robust response to zinc binding in 
FRET sensors [122] which was perfectly suited for a similar role in the design of an 
intensiometric zinc sensor. The zinc fingers are specific to zinc allowing the metal sensor 
to be specific to zinc ions given the physiological concentrations of other metal ions. 
Copper II for example is the only metal that could potentially compete with zinc for 
binding of the zinc sensor [80, 109] although labile copper II in the cell is in femto molar 
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concentrations ([Cu2+]= ~0) [130] therefore the sensor will show high selective response 
to biological zinc. 
 
Figure 5: Structure and Schematic Mechanism of GZnP Fluorescence. ZAP1 zinc 
fingers derived structure derived from PDB 1ZW8 [101]. CpGFP structure derived from 
PDB 3SG3 [131]. 
The circularly permuted GFP is constructed by linking the original GFP N and C 
termini together using 6 amino acids translocating the new N and C termini to the middle 
of the 7th β-strand of the 11-stranded β-barrel, exposing the side of the β-barrel bordering 
the phenolate oxygen of the GFP chromophore [132]. We used enhanced GFP (eGFP) a 
variant of GFP that was designed to enhance the original GFPs photophysical properties 
i.e. increased brightness, lower photo bleaching, etc.[133]. Enhanced GFP is the most 
commonly used variant of GFP for current research making the original GFP obsolete 
due to these photophysical improvements. In addition the super folding GFP mutations 
were incorporated to allow the GFP protein to properly fold to a mature protein and 
prevent misfolding of the sensor when expressed in cells [134]. The GZnP sensors 
display the turn on effect zinc has on the sensor either increasing or decreasing in sensor 
brightness in relation to zinc concentrations (Figure 5). The change in fluorescence of the 
zinc sensor results from a change in the protonation equilibrium of the chromophore 
between an anionic and neutral state [132, 135, 136], changes in the chromophore pKa 
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[137, 138], and structural changes in the zinc fingers that shield the exposed 7th β-strand 
of the β-barrel protecting the chromophore from solvent interactions [131, 137, 138]. 
The above mentioned factors that affect the sensor fluorescence will cause a change 
in both the quantum yield and the molar absorption coefficient of the sensor. The 
extinction coefficient is the molar absorption coefficient of a single photon sensor. The 
extinction coefficient is the efficiency of the sensor to absorb photons at the excitation 
wavelength the higher the efficiency of the sensor to absorb photons the higher chance 
the sensor has to release these bound photons as fluorescence [139]. The quantum yield is 
the sensors ability to convert absorbed photons to fluorescence and not release the energy 
non-radiatively. Both of these biophysical characteristics are either enhanced or 
diminished depending on the changes occurring for the sensor. 
The mechanism for the biophysical changes of the GZnP sensor can be interpreted 
from studies performed on GCaMP sensors a calcium sensor using a similar mechanism 
for sensing calcium. The difference between the GZnP sensor and the GCaMP sensors 
are the GZnP sensor uses zinc fingers instead of the calmodulin and M13 domains used 
for GCaMP sensors, although the same biophysical principals apply to both sensors. The 
mechanism of the sensor is more complicated than simply a dim and bright state for the 
sensor. The sensor can be in a metal-saturated or metal-free state and the chromophore 
can be in a neutral or deprotonated (anionic) state. This offers four different states the 
sensor can be in all of which change the excitation wavelength of the sensor [132]. All of 
these different states have vastly different absorption (excitation) spectrums although the 
reason for exciting at 488 nm is due to the state that absorbs at this wavelength has the 
maximum fluorescence. The anionic state of the chromophore has the highest 
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fluorescence and dominates the emission spectrum which is why this state is what we 
target by exciting at the well-known 488 nm wavelength due to the anionic excited states 
for zinc-free and zinc-saturated states are 504 nm and 497 nm respectively [132]. The red 
shifted absorption of the original GFP chromophore (from ~400 nm to 488 nm) is due to 
mutations in eGFP which alter the stabilization of the phenolate oxygen. The phenolate 
oxygen is stabilized by two amino acids (T203 & H148) and a water molecule in eGFP 
and in the cpeGFP the phenolate oxygen is coordinated by two water molecules which 
result in a red shift of the chromophore emission [138, 140, 141]. The changes between 
the zinc bound and zinc saturated sensor excitation peaks results from changes in the 
local electric field surrounding the chromophore [140]. 
Two states of the chromophore exist the anionic and neutral states, both are excitable 
at different excitation wavelengths. The reason for the majority of the emission 
fluorescence occurring at ~515 nm is due to the anionic species of the chromophore being 
the dominate emission state. The anionic chromophore will emit at 515 nm and any of the 
neutral state chromophore that is excited will be converted to an anionic chromophore 
although in an unrelaxed state (slightly different from the true anionic state) through 
electron stabilization proton transfer (ESPT). The ESPT will occur rapidly following 
excitation of the neutral state chromophore converting the chromophore to the anionic 
state. ESPT occurs due to the tyrosyl group of the chromophore transferring a proton to a 
nearby proton acceptor generating the deprotonated chromophore or the anionic state 
[141]. The ESPT emission is the same as the anionic state emission although the 
structures of the chromophores are slightly different with the ESPT state. The hydrogen 
bonding network for the ESPT state is altered compared to the anionic state with phenolic 
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proton being released to form the anionic state but the phenolic oxygen is only stabilized 
by one hydrogen bond. The anionic state has slightly altered geometries by rotations of 
nearby key amino acids to form hydrogen bonds with the phenolic oxygen stabilizing the 
deprotonated chromophore ~3.8 kJmol-1 compared to the ESPT state [142]. This is why 
the ESPT anionic state is referred to as unrelaxed and the true anionic state is relaxed 
although both when excited at 488 nm will fluoresce at 515 nm. 
Another factor that changes the fluorescence of the zinc saturated and the zinc free 
state of the sensor is the change in the protein pKa. The pKa of the sensor will decrease 
upon binding zinc this decreased pKa will result in an increased brightness of the sensor 
[132]. Why this is occurring is the sensor will increase in brightness as the pH is 
increased due to the anionic state of the chromophore being more favorable (compared to 
the neutral state) resulting in higher fluorescence. Once reaching a sufficiently high pH 
~11.5 the protein will denature and the fluorescence will decrease [132] although up to 
this inflection point the sensor brightness will continue to increase. If the sensor’s pKa is 
decreased this means that the equilibrium of neutral to anionic chromophore will be 
shifted in favor of the anionic form. Because more chromophores will be present in the 
anionic state there will be increased fluorescence (brightness) of the sensor. When the 
sensor binds zinc the pKa of the zinc sensor will decrease resulting in increased 
brightness of the sensor when bound to zinc. The reason why the pKa changes when the 
zinc is bound is most notably due to changes in the electrostatic potential energies of 
interactions between the chromophore and the surrounding protein [143]. The zinc 
fingers are not the only protein domains that change conformation upon binding zinc, the 
GFP structure will have conformational changes, the most important being the polar 
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amino acids surrounding the chromophore. When these charged amino acids change 
position they change the charge potential of the chromophore which subsequently change 
the pKa of the chromophore [132]. The altered pKa is one of the biggest contributing 
factors to the changes in the observed brightness [132]. 
The last factor that influences the sensors dynamic brightness between the zinc-
saturated and zinc-free state is solvent interactions with the chromophore [137, 144]. 
These solvent interactions will dissipate energy when the chromophore is excited 
allowing the excited electrons to non-radiatively decay to the ground state, diminishing 
the fluorescent signal (Figure 4B). This would occur if the chasm in the 7th β-barrel is 
exposed allowing solvent to interact with the chromophore. The opposite effect can also 
occur if the chasm is “covered up” by the zinc fingers preventing solvent attack allowing 
fluorescent radiative decay to become the primary source of energy release. The excited 
electrons will relax back to the ground state no matter what although the mechanism of 
how they relax is what we hope to control i.e. fluorescence. The solvent (mostly water) 
will hydrogen bond with the chromophore especially the phenolate moiety and 
significantly decrease the quantum yield [132]. 
All three of these biophysical interactions influence the biophysical characteristics of 
the sensor (quantum yield and extinction coefficient) [139] which are the characteristics 
we aimed to optimize in the GZnP sensor. Our zinc sensor development and optimization 
utilizes many techniques previously used to improve calcium sensors such as GCaMPs 
and GGECOs [114, 145]. Many of the techniques used to improve calcium sensors were 
applied due to the zinc sensor having a very similar layout and the techniques used on 
calcium sensors have been proven to work through decades of trial and error. This also 
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illustrates why ZF1 & 2 from Zap1 transcription factor were used, a protein that has the 
ability to significantly change conformation upon binding zinc is requisite to protect or 
expose the chasm in the β barrel, change the sensors pKa, and favor the anionic state of 
the chromophore.  
The GZnP sensor design is an intensiometric sensor which have many advantages 
over ratiometric sensors. An advantage of intensiometric sensors is the flexibility to use 
multiple sensors simultaneously without spectral bleed through. Imaging is simplified by 
requiring only one excitation and emission filter decreasing the complexity of imaging 
compared to FRET sensor designs. Single fluorescent intensiometric sensors typically 
have significantly higher dynamic ranges which directly correlates to more sensitive 
measurements of the metal ions. 
This zinc sensor exhibits all the benefits of an intensiometric genetically encoded 
sensor with tremendous potential for photophysical improvement. The dynamic range, 
kinetics, and brightness were all modified to produce an improved variants of GZnP. In 
this chapter our goal was to improve the photophysical characteristics of the GZnP sensor 
characteristics to design a sensor with a larger dynamic range (higher sensitivity to zinc), 
increased kinetics (faster response to changes in zinc concentrations), and maintain a high 
maximum fluorescence and specificity for zinc ions. Improvement of this sensor was 
necessary due to zinc sensors that were available at the time lacked in their sensitivity to 
changes in zinc concentrations. By improving the GZnP sensor we provided an additional 
tool to study biological zinc. The development of new zinc sensors allows new insights 
into how zinc is modulated within the cells and how zinc regulates processes within the 
cell. Multiple examples are shown in later chapters utilizing the newly designed zinc 
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sensors from this chapter. With the ability to more accurately and precisely measure zinc 
concentrations at specific locations within the cell further progress can be made in 
diseases where zinc could regulate their function.   
2.2 METHOD 
CELL CULTURE MAINTENANCE 
HeLa cells were maintained in high glucose Dulbecco’s Modified Eagle Medium 
(DMEM) with 10% fetal bovine serum (FBS). Cells were kept in a 37 degree Celsius 
VWR incubator at 5% CO2. HeLa cells were passaged once a week until confluency was 
~90% for 15 passages then a new flask of HeLa cells was thawed and used. 
TRANSFECTION 
PEI (polyethyleneimine) transfection reagent was used for the transfection in HeLa 
cells (dissolved to 1 mg/ml in water at pH 7.2 with long-term storage at -20 ˚C, short 
term storage at 4 ˚C). Transfection was performed when the cells were approximately 40-
50% confluent. For each transfection reaction in an imaging dish 3 µl of PEI transfection 
reagent and 1.25 µg of DNA were mixed in 250 µl Opti-MEM. The mixture was 
incubated for a minimum of 25 minutes at room temperature before direct addition to one 
imaging dish containing the cells. The addition was to the surrounding media of the 
imaging dish not to the center. The dish was rocked back and forth gently to thoroughly 
mix the transfection reagents with the cells. 
CHELEX WATER AND HHBSS BUFFER SOLUTION 
HEPES-buffered Hanks Balanced Salt Solution (HHBSS) is a buffer solution used to 
image all the cells. This solution is free of any metals except what is supplemented to the 
buffer. There is no phosphate since phosphate species can chelate zinc precipitating this 
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out of solution. Extensive measures must be taken to prevent zinc contamination to 
imaging buffers due to physiological Zn2+ typically being in the pico molar range. Begin 
by preparing Chelex water (4 g per liter). Add MilliQ water to the Chelex water container 
(contains Chelex beads in the container). Stir the water with the Chelex beads for a 
minimum of 8 hours. Once stirred the Chelex beads can extract all the metal ions from 
the water. Let the solution sit without stirring for 10 minutes to have beads settle at 
bottom of the container. Once settled filter the water using a 0.22 µm vacuum filtration 
system to remove the beads from the water. The Chelex treated water can then be 
transferred to a new container for storage. Use plastic containers because glass have large 
amounts of metal ions embedded into the silica. Wash the plastic containers using the 
following guidelines. The container must be washed with soap, sink water, and then 
rinsed several times with milliQ water. Then the container must be washed 3 times with 
Chelex treated water.   
The HHBSS buffer solution was prepared in the plastic beaker with 800-900ml of 
Chelex water. Add a washed stir bar. Add each of the following chemicals one at a time 
until each one dissolves when moving to the next chemical. CaCl2 0.14 g or 1.26 ml 1M 
CaCl2; KCl 0.4 g; MgCl2*6H2O make 1 M MgCl2 solution add 1.1 ml; NaCl 8 g; D-
Glucose 3 g; HEPES 7.144 g. Once each of the components have been added and 
dissolved check the pH using the pH meter. Be sure that the pH meter is calibrated for 
use. Clean the pH meter off by rinsing and submerging the pH meter in milliQ water. 
Bring the pH up to 7.4. This will likely require at least 2 tablets of solid NaOH and add 
drops of 1M NaOH after the two tablets have completely dissolved. If the pH is 
accidently too basic then use HCl to bring the pH lower. Once the pH is adjusted pour the 
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solution into the plastic graduated cylinder. At this point fill the graduated cylinder up to 
1000 ml using Chelex water. Filter the HHBSS buffer using the 0.45 µM vacuum 
filtration system. This will remove any potential bacteria within the imaging solution that 
could cause the buffer to become contaminated. After filtered transfer to new containers 
prewashed containers using chelex water to rinse them. 
ZINC BUFFER SOLUTIONS 
Below is the protocol to make the different zinc buffer solutions. The protocol was 
adapted from a previous paper designed to create calcium buffers [113] and zinc buffers 
(cite my PNAS paper, which I provide more details about the descriptions of the zinc 
buffer) . 
Zinc buffer Solutions, ~pH 7 
A1: Zn2+/Ca2+/EGTA  B1: Ca2+/EGTA 
A2: Zn2+/Sr2+/EGTA  B2: Sr2+/EGTA 
A3: Zn2+/EGTA  B4: EGTA 
A4: Zn2+/ HEEDTA  B4: HEEDTA 
A0: Zn2+/EDTA  B0: EDTA 
Solution A1 
Weigh out 1.958 g of 99% pure EGTA to equal the 0.1 M concentration in the final 
50 ml solution. This takes into account the purity of the EGTA. This will be 5 mmol of 
the EGTA. Because 5 mmol of EGTA is measured out to make the 0.1 M concentration 
4.5 mmol of ZnCl2 will be measured out to be just below equal concentration to perform 
the titration. 0.625 g of 99% pure zinc chloride was measured out. 0.35 M KOH was 
measured out and the purity accounted for (1.225 g of 85% pure KOH). Mix the above 
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measurements in a 50 ml centrifuge vial with 15 ml of chelex treated water. Heat the 
solution to ~100 degrees Celsius to aid in the dissolving of the solutes. Needs to remain 
between a pH of 6.5-8 for the solution to dissolve adjust the pH using 1 M KOH. Use 
small amounts to change the pH ~20 µl. If water evaporates during dissolving the solutes 
then add additional chelex treated water. Once dissolved the pH titration is performed at 
room temperature. Prepare a 1 M ZnCl2 solution in chelex water (~1 ml) fresh to prevent 
the formation of zinc oxide while dissolved in water. 
At this point on the titration will occur. Record the starting pH of the solution. Add a 
predesignated amount of Zinc to the solution (20 µl thus a known mmol amount) and 
record the change in pH. Write a value of the change in pH over the change in zinc. 
When the ΔpH/ΔZn is half what the initial change was the titration is complete. 
Throughout the titration the pH needs to remain neutral (pH 7-8.5) maintain this via the 1 
M KOH. Transfer the solution to a 50 ml conical vial and rinse the original container 
with chelex to ensure the transfer of everything. Add 10 ml of 1 M CaCl2. Bring the 
volume to 50 ml using chelex treated water. 
Solution B2 
Weigh out 1.958 g of 99% pure EGTA to equal the 0.1 M concentration in the final 
50 ml solution. This takes into account the purity of the EGTA. This will be 5 mmol of 
the EGTA. 0.35 M KOH was measured out and the purity accounted for (1.225g of 85% 
pure KOH). 10 ml of 1 M CaCl2 was added to the solution. Mix the above measurements 
in a 50 ml centrifuge vial with 15 ml of chelex treated water. Heat the solution to ~100 
degrees Celsius to aid in the dissolving of the solutes. Needs to remain at a pH of 7 for 
the solution to dissolve adjust the pH using 1 M KOH. Use small amounts to change the 
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pH ~20 µl. If water evaporates during dissolving the solutes then add additional chelex 
treated water. Transfer the solution to a 50 ml conical vial and rinse the original container 
with chelex to ensure the transfer of everything. Bring the volume to 50 ml using chelex 
treated water. 
This protocol was to make the A1:B1 zinc buffered solutions. For the following 
solutions the same protocol will be used but differing chelators will be used for the A and 
B solutions. 
A2:B2 or 0.1M EGTA/ 0.1M Zn2+/ 0.2M Sr2+ and a 0.1M EGTA/ 0.2M Sr2+ 
A3:B3 or 0.1M EGTA/ 0.1M Zn2+ and a 0.1M EGTA 
A4:B4 or 0.1M HEEDTA/ 0.1M Zn2+ and a 0.1M HEEDTA 
A0:B0 or 0.1M EDTA/ 0.1M Zn2+ and 0.1M EDTA 
Table 1: Zinc Buffer Solutions Concentration at pH 7 
 
MUTAGENESIS PCR REACTION 
Combine all the components shown in table 2 below to make a control and a mutant. 
The control is used to ensure that the mutagenesis worked and it is not parent strand DNA 
that transformed. 


























1 9 2770253.6 1 9 9707.537 1 9 117.3226 1 9 0.183613 1 9 0.003266
2 8 6702864.6 2 8 23826.27 2 8 263.9759 2 8 0.413129 2 8 0.00735
3 7 12199407 3 7 44245.3 3 7 452.5301 3 7 0.708221 3 7 0.012599
4 6 19843103 4 6 74111.49 4 6 703.9357 4 6 1.101676 4 6 0.019599
5 5 30488942 5 5 119084.4 5 5 1055.904 5 5 1.652515 5 5 0.029398
6 4 45382081 6 4 190466.9 6 4 1583.855 6 4 2.478772 6 4 0.044097
7 3 66266116 7 3 314556.7 7 3 2463.775 7 3 3.855868 7 3 0.068596
8 2 95223766 8 2 569710 8 2 4223.614 8 2 6.610059 8 2 0.117593
9 1 134817605 9 1 1337450 9 1 9503.132 9 1 14.87263 9 1 0.264585
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Component Mutagenesis (µl) Control (µl) 
H2O 10.5 21 
10 × pfu buffer  2.5 2.5 
10 mM dNTP 0.5 0.5 
5µM Fwd primer 5 0 
5µM Rev Primer 5 0 
Template DNA (50 ng/µl) 1 1 
Pfu Turbo/Ultra 0.6 0 
 
The temperature cycle for mutagenesis PCR is shown below in Table 3. 
Table 3: Temperature Cycle for Mutagenesis PCR 
Step Temperature Time 
Denaturation 95 ˚C 1 min 
Denaturation 95 ˚C 30 s 
Annealing 55 ˚C 1 min 
Elongation 68 ˚C X min (2 min per kb) 
Repeat To 2  18 cycle 
 
Remove the PCR tubes and cool down using ice for 2 minutes. This is to prevent 
denaturation of the Dpn1 enzyme that will be added next. This enzyme will denature 
DNA that has been methylated, all the PCR product DNA is not methylated meaning 
only parent DNA will be denatured leaving the PCR product. 0.5 µl of Dpn1 is added for 
2 hours at 37 degrees Celsius. 
ELECTROPORATION 
Gather 1 mm electroporation cuvette, ice and ice bucket, Top10 electroporation 
competent cells. Keep the competent cells on the ice even for them to thaw. Add 100 µl 
of the Top10 competent cells to the cuvette and 10 µl of the mutagenesis reaction to the 
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cells. Pipette up and down to mix. Place back on ice. Electroporate the cells and within 
one minute add 250 µl of LB to the cuvette. Keep the cuvette on ice. Incubate on the 
shaker at 250 rpm and 37 degrees Celsius for one hour. Plate 100 µl on agar plate with 
antibiotic and incubate overnight at 37 ˚C. 
GZNP SENSOR DEVELOPMENT 
The zinc sensor GZnP2 was created by cell lysate based screening from sensor 
libraries derived from GZnP1 according to previously described methods for GCaMP and 
GGEC01 sensor development, suggesting that previous work on calcium sensors can 
serve as a model of how to optimize the GZnP sensor [145]. This method uses rational 
design and saturation mutagenesis by picking locations on the sensor to mutate to any 
amino acid and analyzing the sensors photophysical characteristics following the 
mutation and compare to the parent variant. In optimization of GZnP the dynamic range, 
brightness, and kinetics were analyzed. 
To optimize GZnP1 and increase its dynamic range, we created sensor libraries with 
saturation mutagenesis in the linker regions between the zinc binding motif and the 
fluorescent protein (Linker 1 and Linker 2, Figure 6A) as well as the zinc binding 
domains (ZF1 and ZF2). Two amino acids were mutated to any permutation of the 20 
amino acids using primers with two codons mutated to any of the nucleotides and the last 
nucleotide in each codon can only be a guanosine or thymine. A library size of 400 was 
used and 800 colonies of Top10 Escherichia Coli bacterial colonies expressing sensor 
variants were picked and grown in deep well plates. 800 colonies were chosen since there 
were 400 possibilities (202). Colonies were grown in 1 ml of LB and 50 µg/ml of 
ampicillin. The colonies were grown at 37 ˚C and 300 rpm until the OD600 reached 0.5. 
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Sensor expression was induced by addition of 0.2% arabinose. After one to two days of 
growing in the shaker at room temperature, the cells were centrifuged at 2250 g for 20 
minutes then decanted and lysed with BPER buffer with protease inhibitor.  After lysis, 
the cells were centrifuged at 2250 g for 20 minutes. Lysates were collected from bacterial 
cells expressing sensor variants and then were treated with 100 µM of the specific zinc 
chelator N, N, N′, N′-tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) and 130 µM 
buffered zinc separately in 96-well plates. New TCEP was made and added at a working 
concentration of 0.5 mM to each of the lysates to reduce the cysteine thiols allowing for 
binding of zinc. The minimal fluorescence intensities of cell lysates with zinc chelation 
(Fmin) and the maximal fluorescence with zinc saturation (Fmax) were read by a M1000 
Tecan fluorescence plate reader (Ex: 488 nm, Ee: 515 nm, 5 nm emission bandwidth) and 
normalized to the fluorescence before treatment (Figure 6A). Normalize data sets: FTPEN 
= FTPEN treatment / FTPEN no treatment FZn
2+ = FZn
2+ treatment / FZn
2+ no treatment. Calculate 
dynamic range (DR): DR = Fmax / Fmin = F Zn
2+ / FTPEN. The sensor variant with increased 
dynamic range as measured by the ratio between maximal and minimal intensity 
(Fmax/Fmin) or increased brightness as measured by Fmax were further examined by in situ 
characterization and then selected for next round of screening (Figure 6B). A minimum 
increase in the brightness or the dynamic range was set and sensors showing favorable 
photophysical characteristics in the high throughput method were advanced to a medium 
throughput method, in situ analysis. The high throughput method showed only a weak 
correlation between increases in brightness or dynamic range so a medium throughput 
method was implemented to confirm more accurately promising mutants of GZnP. 
43 
The medium throughput method utilizes in situ analysis with HeLa cells. Sensor 
constructs were transfected into cells and imaged 48-72 hours post-transfection.  Imaging 
experiments were performed on a Nikon/Solamere CSUX1 spinning disc microscope.  
Images were collected with a 40× 1.3 NA oil objective and imaging data was acquired 
using the MicroManager software.  The acquisition times were 20 seconds, with exposure 
times of 100 ms and a laser power of 10% by the 488 nm laser and exposure times of 50 
ms and a laser power of 3% by the 561 nm laser.  Cells were imaged in phosphate-free 
HHBSS, pH = 7.4.  For sensor calibration, cells were treated with 100 μM N,N,N′,N′-
tetrakis(2-pyridinylmethyl)-1,2-ethanediamine (TPEN) to give the minimum signal and 
2.5 μM pyrithione and 20 μM ZnCl2 to establish the maximum signal. TPEN is a zinc 
specific chelator that will bind zinc more efficiently than any sensor or known biological 
binding location[146]. Pyrithione is a zinc ionophore which can effectively equilibrate 
the extracellular zinc concentration with the intracellular zinc concentration. 
Imaging analysis was performed by Fiji (Image J) [147]. Every image in an image 
stack was aligned to account for drift using the Stackreg plugin and the Rigid Body 
method in Fiji.  For the quantitative analysis, images of the GZnP mutant were 
background corrected by generating a region of interest (ROI) on a blank area of the 
imaging dish and subtracting the fluorescence intensity, e.g. IGZnP (cell) – IGZnP 
(background).  The background corrected GZnP mutant images were used to calculate the 
normalization intensity.  The calibration of the sensors was plotted in the KaleidaGraph 
program.  The baseline GZnP mutant intensity, minimal intensity achieved with TPEN 
(Imin), and maximal intensity achieved with zinc saturation (Imax) were recorded. All in 
situ sensor calibrations were performed at room temperature (RT).  The dynamic ranges 
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and brightness were recorded for determination if the GZnP mutant was an improvement 
over the previous mutation.   If the mutation improved over the previous mutant this 
mutation was kept and more cycles of high throughput and medium throughput saturation 
mutagenesis was performed. Refer to Figure 6 below for the layout of sensor 
optimization. 
 
Figure 6: Engineering GZnP2 with a higher dynamic range compared to GZnP1. (A) 
Optimize GZnP1 sensors by cell lysate based high throughput screening assays. 
Mutations were introduced into the Zn2+ linker regions to generate several sensor libraries 
by saturation mutagenesis. The sensor library was then screened using cell lysates, high-
throughput assays based on sensor fluorescence read with Zn2+ and the chelator TPEN. A 
cutoff was set shown as the red bar and sensors exceeding this cutoff were chosen for 
medium throughput analysis (B) The in situ response (low throughput method) of the 
selected sensor variant in HeLa cells. Sensor fluorescence was decreased when cells were 
treated with 100 µM TPEN, and the fluorescence was increased with the addition of 5 
µM Pyrithione and 100 µM ZnCl2. 
CHARGING CHELATING SEPHAROSE WITH NICKEL SULFATE 
(NISO4(6H2O)) 
The Nickel Sulfate columns were used for the purification of the proteins (zinc 
sensors). These nickel sulfate columns use sepharose beads as a support structure. The 
sepharose have nitrolotriacetic acid (NTA). These triacetate groups at the ends of the 
sepharose beads are deprotonated allowing for the oxygens to coordinate the nickel ion 
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through three coordination bonds and water can coordinate with the three other bonds 
forming the octahedral coordinated nickel ion in the NTA sepharose column. This nickel 
ion being positively charged will then bind to histidine when the pH is over 6 due to the 
pKa of histidine being 6 for the loss of the proton on one of the nitrogen’s. This then 
allows the electron pair on nitrogen to coordinate with the positively charged nickel much 
better than the water molecules that were aiding in the stability of the nickel-NTA 
complex. This design works for the purification of proteins with a histidine tag which 
will effectively get stuck on the Ni-NTA column. The proteins are eluted out of the 
column once bound using an imidazole solution which when reaching a critical 
concentration will elute the histidine tagged protein. Imidazole competes for the same 
location due to imidazole being the functional group on the histidine that is binding the 
nickel. Below is the procedure for the charging of Ni-NTA columns. 
Shake the sepharose bead bottle (GE Health Sciences Chelating Sepharose Fast Flow) 
and add ~20 ml to a column and allow the solution to settle separating the sepharose 
beads from the ethanol suspension solution. Elute the ethanol solution from the beads but 
be sure throughout the use of the columns to not let them dry out as described above the 
water coordinates the nickel to support the Ni-NTA coordination and without the water 
the column will not have the nickel coordinated. Wash out the ethanol using double to 
column height (40 ml) of miliQ water. Now the sepharose beads are ready for the 
addition of the nickel, add the column height volume (10-15 ml) of 0.4 M NiSO4 to the 
column and discard the flow through. The column will change color from white to blue. 
Wash the beads with double column height of miliQ water and a solution of 0.02 M 
sodium acetate, 1 M NaCl at pH 4. The addition of the low pH solution will elute loosely 
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bound nickel in the column. The beads were then suspended in a 20% ethanol solution 
that is the same volume as the beads and stored at 4 ˚C. 
PURIFICATION OF TEV PROTEASE 
Tobacco etch virus (TEV) Protease was homemade by using BL21(DE3)-RIL 
Escherichia coli cells containing pRK793 according to previously described method 
[148]. pRK793 will overexpress the catalytic domain of TEV protease in the form of a 
maltose binding protein that will be cleaved in vivo to produce the catalytic domain of 
TEV with histidine tags on the N-termini and arginine tags on the C-termini [149]. The 
TEV protease was required to cut the histidine tags off the proteins that were purified 
using the Ni-NTA columns. The histidine tag is not normally attached to the protein of 
interest and thus could affect its properties and its removal is necessary using this 
protease. The TEV protease we purify will also have a 6X histidine tag although this does 
not impede the proteases function. 
The BL21(DE3)-RIL Escherichia coli cells were inoculated to an ampicillin plate and 
grown overnight at 37 ˚C then grown again at 37 ˚C in 50 ml of LB broth supplemented 
with 100 µg/ml of ampicillin. The cells were then added to 2 L of LB broth and grown at 
37 ˚C until the OD600 ~ 1.0. Once reaching the mid log phase of growth temperature is 
reduced to 30 ˚C and Isopropyl β- d-1-thiogalactopyranoside (IPTG) (1 mM) is added to 
induce the production of the TEV protein. After 6 hours of induction centrifuge the cells 
at 5000 RPM, 4 ˚C and decant; store cells at -80 ˚C. 
The following buffers were used to purify the TEV protease. Buffer A (50 mM 
sodium phosphate  , 200 mM NaCl, 10% glycerol) pH 8, 1M imidazole pH 8, 
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Equilibration buffer (25 mM imidazole in buffer A), Elution buffer (250 mM imidazole 
in buffer A). 
The cell pellets were dissolved in equilibration buffer then lysed via sonification 
(Branson Sonifier 450). Sonification was performed for 5 minutes in 1 minute intervals 
on ice at 50% duty cycle and output 5. Cells were immediately centrifuged at 15000 g for 
30 minutes to collect cell debris that is heavier than proteins. The supernatant was filtered 
through 0.45 µm filter to remove aggregates. 
One Ni-NTA column was equilibrated using the equilibration buffer. The low 
concentration of imidazole has been shown to increase the purification of the protein of 
interest. Low concentrations of imidazole prevent contaminating proteins from binding to 
the column and ensure the 6X His tagged protein is the only protein binding to the Ni-
NTA column. Add the TEV protein and elute through the column, elute 7 column 
volumes of equilibration buffer to remove any proteins that did not bind the Ni-NTA 
column. The histidine tagged TEV protease was eluted with a linear gradient to 100% 
elution buffer over one column volume at each concentration of imidazole: 40mM, 80 
mM, 100 mM, 200 mM, 250 mM. The increasing imidazole concentration increased the 
competition between imidazole and the histidine’s bound to the nickel which eventually 
the higher concentrations of imidazole out compete the histidine tagged protein eluting 
the protein. The protein concentration was checked for each elution imidazole 
concentration using UV-Vis absorption at 280 nm. Proteins absorb highly at this 
wavelength due to the aromatic rings present in some of the proteins. The purity of the 
protein was also analyzed by checking the absorption at 260 nm where nucleic acid bases 
absorb. Through these the concentration of protein in each elution volume was recorded. 
48 
The TEV protease is purified but in a high concentration of imidazole which can 
interfere with protein-protein interactions that are polar due to the imidazole acting 
similar to a salt. To remove/lower the imidazole concentration Amicon Ultra-15 10K 
centrifugal filter devices were used to filter the protein out of the imidazole through 
dilutions. The purified TEV protease in imidazole solution was added to the Amicon 
Ultra-15 10K centrifugal filter devices and centrifuged at 5000 g for 45 minutes. The 
imidazole solution beneath the filter was discarded and the protein solution diluted with 
12 ml of buffer A. This process was repeated three times to bring the imidazole 
concentration below 1 mM. Calculate concentration using UV-Vis 280 nm and store in -
80 ˚C freezer. 
6X HISTIDINE TAGGED SENSOR PROTEIN PURIFICATION VIA NI-NTA 
AGAROSE 
The sensor protein was expressed in the pBAD vector. The pBAD vector is optimal to 
express recombinant proteins due to its tight regulation of protein expression through the 
regulation of carbon sources. The regulation prevents any toxic effects the expressed 
sensor could cause the cell resulting in plasmid instability. Using the pBAD vector to 
express the sensor allows for optimal production of the sensor protein. The pBAD vector 
contains the bidirectional araBAD promoter which allows the expression of the protein of 
interest and the regulatory protein AraC. This promoter is what gives the regulatory 
control over the sensor protein expression. Without L-arabinose, AraC will dimerize 
forming a loop in the promoter region of the protein of interest preventing transcription. 
Although with L-arabinose AraC will change conformation and bind to other sites in the 
promoter allowing transcription to occur. This system allows for very tight regulation of 
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the expression of the sensor protein, incorporation of L-arabinose increases the 
production of the desired protein >1000 fold and is inexpensive allowing for large scale 
production of the protein [150]. The pBAD vector has an ampicillin resistance gene to 
ensure growth of cells with the pBAD plasmid. 
Our sensor protein is added to the pBAD vector and expressed with a 6X histidine tag 
that will be used in an analogous method to the TEV protease extraction to bind the Ni-
NTA column then elute the sensor protein. The sensor plasmids were transformed into 
Top10 Escherichia coli cells. The Top10 cells perform better with the pBAD vector due 
to no arabinose catabolism which can cause disproportionate production of the sensor 
protein over time after the induction of the protein with arabinose. After transformation a 
colony was picked and grown overnight at 37 ˚C in 50 ml of LB broth supplemented with 
ampicillin (100 µg/ml). The cells were then added to 2 L of LB and grown at 37 ˚C and 
shaking at 250 RPM until the OD600 ~ 0.6. Once reaching the mid log phase of growth 
temperature is reduced to room temperature (RT) and shaking to 200 RPM and 0.02% 
arabinose is added to induce the production of the sensor protein for 24 hours. Centrifuge 
the cells at 5000 g for 5 minutes and decant the solution. 
Resuspend the cells in 25 ml of Bacterial Protein Extraction Reagent (BPER) 
(Thermo Fisher Scientific) and 1 tablet of EDTA free protease inhibitor cocktail to lyse 
the cells. This amount is sufficient to lyse up to 1 L of cells grown up to an OD600. The 
BPER is a nonionic detergent that will solubilize proteins and disrupt the cell membranes 
of cells. The EDTA free protease inhibitor cocktail allows ions such as calcium and 
magnesium to be present and inhibit proteases that may otherwise break down the sensor 
protein. The cells were shaken at 200 RPM for 1 hour then centrifuged at 14000 g at 4 ˚C 
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for 15 minutes. Add supernatant to a charged Ni-NTA column and add imidazole to 
working concentration of 20 mM. 
To charge a Ni-NTA column the ethanol solution was removed from above the beads 
and replaced with a TNS buffer (50 mM Tris, 300 mM NaCl, pH 8) and 20 mM 
Imidazole). The column is rotated for 15 minutes then allowed to settle and the TNS-20 
mM imidazole solution is removed. All the steps involving the Ni-NTA column are 
performed at 4 ˚C to prevent degradation of the protein. Rotate the column with the 
protein for one hour. 
Elute one column volume of TNS buffer-20 mM imidazole to remove any proteins 
that did not bind the Ni-NTA column. The histidine tagged sensor protein was eluted 
with a linear gradient to 100% TNS buffer-100 mM imidazole over one column volume 
at 40mM and 100 mM imidazole. The increasing imidazole concentration increased the 
competition between imidazole and the histidine’s bound to the nickel which eventually 
the higher concentrations of imidazole out compete the histidine tagged protein eluting 
the protein. The protein concentration was checked for each elution imidazole 
concentration using UV-Vis absorption at 280 nm. Proteins absorb highly at this 
wavelength due to the aromatic rings present in some of the proteins. The purity of the 
protein was also analyzed by checking the absorption at 260 nm where nucleic acid bases 
absorb. Through these the concentration of protein in each elution volume was recorded. 
The sensor protein was purified but in a high concentration of imidazole which can 
interfere with protein-protein interactions that are polar due to the imidazole acting 
similar to a salt. To remove/lower the imidazole concentration Amicon Ultra-15 10K 
centrifugal filter devices were initially used to filter the protein out of the imidazole as 
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described above for the TEV protease extraction although the solution was too viscous. 
For this we used an Amicon Stirred Cell which applied positive pressure to the protein in 
the imidazole solution to a filter and performed the same task as the centrifugal filter 
device. This process was repeated three times to bring the imidazole concentration below 
1 mM using the 50 mM Tris buffer pH 8 for the buffer exchange. The concentration was 
calculated using UV-Vis 280 nm. 
The 6X histidine tag must be removed from the sensor. The tags must be removed 
from the sensor to prevent dimerization of the histidine tagged proteins caused by the 
affinity histidine tags have for zinc ions (at nanomolar concentrations) [151]. If dimers 
were formed intermolecular FRET would interfere with future assays designed to 
measure the affinity of the sensor for zinc, other ions, etc. Use a 1:10 ratio of TEV 
protease to sensor protein and incubate the solution overnight at room temperature in a 
dark place. The following day the protein needs to be separated from the histidine tags. 
The same process as described above was performed once again with a charged Ni-NTA 
column (TNS buffer-20 mM imidazole) the protein is added and rotated for one hour. 
Then the solution is eluted through the column with no additional solutions. The elutant 
has the sensor protein, the column now has all the histidine tags bound to it. Calculate the 
protein concentration using UV-Vis 280 nm and store the protein protected from light at 
4 ˚C. The sensor protein was only viable for up to a week from the day of purification. 
 IN VITRO BIOPHYSICAL CHARACTERIZATION OF GZNP SENSORS 
ZINC BINDING CURVE 
Zinc titrations were performed in HEPES buffer (150 mM Hepes, 100 mM NaCl, 0.5 
mM TCEP and 10% glycerol, pH 7.4) with 2 μM sensor protein and Zn2+ buffering 
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solutions with defined Zn2+ concentrations as described in the zinc buffer solutions 
methods. All the possible zinc concentrations (A0:B0, A1:B1…) were used in the 
construction of the zinc binding curve using the zinc buffers at a pH of 7.4. The reducing 
agent TCEP was prepared just prior to running characterization and allowed to incubate 
with the sensor for 10 minutes prior to performing analysis. TCEP was added to the 
solution to ensure a reducing environment which allows the thiol groups on cysteines to 
be reduced and not in an oxidized disulfide bridge state. If in an oxidized state the 
cysteine thiol residues cannot bind zinc and therefore would not be a good indicator of 
zinc without the ability to bind zinc ions. Purified sensor protein was titrated with Zn2+ to 
determine the fluorescence intensity as a function of Zn2+ concentration. The sensor 
responsiveness to Zn2+ was reported as an apparent dissociation constant (Kd’), which 
reflects the Zn2+ concentration midway between the Fmin and Fmax and the proficiency of 
the sensor to separate from the bound zinc ions. This zinc curve was fit using the binding 
equation m1*m0^m3/(m2^m3+m0^m3)+m4; with limits set for each of the m values. M1 
= maximum asymptote; m2= minimum asymptote; m3= Hill coefficient (slope at IC-50); 
m4= kd (IC-50). The in vitro fluorescence measurements used for zinc binding curve 
studies were made on a Tecan fluorescence plate reader using the following parameters: 
Ex = 488 nm; Ee = 515 nm; emission bandwidth, 5 nm. Prior to all measurements the final 
solutions were spun down at 2250 RPM for 5 minutes and incubated for 45 minutes in the 
dark. 96-well polystyrene black bottom plates were used to measure the fluorescence for 
the metal specificity and the zinc binding curve measurements. 
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METAL SPECIFICITY 
Metal selectivity was measured across biologically relevant divalent metals calcium, 
zinc, magnesium, copper, manganese, cobalt, and nickel. 2 mM stock solutions of these 
various metals were made in 100 mM HEPES pH 6.8 and chelex water. The stock 
solutions for zinc and copper need to be remade every time metal specificity tests are 
performed due to the metal precipitating out of solution. For example with zinc, once 
exceeding ~200 µM ZnCl2 at pH 7.4 in water the zinc and chloride ions will be 
dissociated in solution with water. The water is dissociating between protonated and 
deprotonated forms (H3O
+ & OH- Respectively). The central zinc ion is coordinated with 
water which eventually the oxygen will become polarized resulting in the dissociation of 
a proton and the formation of an aquo-hydroxo complex [80]. This complex is favored 
instead of the aqua complex once reaching a critical concentration dependent on the pH 
of the solution then zinc hydroxide will be favored. This is an effect of Le Chatiers 
principal. This same rule applies to the other metals although this critical concentration is 
not reached at 2 mM with the metals used except for Cu2+ too. 
38 µM of each metal and 15 µM of EDTA was added to each well with 0.5 mM 
TCEP. The EDTA was added to chelate any contaminating metal in the solution besides 
the one of interest and the divalent metal ion of interest is at a higher concentration than 
the EDTA making this the only metal available to bind the sensor. These different metal 
solutions were added to zinc titration buffer (150 mM Hepes, 100 mM NaCl, 0.5 mM 
TCEP and 10% glycerol, pH 7.4) and 2 µM of sensor protein. 
The in vitro fluorescence measurements used for metal specificity studies were made 
on a Tecan fluorescence plate reader using the following parameters: Ex = 488 nm; Ee = 
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515 nm; emission bandwidth, 5 nm. Prior to all measurements the final solutions were 
spun down at 2250 RPM for 5 minutes and incubated for 45 minutes in the dark. 96-well 
polystyrene black bottom plates were used to measure the fluorescence for the metal 
specificity. 
To make the EDTA solution need to keep the pH above 8 or else the EDTA will 
precipitate out of the solution. This will require a lot of NaOH to raise the pH above 8 
due to the EDTA being acidic and having many acidic protonated groups. 
QUANTUM YIELD AND EXTINCTION COEFFICIENT 
The quantum yield also referred to as the quantum efficiency was measured for each 
sensor, the quantum yield is the ratio of the number of photons emitted via fluorescence 
to the number of photons absorbed[152]. This is a good indicator if a sensor is suitable 
for fluorescence imaging. If the quantum yield is low then the sensor will be difficult to 
detect despite using the proper excitation wavelength with high laser power and high 
exposure times. If the sensor does not have a high conversion of photons absorbed to emit 
as fluorescence then the sensor will always be relatively dim. 
The quantum yield was measured by diluting the purified sensor in a MOPS solution 
(30 mM MOPS buffer, 100 mM KCl, 0.5 mM TCEP, at pH 7.4). The TCEP solution was 
made and only used the same day. The sensor was compared using fluorescein as the 
control for the calibration curve.  Fluorescein was diluted in 0.1 M NaOH.  The 
absorbance of fluorescein was adjusted to 0.01-0.05 at 494 nm to maintain a linear 
function. Absorbance’s outside of 0.01-0.05 become non-linear, this will prevent using 
the control as a calibration curve for our sensor. 6-10 absorbance’s were measured at 
dilutions within the 0.01-0.05 range using a Varian Cary 100 Bio UV-Vis 
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spectrophotometer. The same protocol as the fluorescein was used for the purified sensor 
with the solvent being the MOPS solution with either 15 µM TPEN or 10 µM ZnCl2 to 
determine the maximum and minimum fluorescence of the sensor.  The same dilutions 
made above for the absorbance’s for each sample are then run through a Cary Eclipse 
Fluorescence Spectrophotometer fluorimeter with excitation at 488 nm and emission 
from 500 nm to 600 nm using 1 nm slits, 1 second integration time and 1 nm steps.  The 
total fluorescence intensities were obtained by integrating the emission spectrum of each 
sample.  These points were then plotted against the absorbance reading at the maximum 
wavelength (494 nm) for the sensor with and without zinc (TPEN) and the controls.  The 
quantum yield was obtained from the slopes of each line using the equation ΦSensor = 
ΦStandard × (Slope of Sensor/Slope of Standard).  See Figure 7 below of the quantum yield 
of GZnP3 after the above measurements and calculations are made. 
 
Figure 7: Quantum Yield Plot for GZnP3. The control is fluorescein with a quantum 
yield of 92.5%. 
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The extinction coefficient is a measurement of how well a sensor absorbs photons of 
the proper wavelength to excite the fluorophore. If the absorbance is low then there is a 
lower number of potential conversion of absorbed photons to fluorescently emitted 
photons. The higher the extinction coefficient of a sensor the higher the likelihood to 
have higher fluorescent emission from a sensor. 
For the extinction coefficient determine a set concentration of purified sensor and use 
this concentration for all measurements. The concentration does not need to fall in a 
specific range as in the quantum yield measurements. The sensor was diluted in a MOPS 
solution (30 mM MOPS buffer, 100 mM KCl, 0.5 mM TCEP, at pH 7.4).  and the 
absorption spectrum of the sensor was measured in Zinc-free buffer (30 mM MOPS, 100 
mM KCl and 15 µM TPEN, 0.5 mM TCEP, at pH 7.4) and Zn2+-buffer (30 mM MOPS, 
100 mM KCl and 10 µM Zn, 0.5 mM TCEP at pH 7.4). The highest absorbance value for 
the respective wavelength was recorded.  The same amount of protein was denatured by 
diluting in 0.1 M NaOH for 3 minutes and the sensor absorption at 446 nm was recorded.  
To calculate the extinction coefficient we used the Beer-Lamperts law of A=εcl 
(A=Absorption, ɛ=Epsilon or extinction coefficient, c= Concentration, l= Path length of 
the light). Given the same sensor protein concentrations and the same path length, we 
determined the extinction coefficient using the equation Ɛ sensor / 44000 =  Asensor / Asensor 
in NaOH. 
PH NORMALIZATION OF GZNP3 SENSOR 
As mentioned in the introduction one of the downsides to using genetically encoded 
sensors is their amino acid composition is extremely susceptible to perturbations in pH 
which will affect the proteins secondary, tertiary, and quaternary structure. This 
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perturbation will affect the characterization of the sensor (kd, quantum yield, extinction 
coefficient, metal specificity, etc.). To avoid these perturbations on GZnP3 we developed 
a method to circumvent the pH effect on the genetically encoded sensor. We 
accomplished this by normalizing the GZnP3 signal to correct for zinc-independent, pH-
dependent changes therefore measuring only the changes in signal resulting from zinc. 
We calculated the changes in sensor intensity across a physiological relevant range of 
pH’s (5.1 to 9) in HeLa cells. Tagging either GZnP3 or the red fluorescent protein-based 
pH sensor, pHuji, with the pDisplay tag we performed in situ pH normalization. The 
pDisplay vector targets our GZnP3 sensor to the surface of mammalian cells. The GZnP3 
sensor is targeted and anchored to the cell surface using the pDisplay N-terminal 
secretion signal and the C-terminal transmembrane anchoring domain, platelet-derived 
growth factor receptor (PDGFR) effectively displaying the protein on the extracellular 
surface of the mammalian cell.  
Buffers were made at pH 5.1, 5.5, 6, 6.5, 7, 7.4, 8, 8.5 and 8.9, using phosphate free 
HHBSS imaging buffer with identical compositions except the chelator changed 
depending on the desired pH (MES for pH 5.1, 5.5, and 6; MOPS for pH 6.5; HEPES for 
pH 7, 7.4, and 8; Tris for pH 8.5 and 8.9). pDisplay-pHuji and pDisplay-GZnP3 plasmids 
were co-transfected into cells and imaged 48-72 hours post-transfection. Images were 
acquired every 20 seconds, using 100 ms exposure at 10 mW laser power for the 488 nm 
laser and 50 ms and 5 mW for the 561 nm laser. Cells were imaged for 5 minutes in each 
pH buffer, then washed with the next sequential pH buffer, beginning with pH 5.1 and 
ending at pH 8.9. Averages of each pH’s sensor intensity for both the pDisplay-GZnP3 
and pDisplay-pHuji sensor were taken to plot the intensity of the GZnP3 sensor as a 
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function of pH. These intensities were normalized to physiological pH (7.4) and standard 
curves were generated for each sensor (Figure 8A & 8B). Sigmoidal functions were fit to 
the curves. The normalized values for each sensor were plotted against each other to 
estimate the change in GZnP3 intensity as a function of change in pHuji intensity (pH) 
creating the standard curve seen in Figure 8C. An exponential curve was fit to this data. 
This then allowed us to normalize the GZnP3 signal despite intracellular pH changes 
using equations 3 and 4. 
59 
 
Figure 8: pH effect and pHuji normalization of GZnP3 sensor. (A) The change in 
fluorescent intensity of pDisplay-GZnP3 was plotted against pH. The sensor intensity 
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was normalized to physiological pH (7.4). Green line shows fitted sigmoidal curve, R = 
0.99927, see Equation 1. (B) The change in fluorescent intensity of pDisplay-pHuji was 
plotted against pH. The sensor intensity was normalized to physiological pH (7.4). Red 
line shows fitted exponential curve, R = 0.99658, see Equation 2. (C) pH effect on 
GZnP3 intensity. The y-axis values from the graphs in (A) and (B) were plotted against 
each other to display the change in GZnP3 signal as a function of detected change in the 
pHuji signal. Blue line shows fitted exponential rise curve, R = 0.99596, see Equation 3. 
This allows for direct normalization of intracellular GZnP3 signal by removing pH-
dependent changes in brightness detected by pHuji, see Equation 4. 
By simultaneously measuring the pH and zinc concentration in cells co-expressing 
GZnP3 and pHuji we can factor in the pH change and not have this signal interfere with 
the quantification of the zinc signal. 
Equation 1: GZnP3 intensity (y) as a function of pH (x). 
y=0.54322+(-1.4458)/(1+(x/7.2184)^20.347 ) 
Equation 2: pHuji intensity (y) as a function of pH (x). 
y=11.201+(-12.13061)/(1+(x/10.409)^7.6328 ) 
Equation 3: GZnP3 intensity (y) as a function of pHuji intensity (x). 
y=0.65638(1- e^(-1.0696x) ) 
Equation 4: pH Normalized GZnP3 intensity (y) as a function of GZnP3 (z) and pHuji 
intensity (x). 
y=z-0.65638(1- e^(-1.0696x) ) 
PLASMID CONSTRUCTION 
PDISPLAY-PHUJI 
For mammalian expression, the sensor was constructed in the mammalian vector 
pcDNA3.1 by PCR cloning. The pDisplay vector must be placed on the C-terminal end of 
the sensor. The pDisplay-GZnP1 was cut with XmaI (N-terminal) and SacII (C-terminal) 
excising GZnP1. Made primers and used PCR to add both restriction sites to the 
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respective locations onto PHuji. The PHuji PCR product with the XmaI and SacII 
restriction sites was restriction digested then ligated into the pDisplay vector in 
pcDNA3.1 already cut with SacII and XmaI. 
PDISPLAY-GZNP3 
For mammalian expression, the sensor was constructed in the mammalian vector 
pcDNA3.1 by PCR cloning. The pDisplay vector must be placed on the C-terminal end of 
the sensor. The pDisplay-GZnP1 was cut with XmaI (N-terminal) and SacII (C-terminal) 
excising GZnP1. Made primers and used PCR to add both restriction sites to the 
respective locations onto GZnP3. The GZnP3 PCR product with the XmaI and SacII 
restriction sites was restriction digested then ligated into the pDisplay vector in 
pcDNA3.1 already cut with SacII and XmaI. 
2.3 RESULTS/DISCUSSION 
Our starting platform for sensor optimization was the probe GZnP1 designed by Yan 
Qin [78]. We used site-directed saturation mutagenesis described above in the methods 
section for GZnP sensor development. This process allowed for all possibilities (amino 
acid mutations) to be analyzed via the high throughput cell lysate assay allowing further 
in situ analysis of promising variants. This method allows us to analyze the majority if 
not all possible mutations narrowing the possibility of missing mutations that may cause 
a favorable change in the characteristics of interest for the sensor. The process worked 
exceptionally well to increase multiple characteristics of the GZnP sensor (Fmax, DR, & 
Kinetics) with a ~5 fold increase in the dynamic range between GZnP1 to GZnP3 while 
maintaining the fluorescence intensity, refer to Table 4 below. 
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Sensors were named as the favorable mutations were produced and characterized. 
GZnP2 improved on GZnP1’s DR by incorporating a mutation to the zinc finger binding 
domain 1 (F to M) and a mutation in the linker 2 domain (T33P). This increased the DR 
of GZnP1 ~2 fold to ~4.5 fold for GZnP2. These mutations allowed for over 100% 
increase in the DR and the brightness remained unaffected at baseline. This baseline 
fluorescence was important as will be observed with the GZnP3 being difficult to detect 
at baseline. Other mutations showed favorable mutations when developing GZnP2, 
GZnP1.1-1.7. Some of these variants were used for future GZnP sensors (GZnP1.3) 
although we used the most favorable of these sensors for further mutation. 
An interesting observation was the only mutation that produced favorable 
characteristics outside the linker regions of the GZnP variants was to the zinc binding 
domain of the zinc fingers for GZnP1.1 (to ZF1 F299M). This mutation was incorporated 
into all future variants of GZnP due to the favorable increase in the dynamic range. Many 
of the mutations made directly to the zinc fingers potentially affect the metal specificity 
of the sensor for zinc possibly decreasing or abolishing the sensors affinity for zinc 
altogether. We still risked zinc affinity of the sensor by modifying this region in hopes to 
produce favorable characteristics. We accomplished this although many other mutations 
to this region completely impeded the sensor to perform the function of a zinc specific 
sensor. This mutation is the likely reason the binding affinity of all the future sensors are 
lower than its predecessor GZnP1, see Table 4 & 6. Although changing the binding 
affinity of the sensors was also a goal of sensor development too. The sensors are 
typically only sensitive an order of magnitude higher or lower than the calculated 
dissociation constant. With different zinc concentrations throughout the cell we ideally 
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want a distribution of zinc sensitivity for our zinc sensors ranging from low picomolar to 
high nanomolar concentrations of zinc. 
In the design of GZnP3 the DR was dramatically increased through a mutation to the 
first two residues in the linker 2 region of the zinc fingers (TH278/279IL) creating 
GZnP1.3. GZnP1.4 also had a high DR although the DR was slightly lower than the 
GZnP1.3 variant therefore GZnP1.3 was retained for further development, Table 4 & 5. 
The baseline fluorescence for this sensor was substantially decreased compared to GZnP1 
& 2 baseline fluorescence although the FMax remained almost unchanged (Table 5). The 
baseline fluorescence of GZnP3 is barely observable over background fluorescence. This 
characteristic made observing the sensor without zinc perturbation difficult although even 
small increases in zinc resulted in dramatic increases in brightness as shown in the large 
DR of 15.5, Table 5. Part of the decreased baseline fluorescence is a result of lower 
affinity of the GZnP3 sensor for zinc compared to GZnP2, kd = 1.3 nM and 0.352 nM 
respectively. Refer to table 4 for the mutations made to all the variants discussed in this 
chapter. Another mutation was made to the ZF1 binding domain of GZnP1.3 (F299M) 
ultimately yielding our final product GZnP3. This mutation slightly increased the DR and 
had no effect on the Fmax. The more dramatic increase in DR from the linker region 
mutations likely results from the greater flexibility provided to the zinc fingers. Increased 
flexibility allowing the zinc fingers to both better protect and expose the GFP 
chromophore to solvent attack. This will allow for a larger range of fluorescence from the 
sensor.  
As mentioned previously we mutated the zinc binding domains (ZF1 & 2) although 
we must account for potential loss of zinc specificity or binding when mutating these 
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domains. Another region we considered during our site-directed saturation mutagenesis 
was the eGFP structure many of the mutations resulted in severe fluorescence quenching. 
This lead to our focus for site directed mutagenesis on the zinc finger linkers and the 
amino acids nearby the linker regions. The linker region is essential to allow the zinc 
fingers to change the conformation of the protein and therefore move to either open the 
GFP chromophore for solvent attack or prevent solvent attack. The eGFP structure 
provides the mechanism for fluorescence so when mutations were incorporated to the 
eGFP structure we observed decreased sensor brightness most likely due to reducing the 
capacity for the β-barrel to hold the chromophore rigid, preventing the excited state 
proton transfer (ESPT) and/or formation of the anionic state, and/or changing critical 
amino acid residues surrounding the chromophore to prevent decreased pKa of the 
phenolate oxygen. The sensor fluorescence was considerably quenched steering our 
mutagenesis away from the GFP structure of the sensor. Modification to the zinc binding 
domains could affect the sensors ability to coordinate the zinc ions causing the ZF 
conformational change, therefore we avoided these regions too. We directed our attention 
to the linker regions and nearby areas for site directed saturation mutagenesis to optimize 
the GZnP sensors. 
While the mutations described above increased the DR which increases the sensors 
sensitivity to zinc perturbations the sensor kinetics are also of high importance. Zinc like 
all metals within a cell is highly regulated and buffered to specific concentrations as 
mentioned in chapter 1.2. Therefore perturbations in the zinc concentrations will be 
quickly buffered back to physiological levels therefore providing a kinetically fast sensor 
is pivotal to respond to fast fluctuations in zinc concentrations. During our site directed 
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saturation mutagenesis we revealed mutations to the linker 1 region specifically 
PW278/279LP amino acids resulted in an increased kinetic response from the sensors. 
We monitored kinetics by observing how long after zinc and pyrithione addition it took 
the sensor to plateau. The GZnP1.3 mutant took ~ 5 minutes longer for the signal to 
plateau after zinc and pyrithione addition when compared to the GZnP1.3 LP variant. 
Mutating the amino acids in the linker 1 region PW to LP we observed dramatically 
increased kinetics when compared to other variants. We hypothesize the mutation from 
PW to LP in linker 1 increases kinetics likely by reducing strain on the linker region 
allowing faster rotation of the ZF into and out of position to cover the exposed 
chromophore of eGFP and positioning of charged amino acids surrounding the 
chromophore to quickly reduce the pKa of the chromophore. We found that mutations to 
the PW amino acids in the linker 1 region resulted in increased kinetics in more than just 
GZnP1.3 to GZnP3. This mutation increased the kinetics between GZnP1.1 vs GZnP1.2 
and GZnP2 vs GZnP2.1 (a mutant of GZnP2 with the mutation PW to LP in linker 1). 
These results show the linker regions have a profound effect on the Fmax, DR, and kinetics 
of the sensor. The linker 1 region appears to have a more pronounced effect on the 
kinetics of the sensor while the linker 2 region has a more pronounced effect on the 
DR/Fmax of the sensor. To explain this linker 2 may not move as much as linker 1 
resulting in linker 1 modifying the kinetics while the relatively immobile linker 2 may 
dictate the overall fluorescence of the sensor. Linker 2 may alter the likelihood of the 
chromophore to be in an anionic state and reduce the pKa while linker 1 may situate the 
chromophore to enter these states faster. One way could be the mutation to linker 2 
provides the correct geometries for amino acids to stabilize the anionic chromophore state 
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and lower the pKa of the sensor but mutations to linker 1 place these key conformational 
changes close to their zinc saturated geometry increasing the kinetics between the zinc-
saturated and zinc-free sensor states. Refer to Table 4 & 5 below for the location and 
identification of the mutations and the results of those mutations on the DR, Fmax, and the 
kinetics. 
The LP mutation was shown to increase the sensor kinetics although it was found that 
it can under some circumstances decrease the stability of the sensor when saturated with 
zinc. This same observation was found in the original design and development of the 
GZnP sensor [78]. One example is shown in GZnP2.1 with the LP mutation after addition 
of zinc and pyrithione the signal becomes unstable and the fluorescence is quenched 
compared to GZnP2 without the mutation to linker 1. This is interesting since the 
GZnP1.3 to GZnP3 does not show this instability when saturated with zinc. The only 
difference between GZnP2.1 and GZnP3 is in linker 2 a PH33/34 to IL33/34 respectively. 
Potentially the proline prevents movement of the zinc finger or the flexibility present 
with other amino acids causing this instability observed in the GZnP2.1 sensor. We 
hypothesize this instability could result from a similar mechanism to why the histidine 
tags must be removed due to dimerization and FRET occurring when high concentrations 
of zinc are present. The zinc could interact with the ZF’s causing dimerization and 
diminish the GZnP signal. Another potential is the conformation the two zinc fingers are 
placed in the zinc saturated state does not fully protect the chasm in the 7th β-barrel 
allowing zinc to interact with the phenolate oxygen when reaching a sufficiently high 
concentration stabilizing the neutral state of the chromophore and preventing ESPT from 
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occurring at the chromophore. Either of these scenarios would cause a decrease in the 
fluorescence once zinc saturated the sensor. 
Table 4: Mutations to Optimize GZnP Sensor. The mutated residues from the 
previous sensor (except GZnP2.1, which is based on GZnP2, and GZnP3, which is based 





Linker 1 Linker 2 
GZnP1 SSLFD LPKNN THLENV 
GZnP1.1 SSLMD LPKNN THLENV 
GZnP1.2 SSLMD PWKNN THLENV 
GZnP1.3 SSLMD PWKNN ILLENV 
GZnP1.4 SSLMD PWKNN IILENV 
GZnP1.5 SSLMD PWKNN ITLENV 
GZnP1.6 SSLMD PWKNN VHLENV 
GZnP2 SSLMD PWKNN PHLENV 
GZnP2.1 SSLMD LPKNN PHLENV 
GZnP3 SSLMD LPKNN ILLENV 
 
Table 5: Results from Site-Directed Saturation Mutagenesis for optimized variants 
with improved DR, Fmax, and/or kinetics. Treatments for both the dynamic range and FMax 
included 100 µM TPEN for FMin and 20 µM Zinc Chloride & 2.5 µM Pyrithione for FMax. 
  Dynamic Range FMax (A.U.) 
GZnP1 2.2 7500 
GZnP1.1 2.2 1800 
GZnP1.2 4.3 1500 
GZnP1.3 15.5 8000 
GZnP1.4 15.0 NA 
GZnP1.6 5.5 10000 
GZnP2 4.5 6500 
GZnP3 11.0 6000 
 
Biophysical characterization of the most promising sensors made was performed to 
determine the specificity of the sensor for zinc, the dissociation constant, and the 
quantum yield & Extinction coefficients. The biophysical characterization was performed 
in vitro on purified sensor derived from Top10 Escherichia coli cells expressing the 
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sensor variant. The sensors were purified and analyzed for metal specificity comparing 
the sensors response to other common biological cations such as calcium, magnesium, 
nickel, copper, cobalt, manganese, potassium, mercury, chromium, and aluminum, refer 
to Figure 9. Some of the sensors were tested against more metals upon request by 
reviewers for publications. All the metals showed no response except for cadmium II and 
copper II. This follows the Irving-Williams affinity for coordination of amino acids. This 
is unavoidable and acceptable due to biological labile copper and cadmium 
concentrations being zero [130]. None of our mutations affected the specificity of the 
optimized probes. GZnP1.1 and GZnP1.5 were excluded due to lower DR’s and unstable 
FMax. There is a significant increase in the sensor fluorescence at 515 nm between the 
zinc-free and zinc-saturated states as shown in Figure 10 below for two sensor variants 
(GZnP2 & GZnP3). 
 
Figure 9: Metal Specificity of Optimized GZnP Sensors. All the sensors remain 
specific to zinc. AA is ascorbic acid and was used to reduce the iron III to iron II. 
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Figure 10: Emission Curve of GZnP2 & GZnP3. There is a substantial increase in 
fluorescence at 515 nm when the sensor is saturated with zinc compared to the zinc-free 
state (TPEN treatment) for both sensors. 
A zinc binding curve was made for the optimized GZnP sensors using the method 
described in the methods section and shown in Figure 11. The zinc binding curves were 
performed at pH 7.4, although the derived constants (hill coefficients and dissociation 
constants) will change at different pH’s for the reasons explained in the introduction for 
genetically encoded sensors. There is variation in the binding affinities of each sensor due 
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to the mutations performed on the zinc linker regions. The biggest change in the binding 
affinity results from the initial change to the zinc finger between GZnP1 & GZnP1.1. 
 
Figure 11: Zinc Binding Curves for Optimized Variants of GZnP Sensor. The 
dissociation constant is shown for each optimized GZnP variant. 
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At higher pH’s the dissociation constant and hill coefficient will decrease (Higher 
affinity) for example GZnP2 has a kd of 352 pM and a hill coefficient of 0.49 at pH 7.4 
while the kd drops to 112 pM and the hill coefficient drops to 0.264 at pH 8, (Table 6 & 
Figure 12). Changes in pH as mentioned in the introduction will dramatically affect the 
brightness of the sensor by altering the pKa of the chromophore which will shift the 
equilibrium of the anionic and neutral state of the chromophore. This can be observed in 
Figure 13 with the higher pH lowering the chromophore pKa enhancing the brightness of 
the sensor by favoring the anionic state of the chromophore. Once dropping down to ~6.5 
pH the sensor brightness dropped off completely likely due to the pH denaturing the 
protein and the chromophore no longer being held rigid and protected diminishing all 
fluorescence. 
 
Figure 12: Zinc binding curve for GZnP2 at cytosolic pH 7.4 and the Mitochondrial 
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Figure 13: Effects of pH on GZnP2 Sensor. The pH will quench the signal at lower 
pH eventually denaturing the protein and will enhance the signal at higher pH due to 
decreasing the chromophore pKa and shifting the chromophore anionic state to be more 
favorable. There is a **** (p<0.0001) between each pH between all the A, B, & C bars 
respectively, n=3 calculated using a one way ANOVA post hoc Tukey. 
 











(n, pH 7.4) 
Hill coefficient 
(n, pH 8) 
GZnP1 34 pM NA 0.6 NA 
GZnP1.3 483 pM NA 0.42 NA 
GZnP1.4 855 pM NA 0.5 NA 
GZnP1.6 552 pM NA 0.29 NA 
GZnP2 352 pM 112 pM 0.49 0.264 
GZnP3 1.3 nM NA 0.34 NA 
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The quantum yield (QY) and extinction coefficients were found for the optimized 
GZnP sensors. As observed in Table 7 the quantum yield for the GZnP1.3 and GZnP1.4 
sensor in the zinc-free state there is almost no fluorescence. This is the reason the sensor 
is difficult to visualize at baseline with low concentrations of zinc but also the reason for 
the large DR of the two sensors compared to the other variants. With the lower limit set 
lower than other variants but with relatively high QY in the zinc-saturated state the 
sensors can increase their brightness substantially more than other sensors with a higher 
QY in the zinc-free state. Interestingly when comparing GZnP1.3 and the LP variant 
(GZnP3) the DR’s are close although the mechanism of increasing the DR is dissimilar. 
The GZnP1.3 sensor relies on a large change in the QY between the zinc-free and zinc-
saturated state while GZnP3 relies on a more significant change in the extinction 
coefficient with a modest increase in the QY. These different mechanisms still 
accomplish the end result of a more sensitive sensor just through different mechanisms. 
The ultimate goal would be a sensor with a large change in both the QY and the 
extinction coefficient leading to a massive DR. All the optimized sensors show an 
increase in the DR due to an increased extinction coefficient or QY in the zinc-saturated 
state or a combination of the two biophysical characteristics, refer to Table 7. 
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GZnP1 0.42 0.57 NA NA 
GZnP1.3 
0.03 0.39 12600 29500 
GZnP1.4 
0.03 0.41 28800 36000 
GZnP1.6 
0.41 0.84 2600 30100 
GZnP2 0.21 0.64 10000 34000 
GZnP3 0.112 0.462 4000 23400 
 
 
The optimization of the GZnP1 sensor produced promising sensor variants with 
improvements in the sensitivity of the sensors for zinc (DR), the kinetics, and sensors 
with a variety of binding affinities for zinc. This offers a spectrum of zinc sensors to 
expand the current toolbox of zinc sensors available for imaging. This sets the stage for 
the next chapter where we required zinc sensitive sensors to monitor mitochondrial zinc 
dynamics. Below is a comparison of all the current mitochondrial zinc probes including 
GZnP1 & 2 discussed in this work shown in Table 8. What can be noticed is our 
mitochondrial zinc probes are the only intensiometric mitochondrial zinc probes available 
offering the benefits of intensiometric sensors over ratiometric sensors.  
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Table 8: Comparison of Currently Available Genetically Encoded Mitochondrial Zinc 



































60 pM 1.4   [126] 
FRET mito-eZincCh 10.0 pM 1.7   [128] 
Single 
FP 
mito-GZnP1 NA 2.2 [153] 
Single 
FP 
mito-GZnP2 112 pM 4.5 [154] 
Single 
FP 
mito-GZnP3 NA 11 [88] 
 
2.4 CONCLUSIONS 
The goal of this chapter was to design improved zinc sensors expanding the toolbox 
of available zinc sensors to analyze a wide variety of physiological situations. This goal 
was accomplished through the improvement and optimization of the GZnP1 a sensor 
originally developed by Yan Qin [78]. GZnP1 was a great starting point resembling 
GCaMP2 & GCaMP3 in respect to the quantum yield (0.57 compared to 0.53 & 0.65 
respectively) but lacked in the DR of such calcium genetically encoded sensors [131]. 
The DR enables sensors to become more sensitive to the ions the sensors are designed to 
detect. In the case of zinc the concentrations are already very small in the picomolar to 
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nanomolar range, to design a sensor with a large DR is necessary to detect dynamics in 
small concentrations of zinc. The GZnP1 sensor has a DR of 2.3-2.6 [78] which is a great 
starting point but needs to be improved to match current calcium sensors with DR’s of 5 
as in GCAMP2 [153] to 111 with GEM-GECO1 [115]. Commonly used calcium probes 
have a DR that falls between 5 and 20 which is sensitive enough to pick up miniscule 
changes in calcium concentrations. Our objective at the onset of this project was to 
design zinc sensors with DR’s between 5-20 to match current calcium sensors. The 
development of GZnP3 and GZnP2 with in situ DR’s of 11 and 4.5 respectively we have 
accomplished that goal to develop more sensitive zinc sensors that will respond strongly 
to slight changes in the zinc concentration. 
In addition to designing the sensors with a higher DR the sensors dissociation 
constant was modified to create a spectrum of sensors that can detect changes in low zinc 
(0.3 pM, GZnP1) to high concentrations of zinc (13 nM, GZnP3). This enables us to pick 
up zinc dynamics occurring at all known physiological concentrations of zinc, from 
almost no zinc as in the mitochondria[84] to high nanomolar concentrations found 
released from lysosomes[88]. The wide variety of developed zinc sensors has improved 
the currently available genetically encoded intensiometric, ratiometric, or small molecule 
zinc probes available. With these improved zinc sensors zinc biology has the tools 
necessary for investigation. 
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CHAPTER THREE: MITOCHONDRIAL ZINC HOMEOSTASIS 
3.1 INTRODUCTION 
Emerging studies have shown that zinc affects certain cellular processes such as 
enzymatic reactions[2], mitochondrial function[3-5], cell division [6] and apoptosis[6]. 
The ambition to explore and elucidate the roles of zinc in these essential cellular 
processes has propelled the development of fluorescent zinc sensors within the past 
decade. Both quantitative and qualitative measurements of total zinc and labile zinc have 
been characterized using fluorescent zinc sensors. The ability to measure labile zinc 
specifically and accurately in various subcellular locations is paramount to understanding 
how zinc modulates various functions within a cell. Although the labile zinc 
concentration is tightly regulated in the cell, it is also highly dynamic both spatially and 
temporally. There are zinc fluxes from different subcellular compartments, exchanges 
between coordinated zinc binding proteins, or communications occurring between the 
extracellular environment and the cell releasing or eliminating zinc. For this reason the 
development of a zinc sensor that can be reliably subcellularly targeted in the cell can 
offer a wealth of information on the zinc dynamics occurring within the cell. 
We established in chapter 2 the importance of developing novel sensitive zinc probes, 
while in this chapter we focus on utilizing and developing these novel zinc probes further 
to understand zinc dynamics occurring in the mitochondria. Both small molecule sensors 
and genetically encoded sensors have been utilized to monitor and measure zinc 
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dynamics and concentrations in the mitochondria including RhodZin-3 and DA-ZP1-TPP 
[154, 155], mito-ZapCY1 [123], mito-eCALWY4 [126] and mito-eZinCh [128]. These 
sensors have opened the door to how zinc is involved in a multitude of processes due to 
mitochondrial zinc fluctuations causing significant interactions with dramatic outcomes. 
Localizing these sensors has become essential in understanding the principal of how zinc 
interacts in the cell. Many zinc interactions involve a complex spatiotemporal mechanism 
where zinc responsive fluorescent probes are perfectly suited for the task. For these 
reasons a probe that can be reliably localized to specific regions of a cell can offer insight 
into how zinc is being trafficked in cells and how this trafficking can alter cellular 
function. For example, DA-ZP1-TPP, a mitochondrial small molecule zinc probe that 
localizes to the mitochondria via electrostatics found that zinc uptake into mitochondria is 
inhibited in tumorigenic prostate epithelial cells compared with non-cancerous cells 
[155]. Inside the mitochondrial matrix, zinc inhibit the aconitase and other energy 
production enzymes [3-5, 44, 45, 156], hence reduced mitochondrial zinc uptake could 
potentially release the suppression of zinc on mitochondrial enzymatic activity, aiding in 
the explosive growth rates of cancer cells. With another mitochondrial targeted zinc 
sensor, Mito-CA-DSRed2, studies found that zinc accumulates in the matrix of the 
mitochondria of neurons during ischemia/reperfusion events depolarizing and destroying 
mitochondrial function [157]. This accumulation of labile zinc is believed to contribute or 
cause neuronal death following an ischemic event. There are many more examples of 
important discoveries derived from the use of mitochondrial targeted zinc probes 
although many of them need improved zinc probes to substantiate their claims. One 
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biological certainty is zinc accumulation in the mitochondria will cause mitochondrial 
dysfunction. 
Due to excess zinc the mitochondrial membrane potential will decrease thereby 
decreasing the ATP production without a strong proton gradient present to produce the 
ATP via the electron transport chain. This causes mitochondrial fragmentation, increased 
ROS production [44], depolarization of the mitochondria [3], and enzymes such as α-
ketoglutarate dehydrogenase, aconitase, all four complexes of the electron transport chain 
but with high affinity for NADH dehydrogenase (complex I), and cytochrome bc1 
complex (complex III) [42, 156, 158] involved in respiratory metabolism to be inhibited 
by zinc. The rise in mitochondrial zinc causes the formation and opening of the 
mitochondrial permeability transition pore (MPTP) which can then release apoptotic 
factors such as cytochrome c, DIABLO/SMAC, and apoptosis-inducing factor (AIF) 
which lead to cell apoptosis [4]. This mitochondrial apoptosis pathway has been 
described for numerous pathologies such as a type of Parkinson’s disease where the 
patients lack the PARK9 gene which encodes for the ATP13A2 protein [40, 41, 159]. 
The ATP13A2 protein is an ATPase that functions in cells to regulate zinc homeostasis 
by sequestering zinc into lysosomes [41]. When this ATPase is not present zinc cannot be 
sequestered in the lysosomes and accumulates in the mitochondrial matrix quickly 
overwhelming the mitochondria causing apoptosis as described above [41]. Zinc 
overcoming the mitochondria has been documented in ischemia, head trauma, and 
Parkinson’s disease [41, 42, 155, 160]. Zinc dynamics depend on many factors requiring 
probes that not only have a high specificity and sensitivity to zinc but also importantly 
have the ability to localize to specific locations within the cells to observe zinc micro-
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environments. In the above examples zinc concentrations in the mitochondria are 
dynamic in response to many different stimuli, in order to monitor and observe these zinc 
dynamics in live cells sensors targeted to specific locations in the cell are necessary. 
Knowledge that arose from experiments utilizing zinc sensors targeted to specific 
locations offers novel pathways for treatments of pathologies associated with zinc 
dyshomeostasis. 
The focus of this chapter surrounds the mitochondria and what zinc dynamics are 
occurring within and around the mitochondria. Labile zinc can dramatically alter 
mitochondrial function which places a high importance on the study of zinc dynamics in 
relation to mitochondrial function. Mitochondrial function has expanded from the initial 
view as only a bioenergetic source of ATP to an integral part in cell signaling events, 
multiple diseases, cell proliferation, and cell death [161]. A biological question that this 
chapter addressed is if the mitochondrial matrix will store excess zinc in the cell to 
muffle the labile zinc concentration. As stated previously zinc will cause mitochondrial 
dysfunction which would indicate the mitochondria would not be a location to store labile 
zinc although indirect evidence has suggested that the mitochondria may act as a source 
or supply of labile zinc [162, 163]. Various studies have shown that the total zinc 
concentrations in the mitochondria are high in several cell types such as the  mammary 
gland cells[162], prostate cells[42], and neurons[154, 164] suggesting that the labile zinc 
could potentially be high in these cells as well. In addition, labile zinc may be released 
from the mitochondria to the cytosol due to increased cytosolic zinc concentrations when 
the mitochondria were depolarized in cultured neurons [154].  Large concentration of 
labile zinc have been recorded in the mitochondria using the FloZin-3 small molecule 
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probe. This probe is not specific to the mitochondria although studies have shown 
through colocalization of a mitochondrial marker that high zinc is present in the 
mitochondria following lysosome permeabilization [165] or induced ischemic events 
[154, 157]. Although, direct quantitative measurements have reported the labile zinc 
concentration in the mitochondrial matrix is very low if not zero using several probes 
such as mito-eZinCh-2 (3.3 pM)[128], Mito-CA-DSRed2 (0.2 pM)[166] and mito-
ZapCY1 (0.14 pM)[123] in HeLa and PC12 cells. The uncertainty if the mitochondria is a 
storage site for zinc needed further attention with a higher sensitivity zinc probe and by 
investigating a variety of cell types. 
Another question related to mitochondrial zinc this chapter addresses pertains to the 
intermembrane space (IMS). This region of the mitochondria is between the inner 
membrane and the outer membrane of the mitochondria. The allure of this region lies in 
the mystery involving the zinc dynamics that occur there. It was still unclear if the zinc 
dynamics in the IMS are a separate moiety from the cytosol. The reason for the belief the 
IMS may be continuous with the cytosol is the integral membrane protein, Voltage 
Dependent Anion Channel (VDAC) or porin, present on the outer membrane of the 
mitochondria. This integral protein is permeable to molecules 3000 Daltons in size or 
less[167]. These channels are water filled and thought to be non-selective allowing 
hydrophilic solutes to pass through them via simple diffusion. It has been inferred that 
zinc ions can diffuse freely across the mitochondrial outer-membrane meaning that the 
zinc concentrations in the IMS are synonymous with the cytosolic zinc concentration 
[168, 169]. However, conflicting studies have shown that the VDAC channel is selective 
and only allows certain solutes through the pore [170]. In fact immunohistochemical, 
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biochemical, and electrophysiological methods have shown that the VDAC channel is not 
isolated in the outer membrane of the mitochondria but also located in other regions such 
as the plasma membrane of B lymphocytes[171] and the sarcoplasmic reticulum of 
skeletal muscle[170, 172]. These locations do not allow simple diffusion to occur with 
molecules below 3000 Daltons. The VDAC channel does have some degree of specificity 
of what can pass through, although the mechanism of how this specificity occurs is 
currently unknown. VDAC does remain permeable to Ca2+ ions meaning there is the 
potential zinc could pass through the channel via simple diffusion [170, 173]. Currently 
the view for zinc is that the VDAC channel is permeable to zinc similar to calcium 
thereby allowing the simple diffusion of zinc from the cytosol to the IMS or vice-versa. 
Although no studies have shown this to be valid there are other grounds for why zinc 
concentrations in the IMS may be vastly different from the cytosol. 
The IMS is a critical site for oxidative phosphorylation reactions which create free 
radicals such as superoxide and hydrogen peroxide which are neutralized in iron-sulfur 
clusters and metallothionien proteins [174]. The metallothionien proteins are major zinc 
buffering proteins that can covalently bind up to seven zinc ions. Studies have shown that 
oxidation can liberate zinc from metallothionien [91, 175]. Due to the high amount of 
oxidation-reduction reactions taking place within the IMS of the mitochondria the free 
zinc concentration could potentially be much higher than the cytosolic concentration of 
free zinc through the release of zinc from the metallothioniens. In addition due to the 
proton gradient from the electron transport chain the pH could potentially drop as well 
also resulting in reduction of the cysteines causing release of zinc from the 
metallothioniens [158]. It is also believed that metallothionien from the cytosol may 
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translocate to the mitochondrial IMS which can also result in the release of zinc when 
entering the redox and/or lower pH environment [158]. In order to address this debate, we 
created a zinc sensor specifically targeted to IMS of the mitochondria which has never 
before been performed. This allowed for direct analysis of the zinc dynamics occurring in 
this region. 
There are two proposed transport mechanisms for labile zinc uptake into the 
mitochondrial matrix; the mitochondrial calcium uniporter (MCU) and the MCU 
independent mechanisms such as ZnT2 protein [176-179]. The mechanism of the export 
of zinc from the mitochondria remains unknown. The MCU is believed to be permeable 
to zinc because of two studies performed using isolated mitochondria [177, 178]. The 
MCU is activated with elevated cytosolic calcium concentrations [180] . Using a 
subcellular targeting sensor to the cells in situ calculations of the calcium uniporter 
channel were tested. The INS-1 β cells were either depolarized or not depolarized in the 
presence of the inhibitor and compared to when the inhibitor was not present. 
Depolarization conditions found no difference in the zinc uptake to the mitochondrial 
matrix, although no depolarization found zinc levels increased faster in cells treated with 
the inhibitor which could be a result of ancillary inhibition of channels other than the 
calcium uniporter changing other factors in the cell to increase mitochondrial matrix zinc. 
The RU360 has been shown to affect a variety of other channels besides the MCU [181]. 
This work filled the gap in our current understanding about mitochondrial zinc 
dynamics occurring in the IMS as well as illuminating the zinc concentration in the IMS 
relative to the cytosol. This offers direct concrete evidence that the cytosolic zinc 
concentration is contiguous with the IMS zinc concentration. The ability to accurately 
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monitor zinc in different subcellular compartments with a sensitive sensor will provide 
insight into zinc dynamics and homeostasis within the cell. This can be taken further 
when examining disease models and monitoring zinc dynamics for ways to mitigate or 
reverse the damaging effects zinc may be causing in various diseases. 
3.2 METHODS 
MITOCHONDRIAL SENSOR PLASMID CONSTRUCTIONS 
For mito-mCherry-GZnP2 construction, three repeats of the coding sequence for the 
first 29 amino acids of the human cytochrome c oxidase subunit 8a (mitochondrial 
precursor; accession number NP_004065) was utilized for mitochondrial matrix targeting 
and incorporated into pcDNA3.1 vector using HindIII. The mCherry fragment was 
inserted between the BamHI and EcoRI restriction sites and the GZnP2 fragment was 
inserted between the EcoRI and XhoI restriction sites. Making a mitochondrial 
ratiometric zinc sensor. 
The fragment mCherry-GZnP2 was amplified from the template mito-mCherry-
GZnP2 and cloned into pcDNA3.1 vector using BamHI and XhoI restriction enzymes. 
This made the zinc sensor a ratiometric cytosolic sensor. 
To construct the SMAC-mCherry-GZnP2, the IMS targeting sequence was amplified 
using the template PCMV1-SMAC-HA-eGFP and cloned into pcDNA3.1 with BamHI 
and KpnI, then the fragment mCherry-GZnP2 was inserted between BamHI and XhoI 
restriction sites. pCMV1-SMAC-HA-eGFP was a gift from Richard Kahn (Addgene 




This microscope was the most utilized instrument in the experiments performed. A 
confocal microscope built by Solamere Technology Group and contains a Nikon Ti-
eclipse inverted fluorescence microscope with a Yokogawa CSUX1 spinning disk 
confocal system. Features of the confocal microscope include: Nikon Ti-E Perfect Focus 
System (PFS) for maintenance of sample focus, motorized XY stage with piezo Z-Drive 
insert for rapid multidimensional (XYZ) imaging, environmental chamber (LiveCell) 
with temperature, carbon dioxide, and humidity regulation, 4 Objectives: 10X (NA 0.45), 
20X (NA 0.75), 40X (NA 1.30), 60X (NA 1.4) and a 1.5X optivar, 6 Laser lines: 405 nm, 
445 nm, 488 nm, 514 nm, 561 nm, and 640 nm, Hamamatsu X2 EMCCD camera, LED 
light for Wide field illumination, and the capacity to operate in simultaneous imaging, 
photo activation, and FRAP modes. 
The microscope parameters are shown below in Table 9. These parameters were used 







































































































MAKING IMAGING DISHES 
Punch holes in the center of the Corning 10 mm x 35 mm imaging dishes (corning 
430165) using the hole punch. Use sand paper to extensively score the plastic around the 
punched hole. Make the glue mixture using a 9:1 ratio of Silicon Elastomer base & f 
Silicon Elastomer curing agent respectively. Use the P1000 pipette to distribute the glue 
evenly around the hole. Apply a glass cover slip on top of the glue being sure to not 
adhere multiple cover slips. Reapply glue around the perimeter of the cover slips after 
being attached to the imaging dishes to ensure a tight seal. Leave the dishes at room 
temperature overnight. 24 hours later leak test the dishes by adding 2 ml of MiliQ H2O to 
each dish. If a dish leaks discard the dish. Wash dishes with MiliQ H2O three times to 
remove any residual glue. Dry then sterilize the imaging dishes using UV light for 1 hour. 
CELL CULTURE 
HeLa cells, HEK293 cells, and Cos-7 cells were maintained in high glucose 
Dulbecco’s Modified Eagle Medium (DMEM) with 10% fetal bovine serum (FBS). INS-
1 cells were cultured in RPMI 1640 media with 10% FBS, 1% sodium pyruvate (100 
mM), 1% HEPES (1 M) and 0.1% 2-mercaptoethanol (2mM). All cell lines were 
incubated at 37 ˚C and 5% CO2. When placing INS-1 and Cos-7 cells in imaging dishes, 
the imaging dishes were precoated with 1 mg/ml of Poly-D-Lysine (PDL) to adhere the 
cells to the dishes. Dishes were incubated with PDL for 24 hours prior to being washed 
3x with DPBS to remove excess PDL. All cell lines were passaged once the cells reached 
~90% confluency for a maximum passage number of 15 passages. All cell lines were 
split by plating 50,000 cells into a cell culture flask. All cell lines except HEK293 cells 
were split 7 days later, HEK293 cells were split every 3 days due to their fast growth rate. 
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TRANSFECTION 
PEI (Polyethyleneimine) transfection reagent (dissolved to 1 mg/ml in water at pH 
7.2 and stored at -20 ˚C for long-term >1 month and 4 ˚C for short term <1 month) was 
used for the transfection in HeLa and HEK293 cells. Lipofectamine 3000 transfection 
reagent and lipofectamine buffer solution (P3000) was used as the transfection reagent 
for INS-1 and Cos-7 cells due to the difficulty in transfecting these cell lines. 
Transfection was performed when the cells were approximately 40-50% confluent.  For 
each transfection reaction in HeLa or HEK293 cells, 2 µl of PEI transfection reagent and 
1.25 µg of the sensor DNA were mixed in 250 µl OPTI-MEM.  The mixture was 
incubated for a minimum of 25 minutes at room temperature before direct addition to one 
imaging dish containing the cells. Transfection of INS-1 or Cos-7 cells was similar to the 
method used to transfect HeLa and HEK293 cells with slight modification. The following 
reagents: 500 µl of OPTI-MEM, 3.75 µl of Lipofectamine 3000 transfection reagent, 1.25 
µl Lipofectamine P3000 and 1.25 µg of the sensor DNA were mixed together. The 
reaction mixture was incubated for a minimum of 25 minutes at room temperature and 
then added the cultured INS-1 or Cos-7 cells.  Sensor can be expressed as little as 12 
hours post-transfection. Imaging was performed 48-72 hours post transfection. The ideal 
method for transfection using any method of transfection was found to be transfecting the 
cells 48 hours after splitting the cells at normal seeding concentrations for the imaging 
dishes (10 mm Corning). The cells were allowed to uptake and express the transfected 
plasmid for 48 hours then imaged. This produced the best results with high transfection 




Homemade competent Top10 cells are thawed on ice for 10 minutes. Once thawed 5 
µl of plasmid is added to the cells and left on ice for 30 minutes to allow the plasmid to 
accumulate around the cells. Heat shock was performed at 42 ˚C for 60 seconds to allow 
the insertion of the plasmid surrounding the cells. 250 µl of LB is then added and placed 
back on ice for 2 minutes to allow the phospholipids of the membrane to seal in the 
plasmid. This is then transferred to a 2 ml micro-centrifuge tube and shakes at 37 ˚C for 
45 minutes. The cells were then plated and incubated overnight on agar plates with the 
correct antibiotic. This method provides a medium level of transfection efficiency ideal 
for most situations unless it is more time effective to use a simple mix and go 
transformation or if this is not efficient enough electroporation would be the optimal 
choice. 
ELECTROPORATION 
The homemade electrocompetent cells are removed from the -80 ˚C freezer and left 
on ice to thaw for 10 minutes. Homemade electrocompetent cells were made by lab 
mates. The pellet is very dense in cells and needs to be diluted using 425 µl of GYT 
(glycerol, yeast extract, tryptone) buffer. Add 100 µl of the diluted competent cells to the 
1 mm cuvette and the plasmid. Pipette up and down to mix thoroughly. Place back on ice. 
For the electroporation instrument select Bacteria, 1 mm, pulse the cells. Within one 
minute add 250 µl of LB to the cuvette. Keep the cuvette on ice. Incubate on the shaker at 
250 rpm and 37 ˚C for one hour. Remove and plate the solution using the correct 
antibiotic. This method is used for extremely difficult transformations such as 
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mutagenesis where the plasmid concentration is extremely low and we need a high 
transformation efficiency. 
CLONING PROTOCOLS 
PCR, restriction digest, and ligation were all used to perform cloning procedures 
throughout this work. 
QUANTIFICATION OF ZINC CONCENTRATION IN THE CYTOSOL, IMS, 
AND MATRIX 
Sensor constructs were transfected into cells and imaged 48-72 hours post-
transfection. Imaging experiments were performed on a Nikon/Solamere CSUX1 
spinning disc confocal microscope. Images were collected with a 40× 1.3 NA oil 
objective and imaging data was acquired using the MicroManager software. The settings 
used for the 488 nm laser were an exposure time of 100 ms and laser power of 10% and 
for the 561 nm laser an exposure time of 50 ms and laser power of 3%, 20 second 
acquisition times were used for all image stacks. Cells were imaged in phosphate-free 
HHBSS, pH = 7.4.  For sensor calibration, cells were treated with 100 μM TPEN for the 
minimum signal (Imin) and 1.25-5 μM pyrithione and 20 μM ZnCl2 to establish the 
maximum signal (Imax). The pyrithione concentration had to be manipulated based on the 
response of some of the sensors. Pyrithione can decrease the stability of the zinc 
concentration by chelating zinc when pyrithione concentrations are too high and this is 
detected by cytosolic sensors. Because unhealthy cells could demonstrate compromised 
sensor response, we only chose the cells with dynamic ranges from 3-4.5 for 
mitochondrial matrix quantification and dynamic ranges 4-6 for cytosolic measurement. 
This eliminated artifacts imposed by unhealthy cells. 
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Refer to Appendix A for details on the image analysis performed to quantify the zinc 
concentration. 
MONITOR CELLULAR ZINC DYNAMICS IN THE MITOCHONDRIAL 
MATRIX, IMS AND CYTOSOL 
To monitor zinc uptake when cells are loaded with high zinc, sensor constructs were 
transfected into INS-1 pancreatic β-cells and imaged 48-72 hours post-transfection.  
Imaging experiments were performed using the same methods described above for the 
microscope and microscope settings.  Cells were imaged in the phosphate-free HHBSS 
buffer, pH = 7.4 with or without extracellular CaCl2. To record the cellular zinc transport 
as close to physiological conditions as possible, cells were maintained in an 
environmental chamber at 37 ˚C, 5% CO2 and 50-70% humidity. Cell depolarization was 
induced using a high KCl HHBSS buffer (100 mM KCl, 1.1 mM MgCl2, 16.8 mM D-
Glucose, 20 mM HEPES, and 41.14 mM NaCl, at pH 7.4). The HHBSS buffers used for 
depolarization were also supplemented with 100 µM ZnCl2 if adding extracellular zinc to 
the media was used for the experiments. All imaging buffers used for the imaging were 
preincubated in a bead bath at 37 ˚C until the buffers reached 37 ˚C. This prevented 
thermal drift from occurring while imaging and after drug treatments of cells as well as 
maintaining a physiological temperature throughout the experiments. When using the 
inhibitor RU360 a concentration of 10 µM was used in each imaging dish. The cells were 
incubated in the RU360 for 30 minutes prior to imaging experiments and maintained at 
10 µM throughout all the imaging buffer changes. 
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3.3 RESULTS/DISCUSSION 
The GZnP2 sensor was used for the zinc quantification of cytosolic, mitochondrial 
matrix, and mitochondrial intermembrane space. The GZnP2 sensor described in chapter 
2 was further modified to account for z-axis drift and expression level variation. Since the 
sensor relies on intensity changes to report the labile zinc concentration changes in either 
the expression level or z-axis can lead to artificially low or high zinc concentrations. 
Changes in the z-axis can result from thermal drift, drug additions, or movement of the 
cell which need to be accounted for due to the changes in the GZnP2 signal. Expression 
levels will change due to the highly dynamic nature of mitochondria undergoing 
morphology changes through frequent fission and fusion as well as variations across cells 
expression of the sensor. Another dynamic factor is the mitochondria move continuously 
through cellular trafficking quickly changing the brightness of a sensor. For these reasons 
we attached GZnP2 with a stable red fluorescent protein mCherry which is insensitive to 
zinc for normalization. The excitation and emission peaks do not bleed through to the 
GZnP2 signal offering a great strategy to convert our intensiometric sensor into a 
ratiometric sensor with the benefits of both types of sensors and none of the drawbacks. 
This strategy has been performed before for labile calcium quantification and shown to 
provide better quantitative analysis of labile metal concentrations [182]. Using this 
strategy, we created three sensors mCherry-GZnP2 for the cytosol, mito-mCherry-GZnP2 
for the mitochondrial matrix and SMAC-mCherry-GZnP2 for the IMS see Figure 14A. 
The cytochrome c subunit 8, which is a frequently utilized tag for mitochondrial matrix 
localization [123], was used to construct mito-mCherry-GZnP2 see Figure 14A & B.  The 
second mitochondria derived activator of caspases (SMAC) was used to target SMAC-
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mCherry-GZnP2 to the mitochondrial IMS see Figure. 14A & C as this SMAC signal 
peptide has been reported previously as an IMS target [183]. The sensor with no 
subcellular tag, mCherry-GZnP2 resides in the cytosol and nucleus see Figure 14A & D. 
 
Figure14: Compare Zinc Measurements in the Mitochondrial Matrix, IMS, and 
Cytosol. (A) Diagram showing the subcellular locations of GZnP2 in the mitochondrial 
matrix, IMS, and cytosol.  The mito-mCherry-GZnP2 is targeted to the mitochondrial 
matrix using the cytochrome c oxidase subunit 8a, the SMAC-mCherry-GZnP2 sensor 
localizes to the IMS using the SMAC/DIABLO protein, while the mCherry-GZnP2 
sensor with no targeting sequence resides in the cytosol. (B-D) Representative images of 
the sensors in HeLa cells at baseline for mito-mCherry-GZnP2 (B), SMAC-mCherry-
GZnP2 (C), and mCherry-GZnP2 (D). (E-G) Representative calibration curves showing 
the percent saturation of the sensor in the mitochondrial matrix (E), IMS (F), and cytosol 
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(G) in HeLa cells. The specific Zn2+ chelator TPEN (100 µM) was used to yield 0% 
saturation, while 5 µM pyrithione and 20 µM ZnCl2 was used to yield 100% saturation. 
 
 
Figure15: Representation of the mCherry-GZnP2 Sensor in Apo and Bound State. 
Subcellular locations where the mCherry-GZnP2 sensor was localized. 
 
Each sensor was calibrated in the three different subcellular compartments 
(mitochondrial matrix, IMS, and cytosol) to compare zinc concentrations in each 
compartment of HeLa cells, see Figure 14E-G. Cellular zinc was chelated using 100 µM 
TPEN for 5 minutes reducing the sensor signal to the minimal saturation (0% zinc), while 
treatment with 5 µM Pyrithione and 20 µM ZnCl2 yields 100% sensor saturation (bound 
to zinc).  
The resting baseline % saturation of mito-mCherry-GZnP2 (matrix zinc) was close to 
0% saturation, while both SMAC-mCherry-GZnP2 and mCherry-GZnP2 were 
approximately 20% saturated by zinc in the resting baseline state see Figure 14E-G.  
Although both mito-mCherry-GZnP2 and SMAC-mCherry-GZnP2 presented the same 
pattern of mitochondrial localization shown in Figure 14B & C, their calibrations 
95 
baseline plots were vastly different as shown in Figure 14E & F. This confirms that these 
two sensors were targeted to the two distinct regions within mitochondria (IMS and 
matrix). The results of the calibration suggest that labile zinc in the mitochondrial matrix 
is substantially lower than cytosolic and IMS labile zinc concentrations, while labile zinc 
concentrations in the IMS and the cytosol are the same. The GZnP2 sensor fluorescence 
was not affected by hydrogen peroxide suggesting that the mild redox environment of the 
mitochondria will not affect the GZnP2 signal (Figure 16). Both the SMAC-GZnP2 and 
mito-GZnP2 showed high Colocalization (Pearson Coefficient >0.85) refer to Figure 17. 
 
Figure 16: Effects of H2O2 on the GZnP2 Sensor. The effect of H2O2 on the sensor 
was evaluated in vitro  in a reducing environment (0.5 mM TCEP) and in a natural 
environment (without TCEP). There was no statistically significant difference for the 
sensor fluorescence treated with hydrogen peroxide (0-1mM). Statistical significance was 
calculated using one way ANOVA post hoc Tukey. 
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Figure 17: Colocalization of SMAC-GZnP2 and mito-GZnP2 with known 
mitochondrial markers.  HeLa cells expressing mito-GZnP2 (A) were stained with 
MitoTracker red (B).  (C) The merged picture of a and b exhibited high colocolizaiton.  
The Pearson coefficient for mito-GZnP2 and Mitotracker red was 0.92 ± 0.009 (A-C).  
HeLa cells expressing SMAC-GZnP2 (D) were stained with TMRM (E).  The merged 
picture of d and e exhibited reasonable colocaliztion.  The Pearson coefficient for SMAC-
GZnP2 and TMRM was 0.85 ± 0.02 (D-F). A minimum of three different replicates were 
performed, n=50. 
This work was expanded to four cell types to quantify the zinc concentrations in the 
mitochondrial matrix and IMS, and the cytosol and determine if the pattern found using 
HeLa cells remained consistent. In situ calibrations were carried out using HeLa cells, 
African green monkey kidney fibroblast (Cos-7) cells, human embryonic kidney 293 
(HEK 293) cells, and rat pancreatic insulin secreting β (INS-1) cells. The GZnP2 sensor 
fluorescence intensity was normalized to the mCherry intensity, the normalized signal 
was then used to calculate the labile zinc concentrations in each subcellular compartment 
(mitochondrial matrix and IMS). In all four cell types evaluated the mitochondrial matrix 
labile zinc concentration was estimated to be less than 1 pM as shown in Figure 18A, 
Figure 19 & Table 10. These results support the mitochondrial matrix does not store zinc 
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and contains minimal labile zinc, at substantially lower concentrations than the cytosol. 
Provided that many mitochondrial matrix enzymes such as glutamate dehydrogenase, α-
ketoglutarate dehydrogenase, and aconitase can be inhibited by labile zinc, low zinc 
concentrations in the mitochondria will prevent these important enzymes from being 
deactivated and ensure efficient energy production required for proper mitochondrial 
function[42, 156, 158] [45, 184] [185].  High zinc concentrations in the mitochondria 
would be deleterious to cells by decreasing or halting production of ATP [44] further 
supporting the low concentrations of zinc observed in the matrix of the mitochondria. It 
appears that zinc does not infiltrate the mitochondrial matrix to decrease the 
mitochondrial function potentially leading to cell apoptosis. 
 
 
Figure 18: Comparison of Labile Zinc Concentrations among Four Cell Types within 
the Mitochondrial Matrix, IMS and Cytosol. (a) In the mitochondrial matrix, the highest 
zinc concentrations were in HEK293 cells and the lowest zinc concentrations were in 
Cos-7 cells. All were less than 1 pM. (b)The labile zinc concentrations in IMS were 
calculated to be between 60-100 pM.  The only difference observed for IMS zinc 
concentrations were between INS-1 cells having higher IMS zinc than Cos-7 cells. 
(c)There was no difference among different cell types for cytosolic concentration of 
labile zinc. The error bars indicate SEM (standard error of the mean). * indicates a p < 
0.05 and ** indicates p < 0.01, p values were determined using the t-test with unpaired 
data and unequal variance. Error bars are standard error of mean. 
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Figure 19: Representative Calibration Curve for Mitochondrial Matrix of Four Cell 
Types. HEK293 (a) cells showed response to TPEN while the other cell three types Cos-7 
(b), HeLa (c), and INS-1 (d) cells showed no response to TPEN. 
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Table 10: Measurement of Zinc Concentrations in the Mitochondrial Matrix, IMS and 
Cytosol Among Various Cell Lines. The mean and standard error of mean were reported. 




Matrix IMS Cytosol 
Cos-7 
0.0010 ± 0.00055a (n = 
5) 65 ± 4.3d (n = 7) 79 ± 8.1de (n = 12) 
HEK 0.50 ± 0.21c (n = 21) 100 ± 16de (n = 11) 120 ± 28de (n = 11) 
HeLa 0.0070 ± 0.0025b (n = 7) 89 ± 12de (n = 11) 76 ± 9.6de (n = 16) 
INS-1 0.0040 ± 0.0029b (n = 8) 99 ± 15e (n = 21) 94 ± 16de (n = 26) 
 
The zinc concentration in the IMS and the cytosol were the same across all four cell 
types tested. The zinc concentration in the cytosol was between 75-115 pM and the zinc 
concentration in the IMS was between 65-100 pM see Figure 18B & C and Table 10. The 
homogeneity between the IMS and the cytosol of all four cell types suggests the outer 
mitochondrial membrane is permeable to zinc allowing passive diffusion of zinc between 
the IMS and cytosol likely through the VDAC protein. 
We then compared the zinc concentration in the mitochondrial matrix between the 
four cell types analyzed. Interestingly a high heterogeneity was found in the zinc 
concentration in the mitochondrial matrix with the highest zinc concentration being in 
HEK293 cells (0.5 pM) and the lowest in the Cos-7 cells (0.001 pM) also refer to Table 
10 and Figure 18A. There was almost no heterogeneity between the IMS and cytosol zinc 
concentration of all the four cell types tested see Figure 18B & C & Table 10. The lack of 
heterogeneity is possibly due to the cytosol and IMS containing high capacity zinc 
buffering proteins such as metallothionien and glutathione[110, 174, 186, 187], which 
maintain static zinc concentrations in both compartments (IMS & matrix) while the 
mitochondrial matrix lacks any evidence of containing such zinc buffering proteins. This 
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lack of zinc buffering proteins may also be the reason for the cell variability in 
mitochondrial matrix zinc concentrations. The mitochondria may lack these zinc 
buffering proteins since zinc is prevented from entering the mitochondrial matrix 
therefore there would be no need to have such zinc buffering proteins. All zinc 
concentrations were calculated using an adjusted pH for the mitochondrial matrix which 
is typically around 8 instead of pH 7.4 for the cytosol and the IMS. 
To address the other question proposed at the beginning of this chapter whether the 
mitochondria is a sink for labile zinc we analyzed zinc transport in the matrix, IMS, and 
cytosol of INS-1 pancreatic β cells. The mitochondria has been reported to be a location 
for zinc sequestration within cells under stress [154, 163]. One example is the 
mitochondria have been reported to uptake labile zinc following ischemia/reperfusion in 
neurons [154, 157]. We will evaluate this further to see if the mitochondria can perform 
the function of a sink to sequester excess labile zinc and lower cytosolic labile zinc 
concentrations. INS-1 pancreatic β cells will be used to observe the zinc dynamics after a 
large influx of zinc. Previous studies have shown that high labile zinc can flux into 
pancreatic β cells through voltage dependent calcium channels when the cells are 
depolarized [54, 188]. Utilizing this method we induced zinc influx into pancreatic β cells 
and observed the zinc uptake into the cytosol, IMS, and the mitochondrial matrix. INS-1 
pancreatic β cells were depolarized using high concentrations of KCl (100 mM) in the 
presence of high extracellular zinc (100 µM), while control cells were only treated with 
high extracellular zinc, both were performed in calcium free containing buffer see Figure 
20A-B. In the presence of extracellular calcium 100 µM zinc and 100 mM KCl quickly 
induced cell death, therefore the concentration of zinc was reduced to 50 µM to prevent 
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cell death see Figure 20E. Depolarized zinc influx into the cytosol and mitochondrial 
IMS were faster and ended with a higher intracellular zinc concentration when compared 
to controls not using depolarization see Figure 20B & C and was similar between the two 
subcellular compartments Figure 20F. This further supports that labile zinc can passively 
diffuse between the cytosol and the IMS. Although depolarization did not cause more 
zinc uptake into the mitochondrial matrix which was independent of extracellular calcium 
(Figure 20A & E, & 21). These results show that higher cytosolic zinc did not induce 
higher zinc flux into the mitochondrial matrix only into the IMS (Figure 20B & C). 
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Figure 20: Observing Zinc Uptake in the Mitochondrial Matrix, IMS, and Cytosol of 
INS-1 Cells with and without Depolarization. 100 mM KCl was used to induce 
depolarization. (A-C) The zinc uptake in the mitochondrial matrix (A), IMS (B) and 
cytosol (C) in INS-1 cells treated with 100 µM ZnCl2 with or without 100 mM KCl in the 
absence of extracellular calcium. Higher zinc was taken into the cytosol and IMS when 
depolarized, but not the matrix. (D) The calcium uptake in the cytosol and mitochondrial 
matrix recorded using GGECO1 and mito-RGECO1 in INS-1 cells treated with 100 mM 
KCl. The mitochondria rapidly sequestered a substantial amount of calcium while the 
cytosolic calcium increased and dropped back to baseline quickly. (E) The zinc uptake in 
the mitochondrial matrix of INS-1 cells treated with 50 µM ZnCl2 with or without 100 
mM KCl in the presence of extracellular calcium. Extracellular calcium did not induce 
more zinc uptake into mitochondrial matrix when cells were depolarized. (F) A 
comparison of the maximal zinc concentrations in the mitochondrial matrix, IMS, and 
cytosol of INS-1 cells incubated with 50 or 100 µM ZnCl2 with or without depolarization. 
There is a significant difference between the control and depolarized cells for zinc 
concentrations in the cytosol and IMS, but no statistically significant difference was 
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recorded in the mitochondrial matrix between the control and the depolarized cells with 
and without extracellular calcium. (G) and (H) show that there is no difference between 
addition of RU360 the active inhibitory component of ruthenium red on the uptake of 
zinc into the mitochondria. *** signifies p < 0.001. 
 
Figure 21: Zinc uptake in the mitochondrial matrix and IMS after depolarization. 
INS-1 β-cells were depolarized using a high potassium solution (100 mM) in 
combination with 100 µM ZnCl2 to allow the influx of zinc ions into the cells.  (A & 
B)The zinc concentrations in the mitochondrial matrix were monitored by the sensor 
mito-mCherry-GZnP2 before (A) and after (B) depolarizaiton with 100 µM ZnCl2 . (C & 
D) The zinc concentrations in the mitochondrial IMS were monitored by the sensor 
SMAC-mCherry-GZnP2 before (C) and after (D) depolarizaiton with 100 µM ZnCl2. The 
experiments were performed in HHBSS buffer without phosphate or calcium at pH = 7.4. 
 
When INS-1 cells are depolarized, calcium will influx into the cytosol of the cells 
activating the MCU with a high calcium concentration causing the cytosolic calcium to 
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then flux into the mitochondrial matrix via the MCU [180]. Consistent with previous 
studies the cytosolic calcium initially increased dramatically following depolarization 
although the calcium concentration rapidly dropped off  shortly after, while the 
mitochondrial matrix calcium increased rapidly then plateaued at a high concentration 
(Figure 20D). This confirms that the mitochondria muffles the excess calcium by acting 
as a storage site to sequester excess calcium when the cytosolic calcium concentrations 
are increased too high. Unlike calcium, zinc was not sequestered into the mitochondrial 
matrix after depolarization and the cytosolic zinc concentration was not buffered 
immediately after being increased (Figure 20A-C). This was true in the presence of 
calcium which should activate the MCU allowing zinc to be taken into the mitochondria 
(Figure 20E). This conflicts with previous studies results claiming the MCU can mediate 
mitochondrial zinc uptake. We believe the difference in the results was a result of 
previous studies being performed on isolated mitochondria while these studies were 
performed using native mitochondria. To further support this finding we observed the 
zinc uptake into the mitochondrial matrix under high zinc conditions with and without the 
MCU inhibitor RU360. In the presence of RU360 we observed a slightly faster uptake of 
zinc into the mitochondria contrary to what was expected using an inhibitor of the MCU, 
Figure 20G. Although under depolarization conditions there was no change in the zinc 
uptake into the mitochondrial matrix. Given that all previous evidence supporting the 
permeability of MCU to zinc were collected from isolated mitochondria [177, 178], the 
metal selectivity of MCU can differ from an in situ environment. The data supports 
another mechanism for zinc transport to the mitochondrial matrix other than the MCU. 
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Further testing needs to be performed to clarify the roles of the MCU in regulating 
mitochondrial zinc in living cells. 
Both the low mitochondrial zinc under resting conditions and the finding of zinc not 
being stored in the mitochondria supports our logic before performing the experiments. 
Logically the cell would store zinc in a location where the zinc would not disturb any 
cellular process hence performing the function of a cellular buffer. If the zinc was stored 
in a compartment such as the mitochondria then it would defeat the purpose of a storage 
site for excess zinc. This is what led to our investigation into the question if the 
mitochondria was performing the function of a zinc sink since the mitochondria is highly 
affected in a negative manner by zinc that has the potential to ultimately cause cell 
apoptosis is this really a storage site for excess zinc? Our results show the mitochondria 
is not a storage site for excess zinc which coincides with our logic dictating that the 
mitochondria should not be a sink of zinc due to mitochondrial enzymes being inhibited 
decreasing the energetic output of the cell while also releasing apoptotic factors into the 
cell. This makes the mitochondria one of the last places the cell would want to store 
excess zinc in, if there is a scenario where high zinc permeates the cell. 
One other aspect tested during this chapter was the effect of mild redox stress 
inducing cellular zinc dynamics. After we measured the zinc distributions in the 
mitochondrial matrix, IMS, and cytosol in cells at resting state, we then investigated zinc 
oscillation in these compartments when cells were exposed to redox stress. A few studies 
have shown that mitochondrial matrix zinc was increased by redox stress either induced 
by high glucose or incorporation of 50 µM hydrogen peroxide [165, 189].  Here we 
introduced mild oxidative stress in HeLa cells using low concentrations of hydrogen 
106 
peroxide (100 µM). Hydrogen peroxide is a natural by product from oxidative 
phosphorylation occurring within the mitochondria. Using a hydrogen peroxide 
fluorescent sensor (Hyper-Red), we showed that 100 µM hydrogen peroxide simulates 
oxidative stress within the cell (Figure 22C). The hydrogen peroxide concentration in the 
cell can reach the milimolar range as estimated from the Km of catalase ~1.2 mM [190] 
and ~45 µM for peroxidases indicating that 100 µM is within physiological conditions. In 
addition, we found that 100 µM hydrogen peroxide did not alter mitochondrial membrane 
potential by measuring mitochondria membrane potential using the mitochondrial dye 
TMRE (Figure 22D), further confirming that mitochondria membrane potential was not 
dissipated with brief exposure to mild redox. Because the cysteine residues in the zinc 
binding motif of GZnP2 sensor could be oxidized by hydrogen peroxide, we examined 
how sensor fluorescence was affected by different concentrations of hydrogen peroxide 
(Figure 16). No significant difference in sensor fluorescence was detected in purified 
GZnP2 protein exposed to 0-2 mM hydrogen peroxide concentrations (Figure 16), 
suggesting that GZnP2 was not affected by low concentrations of hydrogen peroxide.  
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Figure 22: Hydrogen Peroxide Zinc Increase Detected Using Other FP & Hydrogen 
Peroxide Permeates Cell. (A) Mito-ZAPCY1 a mitochondrial matrix zinc FRET sensor 
detects there is an increase in labile zinc upon addition of 100 µM H2O2. (B) Mito-
ZAPCV5 is another mitochondrial zinc FRET sensor also detects an increase in 
mitochondrial matrix labile zinc upon addition of 100 µM H2O2. (C) The hydrogen 
peroxide sensor PC1-Hyper-Red detected an increase in the cytosolic hydrogen peroxide 
when 100 µM hydrogen peroxide was added to the extracellular milieu. (D) 
Mitochondrial membrane potential after hydrogen peroxide addition. After dying the 
cells with TMRM results show no change in the mitochondrial membrane potential after 
the addition of the 100 µM hydrogen peroxide. The different colors correspond to 




Figure 23: Mild redox by hydrogen peroxide induced zinc dynamics in the 
mitochondrial matrix, IMS, and cytosol. The changes in zinc after HeLa cells were 
treated with 100 µM hydrogen peroxide in different subcellular locations: (A) the 
mitochondrial matrix using mito-mCherry-GZnP2 (B) the IMS using SMAC-mCherry-
GZnP2 and (C) the cytosol using mCherry-GZnp2. 
We recorded zinc dynamics in HeLa cells treated with 100 µM hydrogen peroxide.  
Consistent with previous studies using high concentrations of hydrogen peroxide, we 
found that mild redox also increased the labile zinc in the mitochondrial matrix (Figure 
23A). The same results were found using the FRET based mitochondrial zinc sensors 
mito-ZAPCV5 & mito-ZapCY1 (Figure 22A & B).  Surprisingly, we found that labile 
zinc within the IMS and the cytosol were reduced with treatment of low hydrogen 
peroxide (Figure 23B & C), suggesting that zinc might be transported from the cytosol 
and IMS into mitochondrial matrix under mild redox.  The transporter or channel proteins 
localized in mitochondrial inner-membrane might mediate such zinc communications. 
For example, studies have shown the TRPM2 channels can be activated by hydrogen 
peroxide and induce more zinc uptake into the mitochondrial matrix [165]. The increased 
mitochondrial zinc under mild redox might modify the activities of mitochondrial 
enzymes as mentioned above through enzyme inhibition and hence alter mitochondrial 
function. The GZnP sensor fluorescence can be perturbed by changes in pH as mentioned 
in chapter 1 because of the chromophore protonation at low pH [78]. With 100 µM 
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hydrogen peroxide, the cellular pH was altered (Figure 24), confirming that any GZnP2 
signals induced by hydrogen peroxide were likely a result of pH changes. 
What we learned while investigating the redox stress relationship with zinc was to 
check all possible artifacts prior to continuing with an investigation. We had solid logic 
for what we thought were observed changes in zinc concentrations although these 
changes were artifacts of the pH changing altering the binding affinity of our GZnP 
sensor. When the pH increased after the addition of hydrogen peroxide the sensors 
binding affinity for zinc increases as observed in the difference of dissociation constants 
between pH 7.4 & 8 for the cytosol and mitochondrial matrix increasing the brightness of 
the sensor. This increase in the binding affinity (decrease in dissociation constant) makes 
the sensor bind better to zinc making the sensor brighter despite there not being any more 
zinc present in the environment. From this we learned that obvious pitfalls of experiments 




Figure 24: PH Changes in the Mitochondrial Matrix Following H2O2 Addition. The 
sensor mito-PHuji was transfected into HeLa cells and then treated with hydrogen 




























In this chapter we constructed three probes for recording zinc concentrations and 
dynamics within the mitochondrial matrix, IMS, and cytosol. We developed the first zinc 
sensor targeted to the mitochondrial IMS, providing the first direct evidence of zinc 
concentrations & dynamics in this location. By constructing the different subcellularly 
targeted sensors from the same sensor we avoided variations in the biophysical features if 
different sensors were used providing a better platform to compare zinc concentrations 
among the different subcellular compartments. 
We were able to quantify the labile zinc concentrations occurring in the mitochondrial 
matrix, IMS, and cytosol of the cells at resting conditions as well as observe the zinc 
dynamics when the cells were exposed to excess zinc. First we found that the zinc 
concentration in the cytosol and the mitochondrial IMS are the same across all four cell 
types tested. This same finding was confirmed when depolarizing INS-1 pancreatic β 
cells with extracellular zinc, the zinc influx was the same between the cytosol and the 
mitochondrial IMS. We believe the non-selective VDAC channels located on the outer 
membrane of the mitochondrial membrane facilitate the diffusion of zinc between the 
cytosol and the IMS. Second we found the mitochondrial matrix zinc concentrations are 
heterogeneous between the four different cell types tested. Despite this heterogeneity the 
zinc concentration in the mitochondrial matrix remains well below 1 pM in all cell types. 
A 1 pM concentration when taking into account the volume of mitochondria equates to 0-
1 free zinc ions being present in the mitochondrial matrix. This difference in the zinc 
concentrations may be a result of the mitochondrial matrix lacking zinc buffering proteins 
that are present in the cytosol and the IMS of the cell. These proteins are not present in 
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the matrix of the mitochondria likely because no zinc is brought into the mitochondria. 
Lastly we determined that zinc does not sequester into the mitochondrial matrix faster or 
in higher concentrations when the cytosolic zinc is increased. This data suggests that the 
mitochondrial IMS not the matrix may sequester excess zinc. Although these experiments 
were performed over 30 minutes meaning over longer periods of time the mitochondrial 
matrix could act as a potential site for the sequestration of excess zinc. Finally we found 
that hydrogen peroxide may cause zinc dynamics to be altered but due to the hydrogen 
peroxide causing the pH of the cell to change our genetically encoded sensors could not 
reliably confirm if there was a change in the labile zinc concentrations. For potential 
future experiments calibration of the mCherry-GZnP2 sensors could be performed for pH 
changes as done for GZnP3 in chapter 2. 
In conclusion we developed new sensors that can monitor zinc distributions in the 
mitochondrial matrix, IMS, and cytosol, providing the first direct measurement of zinc 
concentrations in the mitochondrial IMS showing the benefits of these new probes for 
recording zinc concentrations and dynamics. Importantly we established the 
mitochondrial matrix and IMS perform different roles in regulating cellular zinc 
homeostasis. These new zinc sensors will provide scientists with tools to evaluate zinc 
concentrations in these two distinct regions of the mitochondria despite the resolution 




CHAPTER FOUR:  ZINC’S AFFECT ON MICROTUBULE-BASED 
CELLULAR TRAFFICKING 
4.1 INTRODUCTION 
All cells are surrounded by a lipid membrane that separates the interior of the cell 
from the environment the cell survives in. Eukaryotic cells expanded on this concept to 
create lipid membranes and subcellular compartments within the cell. This idea allowed 
for the expansion from single celled organisms to vast multicellular organisms arguably 
one of the most advantageous evolutions of a cell. One requirement for a 
multicompartmental cell is the cell must have the ability to communicate between the 
different compartments of the cell. One of the main methods for communication is 
through vesicular transport, endocytic, and exocytic transport all of which rely on the 
cytoskeletal network. These pathways govern protein transport, protein modification, 
disposal of waste, distribution of necessary biological materials, communication with the 
cell environment, etc. [191]. All of these processes have intricate relationships with each 
other for example the endocytic and exocytic pathways must regulate each other to 
maintain compartmental sizes after fusion events. These relationships rely on 
sophisticated machinery and communication between different compartments of the cell. 
The cytoskeletal network is the key player in communication and transport within the 
cell. The cytoskeletal network relies on three separate components for tracks within the
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cell; microtubules, intermediate filaments, and actin (microfilaments). Microtubules rely 
on the motor proteins from the kinesin and dynein family to transport cargo such as 
organelles long distances within the cell [192]. The intermediate filaments are not known 
to transport cargo within the cell rather they perform the function of structural support for 
the cell [193]. Actin is responsible for cellular trafficking small distances, structural 
support, and cell movement with the motor proteins in the myosin class utilizing these 
filaments [194]. The entirety of these processes is not well understood offering 
opportunities to discoveries of how the cell regulates cellular transport. The long distance 
cellular trafficking is the focus of this chapter. 
One piece of technology that has advanced the progress of cellular trafficking 
immensely is live cell microscopy. This instrument above all others has advanced our 
knowledge of trafficking because of the inherent nature of trafficking involving 
movement and live cell imaging being able to track this movement using time lapse 
videos. Although live cell samples can be converted to non-living samples to 
accommodate static measurements the more the sample digresses from its native state the 
higher chance of introducing artifacts. One of the principal questions pertaining to 
cellular trafficking is how the cell coordinates the movement of all intracellular cargos. 
One impressive example of the importance of cellular transport is the construction 
and maintenance of a complex functioning neurons. Neurons contain active synapses 
requiring basic building materials such as lipids, proteins, carbohydrates, mitochondria, 
synaptic vesicles, etc. that must be sorted to locations sometimes spanning meters in 
length [195, 196]. It is common knowledge that intracellular transport in neurons is 
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performed by motor proteins that either travel along microtubules or actin filaments. 
Actin filaments are responsible for short range movement of cargo carried by motor 
proteins from the myosin family [197, 198]. Microtubules are commonly used for long 
range trafficking to axon terminals or from terminals to the soma of the neurons. 
Microtubules rely on two classes of motor proteins, kinesin motors traveling in the 
anterograde or “plus” direction of the microtubule and the cytoplasmic dynein motor 
protein which travels in the retrograde or “minus” direction of the microtubules [199-
201]. Both the kinesin and dynein proteins are ATPase proteins require the hydrolysis of 
ATP for binding to and directed movement on microtubules. 
Human kinesin is a superfamily of 45 motor proteins broken down into 14 
subfamilies (named kinesin1-14) based on structure [199]. The structure of kinesin is a 
dimer of kinesin heavy chain (KHC) subunits and a dimer of kinesin light chain (KLC) 
subunits[202]. This structure can vary across the 14 subfamilies of kinesin although this 
is the prototypical structure of kinesin-1. The KHC subunits are the motors and 
microtubule binding domain for the protein which are conserved across all the 
subfamilies of kinesin proteins. The microtubule binding domain (MTBD) and the ATP 
binding domain both are on KHC and completely conserved for all the kinesin motor 
proteins. The KLC bind cargos for transport. KHC is typically ~60 kDa and KLC is ~32 
kDa. The kinesin motor proteins affinity for microtubules is highest when bound to ATP. 
Almost the entirety of kinesin walk in the anterograde direction (+) although a select few 
can also walk in the retrograde direction (-), for this work we will monitor only kinesin 
that travel in the anterograde direction. 
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The dynein motor proteins are responsible for retrograde movement along 
microtubules typically originating at the microtubule organizing center at the center (near 
the nucleus) of the cell. When scientists discovered dynein is a member of the AAA+ 
protein superfamily [203] it was surprising since AAA+ proteins typically function by 
unfolding proteins not behaving as a molecular motor. Another surprise was dynein’s 
structure and function were both expected to be similar to kinesin although both are 
completely different, kinesin retains more similarity to myosin motor proteins despite 
moving on different tracks (actin vs microtubules) [204]. Dynein’s structure contains six 
AAA+ rings forming a bound hexameric ring structure referred to as dynein heavy chain 
because of its size ~500 kDa. This heavy chain is the motor of the protein and is linked to 
dynein intermediate light chain, dynein intermediate chain, dynein light chain which help 
the motor bind cargo. On the other end of the heavy chain is the stalk with the 
microtubule binding domain. Cytoplasmic dynein is a colossal 1.5 MDa dimer of dimers 
making this motor not only significantly larger than kinesin but so large it is only half the 
size of the largest protein ever found titin (~3 MDa) [205]. Cytoplasmic dynein is 
responsible for almost all retrograde transport in neurons and most cells. Cytoplasmic 
dynein has a high affinity for microtubules when unbound to ATP [206] opposite 
kinesins binding affinity. Cytoplasmic dynein is the only form of dynein actively 
performing retrograde movement in the cell which varies dramatically from the 45 
different kinesin proteins responsible for anterograde movement. 
From the brief description of the two microtubule-based motor proteins it is obvious 
how vastly different these two classes of proteins are both in their structure and function 
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despite employing the same microtubule tracks. Both of these proteins have different 
origins that coincided to form motor proteins using the same tracks for traveling, 
microtubules. 
Microtubules are hollow tubes approximately 25 nm in diameter with the walls of the 
tube formed from αβ tubulin dimers stacked head to tail to form 13 protofilaments 
running parallel along the wall of the microtubule giving polarity to the tube [207, 208]. 
This polarity is coined the plus end where β tubulin terminates and minus end where α 
tubulin initiates the microtubule. Microtubules originate from microtubule organizing 
centers (MTOC) and extend outward to the periphery of the cell leading with the plus end 
of the microtubule and the minus end remaining at the MTOC. The α and β tubulins are 
strongly conserved proteins across all eukaryotic cells maintaining 60% sequence 
conservation [207]. These α and β tubulin monomers are relatively small ~55 kDa in size. 
Both monomers of tubulin can bind guanosine triphosphate (GTP) although the β tubulin 
is also a GTPase with the capacity to hydrolyze GTP to GDP. The hydrolysis of GTP to 
GDP will create subtle conformational changes in the tubulin that will destabilize the 
microtubule if hydrolysis occurs at the plus end of the microtubule. To stabilize a 
microtubule the plus end (β tubulin) needs to remain bound to GTP while the β tubulin 
monomers following the cap are mostly GDP bound [209]. Microtubules have a 
conserved binding site for both kinesin motor proteins and cytoplasmic dynein along the 
H11-12 C-terminal loop of α tubulin (AA 409-424) [210]. This region is rich in 
negatively charged amino acids at physiological pH (aspartate and glutamate) which 
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electrostatically attract the positive amino acids of the MTBD on the motor proteins 
[211]. 
Although there are a plethora of motor proteins available for the cells to use for 
transport of cargo the diversity of motor proteins alone cannot explain the precise timing, 
specificity, and directionality of cargo delivery. Regulation of microtubule-based 
transport has been shown through processes such as activation and deactivation of motor 
proteins, microtubule associated proteins (MAP), and microtubule post translational 
modifications (MPTM) [212-214]. All of these processes still do not account for the 
precise spatiotemporal control cells maintain over microtubule-based transport. Further 
investigation into how microtubule-based transport is regulated spatially and temporally 
provides an exciting emerging field for scientists. 
Proper cellular trafficking is especially important in neurons where there are extreme 
lengths the cell must maintain sometimes as long as a meter in length. Neurons are 
particularly susceptible to defects in cellular trafficking which result in neurodegenerative 
or neurological disorders [215]. Examples include axonal pathologies that impede 
cellular trafficking such as Huntington’s, Parkinson’s & Alzheimer’s Disease ultimately 
leading to neuronal death [216]. It is unknown if the accumulations that impede cellular 
trafficking in these pathologies are caused by issues with cellular trafficking or if the 
cellular trafficking defects are a result of the accumulation in these diseases. In either 
scenario cellular trafficking is vitally important to maintain a functional cell. Mutations 
have been found in some of these diseases to the α-β tubulin dimers which may impact 
cellular trafficking of neurons contributing or causing the eventual cell death [217-219]. 
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Deciphering the methods a cell utilizes to control microtubule-based trafficking in cells 
could potentially offer a variety of therapies for pathologies affecting cellular trafficking. 
In this work we used a variety of methods and techniques to show that increased 
labile zinc inhibits microtubule-based motility. The movements of a variety of organelles 
within cells were shown to be inhibited by increased zinc. We narrowed down the 
location of the inhibition by learning both anterograde and retrograde transports are 
inhibited when labile zinc was increased in primary rat hippocampal neurons. Finally the 
location where zinc inhibits cellular trafficking was established on microtubules. Zinc 
interacts with the alpha tubulin monomer by coordinating with two amino acid residues 
H192 and H283. H192 and H283 were found to be imperative for the coordination of zinc 
at this site [220]. The coordination of zinc using these two amino acids is believed to alter 
the conformation of the alpha tubulin acting as an allosteric inhibitor of motor protein 
landing and walking on microtubules.  
4.2 METHODS 
SENSOR PLASMID CONSTRUCTIONS 
To construct mito-mCherry, four repeats of the coding sequence for the first 29 amino 
acids of the human cytochrome c oxidase subunit 8a (mitochondrial precursor; accession 
number NP_004065) was utilized for mitochondrial matrix targeting and incorporated 
into pcDNA3.1 vector using HindIII. The mCherry fragment was inserted between 
BamHI and EcoRI sites. 
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To construct the LAMP1-mCherry, mCherry was subcloned into LAMP1-GZnP3 
using BamH1 for the forward restriction site and Xho1for the reverse restriction site. 
GZnP3 was cut out of the LAMP1-GZnP3 and mCherry was inserted into the vector. 
pWBC was a gift from Ron Vale (Addgene plasmid # 15239). The pWBC C terminus 
stop codon was removed through PCR. mCherry was cut out of TRPML1-mCherry with 
EcoR1 forward and Xho1 reverse restriction sites and ligated into pcDNA3.1. The 
mCherry-pcDNA3.1 and the pWBC plasmids were digested with EcoR1 and BamH1, 
then the KIF5A plasmid was ligated into the mCherry in pcDNA3.1. 
EGFP-IC2-FL was a gift from Trina Schroer (Addgene plasmid # 51409). The 
mCherry was cloned with an AgeI forward restriction site and a BghlII reverse restriction 
site. The mCherry product and the eGFP-IC2-FL were digested with AgeI and BghlII 
then the mCherry was ligated into the IC2-Fl plasmid. 
TRANSFECTION NON-NEURONAL CELLS 
HeLa cell transfection was performed when the cells were approximately 40-50% 
confluent.  For each transfection reaction in HeLa cells, 3 µl of PEI transfection reagent 
and 1.25 µg of the sensor DNA were mixed in 250 µl OPTI-MEM.  The mixture was 
incubated for a minimum of 25 minutes at room temperature before direct addition to one 
imaging dish containing the cells.  Sensor can be expressed as little as 12 hours post-
transfection. Imaging was performed 48-72 hours post transfection. 
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PRIMARY RAT HIPPOCAMPAL NEURON CULTURE AND 
TRANSFECTION 
Primary hippocampal neurons were prepared from rat embryos at embryonic day 18 
(E18) by graduate students Chen Zhang and Taylor Minckley. Neurons were transfected 
between DIV 6-13, using the Lipofectamine 3000 transfection kit (Thermofisher) in 500 
µL Opti-MEM. When transfected too early the neurons do not have synapses and after 
DIV13 the transfection efficiency is too low. The reagent-DNA mixture was incubated 
for a minimum of 25 minutes at room temperature before direct addition to the neuron 
imaging dishes. Before adding reagent-DNA, 1 mL media was removed from each 
imaging dish and syringe filtered (0.22 µm) with an equal volume of fresh neuron culture 
media (50:50 media). After incubation at 37 ˚C for 4 hours, neurons were washed three 
times with 1 mL prewarmed neuron culture media. Then, 2 mL of the 50:50 media was 
added to the neuron imaging dishes and they were incubated at 37 ˚C until imaging. 
LIVE CELL MICROSCOPY 
Cells were imaged 48 hours post-transfection, and cells were washed three times with 
the indicated imaging buffer immediately before imaging. All imaging was performed on 
an inverted Nikon/Solamere CSUX1 spinning disc confocal microscope with a 40x (for 
time-lapse) or 60x (for colocalization) 1.4 NA oil immersion objective. Data was 
collected using MicroManager software and analyzed with Fiji (ImageJ). 
All experiments were performed at 37 ˚C except for the microtubule motility 
experiments. We used a Live cell chamber by Pathology Devices. Imaging for HeLa cells 
(VAMP2, LAMP1, Rab7, and mito tagged organelles) was performed using 20 second 
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acquisitions. 10 second image acquisitions were performed for the microtubule motility 
imaging experiments. The microscope settings for 488 nm were 100 ms exposure times & 
10% laser power; 561 nm were 50 ms exposure times & 5% laser power. All drug 
additions were performed manually by pipetting in the drugs and mixing the imaging 
solution by pipetting up and down three times. All the buffers were incubated in a 37 ˚C 
bead bath prior to additions to the imaging chamber. The only buffer used was HHBSS 
pH 7.4, with or without calcium and magnesium. 
Imaging for zinc and pyrithione treatment on HeLa cells motility experiments were 
performed with a 5 minute baseline then a 5 minute treatment with 2.5 µM pyrithione and 
20 µM ZnCl2 followed by a wash out and treatment with 100 µM TPEN for 10 minutes. 
High extracellular zinc incubation (100 or 200 µM ZnCl2) were performed with a 5 
minute baseline then a 30 minute incubation with high zinc then a wash out and addition 
of 100 µM TPEN. Controls for HeLa cells using pyrithione were treated for 5 minutes 
with 2.5 µM pyrithione and 10 minutes with 100 µM TPEN. 
Imaging for neurons was performed at 37 ˚C for all experiments presented. The 
microscope settings for 561 nm were 100 ms exposure times & 5% laser power. Motility 
experiments performed on mitochondria, endosomes, VAMP2 vesicles, and lysosomes 
had acquisition times of 2.5 seconds and increased to 1.5 seconds for kinesin and dynein 
experiments. Motility experiments followed the same time lengths used for HeLa cells 
with 10 minute incubations with 100 µM TPEN, 5 minute incubations with 2.5 µM 
pyrithione and 20 µM ZnCl2, 30 minute incubations with high extracellular zinc or 
depolarization with high zinc (high K+), and 10 minute baselines were used. One 
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difference was using glutamate and glycine to activate channels permeable to zinc only 5 
minute incubation was used. When looking for neurons only healthy neurons were 
chosen where there were minimal or no clusters of fluorophores on the axon and there 
was high motility at baseline. If little to no motility was present on the axon we found the 
cell was not healthy and not a good representation of the cellular motility. The cell soma 
was observed prior to imaging any of the axons to ensure the cell looked healthy. 
IMAGING DATA ANALYSIS 
Neurons motility: Refer to Appendix B for image analysis for motility using the 
ImageJ plugin “Kymolyzer”. 
HeLa cells mitochondrial motility: Refer to Appendix A for image analysis for 
motility using the ImageJ plugin “Total_Motility”. 
HeLa cells lysosome, endosome, and VAMP2 motility: Refer to Appendix A for image 
analysis for motility using the ImageJ plugin “Particle Tracker 2D/3D”. 
COMPONENT DETERMINATION OF MITOCHONDRIAL SPEEDS 
The data set was analyzed using the program Kymolyzer described in Appendix B. 
Once the speeds were determined for each treatment (baseline, MLSA-1, and TPA) the 
files were run through the R Version 3.6.3. Refer to Appendix C for analysis using the 
computer software R. 
DETERMINE THE DOSE-RESPONSE OF INHIBITION OF ZINC ON 
ORGANELLAR MOTILITY 
 HeLa cells were cotransfected with GZnP2, previously developed in the Qin lab[84], 
and one of the following plasmids mCherry-Rab7, VAMP2-mCherry, or mito-mCherry. 
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The HeLa cells were imaged with 10 second acquisition times with the following 
microscope conditions: 488 nm laser 10 mW power, 100 ms exposure time; 561 nm laser 
5 mW power, 50 ms exposure time. The cells were imaged in phosphate free HHBSS pH 
7.4 with calcium and magnesium for a 600 second baseline, 500 second treatment with 
100 µM TPEN, washed out, 1000 second treatment of 20 µM zinc chloride and 2.5 µM 
pyrithione. Imaging analysis was performed by Fiji (Image J). The image stacks of 
GZnP2 and the mCherry tagged sensor were split. Every image in an image stack was 
aligned to account for drift using the Stackreg plugin in Fiji with the Rigid Body 
transformation. The zinc concentrations were determined using the equation as 
previously described[84]. For the quantitative analysis of zinc, images of both GZnP2 
were background corrected by generating a region of interest (ROI) on a blank area of the 
coverslip and subtracting the fluorescence intensity of each channel, e.g. IGZnP2(cell) – 
IGZnP2(background).  The background corrected GZnP2 images are used to calculate the 
normalization intensity.  The calibration of the sensors was plotted in the KaleidaGraph 
program.  The baseline GZnP2 intensity (I), minimal intensity achieved with TPEN (Imin), 
and maximal intensity (Imax) obtained with zinc saturation were used for cytosolic zinc 
quantification using the equation [Zn2+] = Kd [(R – Rmin) / (Rmax – R)]
1/n (Kd & n were 
characterized previously[84]).  All in situ sensor calibration were performed at 37 ˚C.  
Particle motility for all measurements came from the Total_Motility program described 
under Data Analysis HeLa cells mitochondrial motility. The zinc concentrations were 
plotted against the reduction in motility normalized to baseline motility with the 
respective zinc concentrations. The zinc concentrations varied from less than 0.1 
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picomolar to more than 8 micromolar. The IC-50 was determined from the curve using 
the binding curve equation (m1*m0m3)/(m2^m3+m0^m3)+m4 [78, 84]. 
ATP END POINT IN VITRO ASSAY 
The Cytoskeleton Inc. Kinesin ATPase End-Point Biochem kit was used for the 
analysis of kinesin function. The kinesin function was measured indirectly through the 
hydrolysis of ATP to ADP and Pi measuring the amount of Pi produced. This design was 
based off the malachite and ammonia molybdate forming a complex when bound to Pi 
and absorbing at 640 nm compared to 446 nm when in the apo state, a procedure 
originally described by Hess[221, 222] and further improved by Lanzetta [223]. 
Cytoskeleton Inc. designed a kit using the improved method designed by Lanzetta to 
detect the inorganic phosphate. 
The first step in the procedure is to create a standard curve to be able to calculate the 
phosphate produced through motor protein functioning by only measuring the 
absorbance. A known amount of phosphate is added to wells (0-2 nM) and reacted under 
the same conditions described for the motor protein function and the absorbance 
measured at 650 nm. These absorbance values will correlate to a known phosphate 
concentration creating a linear relationship allowing any concentration within these 
values to be determined. 
Kinesin buffer (100 mM PIPES, 2 mM MgCl2, pH 6.8) is supplemented with 20 µM 
Taxol to stabilize microtubules. Add stabilized microtubules to kinesin buffer 
supplemented with taxol to a concentration of 0.2 mg/ml. The microtubules are stable at 
room temperature but will disassemble if placed on ice, keep at room temperature for up 
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to a day. KIF5A kinesin motor protein is diluted in kinesin reaction buffer to a 
concentration of 0.08 µg/µl. Experiments can be set up using these solutions using half 
area 96-well plates with a total volume of 30 µl. The working concentration of 
microtubules is 0.067 mg/ml, kinesin is 0.007 µg/µl. Once all the testing conditions are 
set the experiment is started by the addition of ATP (0.3 mM), perform this using a 
multichannel pipette. The reaction is allowed to proceed for 5 minutes then stopped 
through the addition of 70 µl of Cytophos reagent. The Cytophos reagent is the malachite 
green with the ammonia molybdate which if inorganic phosphate is present will absorb at 
650 nm. This is allowed to react for 10 minutes then the absorbance is measured at 650 
nm. 
4.3 RESULTS/DISCUSSION 
What initially led our research to focus on the work in this chapter was the 
observation that increased zinc inhibited mitochondrial motility in HeLa cells without 
distorting the morphology of the mitochondria. We determined this observation was 
separate from calcium dependent inhibition of mitochondrial motility for two reasons. 
One is calcium induced mitochondrial inhibition changes the morphology of 
mitochondria [224], two increased zinc decreased the motility of organelles other than 
mitochondria while calcium is specific for mitochondria (Figure 25). Other organelle 
motility is not regulated by calcium, calcium dependent microtubule-based motility is 
specific to mitochondria. Upon determining our observation was separate from a known 
and established calcium dependent regulation of cellular trafficking we drove to 




Figure 25: Inhibition of Organellar Motility in HeLa Cells. The motility of all the 
mitochondria, lysosomes, Endosomes, and VAMP2 vesicles in HeLa cells were analyzed 
at baseline, after treatment with 2.5 µm PTO & 20 µm ZnCl2, and after washout and 
treatment with 100 µm TPEN. The motility was normalized to baseline (100%) showing 
a significant reduction in motility after treatment with zinc and restoration back to 
baseline or slightly above baseline motility. The mitochondria were analyzed using an 
ImageJ plugin designed to evaluate % change in motion between frames which works 
well for oblong shapes. The lysosomes, endosomes, and VAMP2 vesicles were analyzed 
using a particle tracker ImageJ plugin which is ideal for circular shaped objects. 
Statistical significance was performed using two-way T-Test, * represents p < 0.05; ** 
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. n=3 for 
mitochondria; n=5 for lysosomes; n=6 for endosomes; n=6 for VAMP2 vesicles. 
Intracellular zinc was revealed to be both dose and time dependent with respect to 
inhibition of organelle motility (Figure 26 & 27 respectively). Higher concentrations of 
zinc (zinc and pyrithione) would have a more pronounced inhibition of motility compared 
to lower concentrations of zinc (incubating with high zinc alone). A time dependence was 
established when discerning zinc inhibition is reversible upon removal of zinc via the 
chelator TPEN. This further supports that zinc is the only cation responsible for this 
inhibition due to the exceptionally exclusive and high binding affinity of TPEN (kd=6.4 x 
10-16) for zinc [225, 226]. We believe the time dependent nature to reverse the zinc 
inhibition is a result of the zin ions altering the structure of the α and β tubulin subunits of 
 
128 
microtubules. Previous studies suggest that zinc binding to the α and β subunits will alter 
the quaternary structure of the microtubules more dramatically the longer they are 
incubated with the proteins possibly leading to irreversible changes in the protein 
structure [227-229]. Therefore the longer the zinc ions are coordinated with the 
microtubule the more difficult the changes in protein structure are to revert back to the 
native conformation. This happens often during protein folding where a conformation 
other than the native conformation for the protein is more stable than the proper native 
conformation. 
 
Figure 26: Mitochondria Motility Controls and Other Conditions Tested. The changes 
in mitochondrial motility are documented in HeLa cells under various conditions of 
showing a dose dependent decrease in mitochondrial motility: Zn-PTO n=3, 200 µM 
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ZnCl2 n=3, 100 µM ZnCl2 n=6, 100 µM TPEN n=3, and 2.5 µM PTO n=3. Statistical 
significance was performed using ANOVA post hoc Tukey, * represents p < 0.05; ** 
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. 
 
 
Figure 27: Time-Dependence of Zinc Restoration. The zinc inhibition can be 
reversible under high zinc concentrations (micromolar) only under 5 minutes once 
incubated with zinc beyond this timeframe the inhibition becomes more permanent. 
We confirmed that zinc induced inhibition of organelle motility was not an artifact of 
the drugs being used to change the zinc concentrations within the cells (Figure 26). We 
observed that the zinc inhibition is separate from calcium induced inhibition of 
mitochondria motility although we needed to confirm that another biologically relevant 
cation was not responsible for the inhibition of organelle motility. 
We expanded our search to determine if another cation could be responsible for the 
zinc induced inhibition of cellular trafficking. Magnesium and calcium are both prevalent 
free divalent cations in the cell and are at significantly higher concentrations than free 
zinc, 10,000 & 1,000 fold higher concentrations respectively [230]. A previous study 
reported magnesium in addition to zinc was essential to influence kinesin motility [231]. 
We performed zinc inhibition experiments using HeLa cells and compared the degree of 
inhibition observed in buffers either containing or not magnesium and calcium. We 


















endosomes although we did see a change in the inhibition for VAMP2 vesicles (Figure 
28A). VAMP2 is a target for synaptic vesicles and since there are no synaptic vesicles in 
HeLa cells it is unknown what the VAMP2 tag localizes to in HeLa cells. This could 
explain the discrepancy with this tag. Further testing was performed on kinesin in rat 
hippocampal neurons to determine if increased calcium affected their movement. No 
observable change was observed in kinesin motility after incubating with ionomycin in 
calcium containing imaging buffer (Figure 28B & C). We then evaluated the effect 
calcium has on dynein in vitro as opposed to in vivo due to the dynein imaging being 
notoriously obscured by background fluorescence. 
Additional experiments were performed by permeabilizing the cell membrane using 
10 µM digitonin for 3 minutes then washout then addition of 1 µM ZnCl2. During these 
experiments we included different concentrations of magnesium in the extracellular 
buffer to determine if magnesium was needed to inhibit cellular trafficking with zinc as 
was cited by Bohm [232]. Most times the cell became unhealthy following treatment with 
the zinc and various concentrations of the magnesium although every time the inhibition 
was still observed from zero magnesium to 15 mM magnesium. These were always 
performed in zero calcium buffer to avoid cell death. In addition we performed 
experiments using a magnesium ionophore 4-bromo-A23187 to load or deplete 
magnesium from the cells [233]. To load the cells with magnesium we would incubate 
the cells with 2 µM of the ionophore and 10 mM magnesium for 5 minutes then treat with 
pyrithione and zinc. To deplete the cells the cells were treated with 2 µM of the 
magnesium ionophore and zero magnesium with 50 µM EDTA, this solution was washed 
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out after 5 minutes and zinc and pyrithione were added. The cells using the ionophore 
became unhealthy regardless of the incubation time frame unless the magnesium 
concentration was close to physiological (+/- 1 mM). This prevented analysis although 
the motility was completely stopped under all these conditions. The changes in 
magnesium concentration appear to be fatal to the cell. With these experiments we were 
sure that zinc was the key ion responsible for inducing inhibition of cellular trafficking. 
 
Figure 28: Effects of Other Biologically Relevant Divalent Cations on Cellular 
Trafficking. (A) The bar graph shows the decrease in the motility of mitochondria, 
lysosomes, endosomes, and VAMP2 vesicles after treatment with high zinc and 
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pyrithione either in a buffer with or without calcium and magnesium. The graph was 
normalized to baseline motility (100%). The mitochondria were analyzed using an 
ImageJ plugin designed to evaluate % change in motion between frames which works 
well for oblong shapes. The lysosomes, endosomes, and VAMP2 vesicles were analyzed 
using a particle tracker ImageJ plugin which is ideal for circular shaped objects, n=3-7 
depending on the organelle. (B) Representative kymograph of kinesin (KIF5A) motility 
in primary rat hippocampal neurons at baseline and after treatment with ionomycin 
(calcium ionophore), and TPEN. (C) Quantification of the kinesin kymograph in (B) n=4. 
Statistical significance was performed using two-way T-Test, * represents p < 0.05; ** 
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. 
After establishing zinc inhibits cellular trafficking in HeLa cells we wanted to expand 
our research to focus on neurons which show large physiological increases in zinc. HeLa 
cells will not experience large changes in zinc concentrations hence why we adjusted our 
research focus to a cell type that will see large fluctuations in zinc dynamics. 
Glutamatergic neurons are the specific type of neuron used for this work because they 
have zinc containing vesicles and release these vesicles into the synaptic cleft allowing 
large influxes of zinc to nearby neurons [234]. There are many channels that are 
permeable to zinc on neurons when activated or opened depending on the method 
allowing extracellular zinc to flood into neurons (Figure 29). Voltage gated calcium 
channels (VGCC) and GluR2-lacking AMPA (Alpha-amino-3-hydroxy-5-methyl-4-
isoxazole propionoic acid receptors (AMPARCa-Zn) are the two major channels for zinc to 
enter into cells and thus establish a zinc concentration gradient between the extracellular 
matrix and the cytosolic gradient of zinc. These two channels along with the N-methyl-D-
aspartate (NMDA) receptors are prevalent at post-synaptic terminals of neurons. The 
reason being is when the glutamate and zinc from the gluzinergic neurons (neurons that 
release both zinc and glutamate) releases these two neurotransmitters the zinc is picked 
up by the subsequent neuron via one of these three channels. When the zinc contacts the 
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AMPAR or VGCC zinc is transported into the cell, although when zinc contacts the 
NMDAR's it will inhibit the channel from being a receptor of glutamate while retaining 
the permeability of the ion channel to zinc. The channel primarily responsible for zinc 
import into the post synaptic neuron is the AMPARCa-Zn channel. Both NMDA and 
AMPA receptors can be activated through glutamate and glycine addition while the 
VGCC’s can be activated by high potassium. High potassium depolarizes the cell by 
decreasing the flux of potassium into the cell while the sodium channels remain 
unaffected and continue the rapid influx of sodium into the cell. This causes the cell to 
depolarize activating the voltage gated sodium channels allowing more sodium ions into 
the cell depolarizing the negatively polarized state creating a chain reaction for the 
voltage gated sodium channels. VGCC’s are also activated which are permeable to zinc 
allowing zinc to influx into the neuron if present extracellularly. These methods activate 
the zinc permeable channels on the neuron allowing us to mimic the excitability inherent 




Figure 29: Zinc Influx in Rat Hippocampal Neurons. Primary rat hippocampal 
neurons were depolarized using either a high potassium or addition of glutamate and 
glycine. This depolarization will open channels on the surface of the neurons that are 
permeable to zinc. With high extracellular labile zinc opening the channels causes a large 
influx of zinc into the neurons. 
Due to the ease of activating zinc channels on the neuron under physiological 
conditions we focused our research on how neurons manage changes in labile zinc in 
relation to cellular trafficking. This presents a physiological model to analyze zinc 
induced inhibition of cellular trafficking with minimal perturbations from physiological 
conditions preventing introduction of artifacts. We began by increasing zinc in primary 
hippocampal rat neurons where we were able to confirm that both mitochondrial and 
lysosomal motility was inhibited significantly upon incubation for 5 minutes with 20 µM 
zinc chloride and 2.5 µM pyrithione and motility was restored with 100 µM TPEN zinc 
chelation (Figure 30A-D) consistent to the work performed on HeLa cells. Depolarization 
of the neuron and the subsequent activation of zinc permeable channels were analyzed for 
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organelle motility inhibition while using high extracellular zinc which when depolarized 
caused a large influx of zinc into the rat hippocampal neurons and inhibition of motility 
(Figure 30C & D). We found that the addition of zinc inhibited cellular trafficking in 
primary rat hippocampal neurons, HeLa cells, and in vitro experiments performed with 
yeast dynein and kinesin showing this inhibitory mechanism appears to be universal 







Figure 30: Zinc Influx Arrests Mitochondrial and Lysosomal Trafficking in Neurons. 
(A & B) Representative kymograph of mitochondria and lysosomes in primary rat 
hippocampal neurons baseline speeds, speed after depolarizing the neuron using high 
potassium and 100 µM zinc, speed following wash out and treatment with TPEN, and 
speed after treatment with 20 µM zinc and 2.5 µM pyrithione. (C & D) The average 
speed of mitochondria and lysosomes in primary rat hippocampal neurons at baseline, 
after depolarizing using high potassium and 100 µM zinc, wash out and treatment with 
100 µM TPEN, and washout and treatment with 20 µM zinc and 2.5 µM pyrithione. All 
statistical significance was performed using ANOVA post hoc Tukey, * represents p < 
0.05; ** represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. n=13 
& n=8 for mitochondria and lysosome respectively. (E, F, G, & H) Representative trace 
of mitochondria, lysosomes, endosomes, and VAMP2 vesicles reduction in motility 
plotted against the concentration of zinc in pico moles. The inset value is the IC-50 value 
for mitochondria, n=6, n=5, n=4, n=5 for mitochondria, lysosome, endosome, and 
VAMP2 vesicles respectively. 
 
After establishing zinc is responsible for the inhibition of cellular trafficking across 
multiple cell types we then concentrated on determining the threshold concentration of 
zinc that inhibits cellular trafficking. Thus far zinc induced inhibition of cellular 
trafficking was only evaluated under high zinc conditions. The zinc concentrations 
assessed thus far have been in the micro-molar range while more common physiological 
concentrations typically rest in the pico-molar to nano-molar range [78, 84, 122, 128, 
163] with synaptic concentrations reaching micro-molar concentrations [86]. Due to the 
disparity in the concentrations evaluated from physiological ranges we sought to 
ascertain the IC-50 concentration of zinc induced inhibition of cellular trafficking. HeLa 
cells were used to monitor both the labile zinc concentration and the motility of 
lysosomes and mitochondria. Cytosolic GZnP2, a green zinc probe designed to accurately 
and specifically measure zinc concentrations [84], was co-transfected in combination 
with an mCherry fluorophore tagged with a localization sequence for either the 
mitochondria or the lysosome (cytochrome c oxidase target or lysosome associated 
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membrane protein 1, respectively) (Figure 31A-B). This allows both the zinc 
concentration and the motility of the respective organelle to be quantified simultaneously. 
Once co-transfected these cells were treated with 100 µM TPEN for 10 minutes then with 
20 µM ZnCl2 and 2.5 µM pyrithione for 5 minutes. By monitoring both the mCherry 
tagged mitochondria or lysosome motility and the GZnP2 fluorescence we were able to 
connect the motility associated with a specific concentration of zinc (Figure 31C). The 
zinc concentration can be quantified by evaluating the GZnP2 fluorescence at any given 
point and plugging this fluorescence into the equation in Figure 31D as the variable “I”. 
The hill coefficient and kd were previously characterized [84] and the Imin and Imax are 
determined during the experiment by depleting the sensor using TPEN and saturating the 
GZnP2 sensor with zinc and pyrithione respectively. The motility of the organelles was 
calculated using the ImageJ plugin called “Total_Motility” designed by Kurt Vos Et. Al 
[235]. The motility can then be paired with the respective zinc concentration at the same 
time point to construct a sinusoidal curve with the zinc concentration on the x-axis and 
the motility of the organelle on the y-axis. The paired concentration of labile zinc and 
motility for the respective organelle can then be plotted together to create a graph as 
shown in Figure 31E-H, & 32E. Using this plot the kd of labile zinc (IC-50) could be 
determined for the inhibition of lysosomes, mitochondria, endosomes, and VAMP2 
vesicles (17 nM, 26 nM, 1.6 nM, & 7 nM respectively). The calculated inhibitory labile 
zinc concentrations are within the more common physiological concentrations labile zinc 
observed. This indicates that zinc acting as a cellular trafficking inhibitor may be 
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common to all cells where small concentrations of zinc can be released to regulate the 
movement of cellular cargo. 
 
Figure 31: Method for Calculating Threshold Concentration of Zinc Induced 
Inhibition In Vivo. (A) Subcellular targeting of fluorophores in this example to the 
mitochondrial matrix specifically the cytochrome c oxidase enzyme on the electron 
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transport chain. This fluorophore is not sensitive to changes in zinc or other factors and 
will just mark the location of the subcellular target. The other fluorophore which will 
have no tag and thus go to the cytosol of the cell is GZnP2 (Green zinc probe 2) one of 
our labs novel intensiometric zinc probes. The zinc probe is sensitive to changes in labile 
zinc concentrations. (B) Both the subcellularly targeted fluorophore and the zinc probe 
will be cotransfected into HeLa cells as shown in the representative images. (C) The Hela 
cells will be treated with TPEN then zinc and pyrithione to determine the minimum zinc 
probe intensity and maximum zinc probe intensity as well as the motility of mitochondria 
in this example for each respective concentration in zinc. The mitochondrial motility can 
be correlated with each respective zinc concentration. (D) The maximum and minimum 
intensity of the zinc probe are necessary to calculate the concentration of zinc throughout 
testing. This equation requires the maximum and minimum intensity for the cells, the hill 
coefficient (n) and the kd are both determined a priori through sensor characterization in 
vitro. These concentrations were calculated through the full range of zinc concentrations 
from the minimum to the maximum zinc concentration. (E) Once calculating the zinc 
concentration at every step from the minimum ([Zn2+] = 0 to the maximum ~micromolar 
range) and the respective motility at each step both were combined to form the axis of a 
graph and the threshold concentration for zinc was determined through the IC-50 value. 
Once zinc was found to be inhibiting cellular trafficking in a physiological range 
pertinent to most cell types and not solely neurons we pursued the location of where zinc 
ions interact to inhibiting cellular trafficking. This work found increased labile zinc 
inhibited the motility of a variety of organelles therefore the zinc was not interacting 
directly with the organelles. Although the zinc could be inhibiting the motor proteins 
dynein and kinesin which then prevent microtubule-based motility. We constructed two 
mCherry tagged constructs one to kinesin heavy chain isoform 5A (KIF5A) and another 
to dynein intermediate chain 2C (IC-2C). The motility was monitored in rat hippocampal 
neurons due to the signal being saturated by background fluorescence in HeLa cells. The 
motor protein motility after zinc addition was inhibited for both motor proteins in both 
the retrograde and anterograde direction (Figure 32A & B). All the organelle motility in 
both the anterograde and retrograde direction were inhibited by zinc too. An observation 
that the two motor proteins moved in both directions (anterograde & retrograde) which is 
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due to the opposite motor protein trafficking the motor to the opposite side of the 
microtubule. There is still debate how motor proteins get back to their respective start 
positions although an accepted principal is the motor proteins rely on the opposite motor 
to transport them back to the opposite end of the microtubule. This is why the motor 
proteins appear to be moving both anterograde and retrograde. The Fiji plugin Kymolyzer 
previously developed was used to performed quantitative analysis of motor protein 
speeds in either the anterograde or retrograde direction [224]. TPEN once again was able 
to restore both retrograde and anterograde motility for both motor proteins. KIF5A 
(Figure32C & E) and IC-2 (Figure 32D & F) in rat hippocampal neurites is significantly 
inhibited by zinc and pyrithione and restored through chelation of zinc using TPEN. Both 
of the motor proteins were inhibited by zinc which aligns with our previous finding that 
both retrograde and anterograde motility of the organelles was inhibited by zinc because 
the organelles rely on motor proteins for microtubule-based cellular trafficking. Controls 
were performed using the rat hippocampal neurons to ensure that the methods used to 
increase or decrease zinc concentrations were not artifacts on the cellular trafficking. 
Figure 33 shows the controls performed to ensure no artifacts were present to cause 




Figure 32: Zinc inhibits both anterograde and retrograde axonal transport. (A) The bar 
graph indicates the speed of the kinesin and dynein (B) in primary hippocampal neurons 
at baseline, after treatment with high zinc and pyrithione, wash out and treatment with 
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TPEN in the anterograde and retrograde direction, n=9 & 8 for kinesin and dynein 
respectively. (C) Representative kymograph of kinesin (KIF5A) and dynein (Dynein 
intermediate chain 2C or IC2C) (D) in primary hippocampal neurons in primary 
hippocampal neurons at baseline, treatment with high extracellular zinc and pyrithione, 
washout and treatment with TPEN. Shows the speed of the kinesin (E) & dynein (F) in 
primary hippocampal neurons at baseline, after treatment with high zinc and pyrithione, 
and wash out and treatment with TPEN. There was significant reduction in motility of 
kinesin by increasing the zinc concentration and significant restoration of motility of 
kinesin by removal of zinc with TPEN indicating zinc inhibits kinesin motility. Statistical 
significance was performed using ANOVA post hoc Tukey, * represents p < 0.05; ** 
represents p < 0.01; *** represents p < 0.001; **** represents p < 0.0001. n=9 & 8 for 




Figure 33: Controls and Other Conditions Evaluated on Motor Proteins and 
Mitochondria. All of the controls shown were performed in primary rat hippocampal 
neurons. (A) Kinesin (KIF5A) & Dynein (IC2) (I) & mitochondria (K) after treatment 
with glutamate, glycine, and high extracellular zinc, wash out and treatment with TPEN, 
and washout and treatment with high zinc and pyrithione, n=4,3, & 3 respectively. (B) 
Shows the speed of kinesin (KIF5A) & mitochondria (L) are unaffected by high K+ 
alone, n=3. (C) Kinesin & mitochondria (M) speed with pyrithione alone, n=3. (D) 
Shows the kinesin after treatment with zinc pyrithione in zero calcium imaging, n=9. (E) 
Kinesin & dynein (J) & mitochondria (O) speed after treatment with high extracellular 
zinc (100 µM) in calcium containing buffer, n=3 and in zero calcium buffer (F), n=3. (G) 
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Kinesin & dynein (H) speed after high K+ and 100 µM ZnCl2, n=3 & 8 respectively. (N) 
Shows the speed of mitochondria after treatment with TPEN alone, n=3. Statistical 
significance was performed using a two-way T-Test, n=3. Statistical significance was 
performed using ANOVA post hoc Tukey, * represents p < 0.05; ** represents p < 0.01; 
*** represents p < 0.001; **** represents p < 0.0001. 
At this point we established the motor proteins are being inhibited which defaults to 
inhibiting organelle microtubule-based cellular trafficking. Although the motor proteins 
still do not appear to be a strong site for zinc interaction since there are numerous kinesin 
proteins and the structures are completely different from dynein. When encountering this 
it made more sense the zinc was interacting at one location which then caused the 
downstream observation of inhibition of cellular trafficking. We needed to eliminate 
many of the potential routes zinc could be interacting with to cause the inhibition 
observed. One way to eliminate many of the conceivable zinc interaction sites was to 
perform an in vitro assay on kinesin motility where we can begin with the basic 
necessities for motility then titrate in anything into the experiment to learn what zinc is 
interacting with. Our starting evaluation began with minimum Mg-ATP, microtubules, 
and kinesin, and we found kinesin motility was inhibited. This narrowed down our 
potential zinc interaction sites considerably. Our in vitro assay evaluated the hydrolysis 
of ATP to ADP + inorganic phosphate (Pi). We purchased the Kinesin ATPase End-point 
Biochem Kit (Cytoskeleton Inc.) to determine if kinesin is functioning. The kit works by 
indirectly measuring kinesin activity via hydrolysis of ATP to ADP + Pi. The free 
phosphate will bind ammonia molybdate forming a complex. This ammonia molybdate 
phosphate complex binds malachite green which absorbs strongly at 640 nm when bound 
versus malachite green absorbing at 446 nm in the apo state (Figure 34A). UV-Vis 
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absorbance of the ammonia molybdate-malachite green complex allows for very precise 
and accurate measurements down to 100 pM of inorganic phosphate. When adding only 
microtubules, ATP, magnesium, and kinesin, the kinesin motor protein was inhibited 
narrowing down the zinc interaction site to one of these components. The motor proteins 
are likely not the interaction site due to the zinc needing to inhibit two completely 
separate proteins despite them performing similar roles. We then looked into ATP being a 
possible candidate since zinc outcompetes magnesium to form an ATP complex (ATP-Zn 
kd=7.7x10
-6; ATP-Mg kd=3.5x10
-5) [80]. ATP is only biologically available once 
coordinated with magnesium due to the magnesium stressing the gamma phosphate bond 
allowing hydrolysis of this last phosphate from ATP. It has been shown that ATP 
coordinated with other metals either decreases or stops enzyme function [232, 236] 
leading ATP coordinated to zinc to be a possible interaction site. 
Our rationale for the ATP not being the target for zinc interaction is the ATP 
concentrations in the cell are in the low milimolar range similar to magnesium, while zinc 
concentrations are typically in the hundreds of picomolar range with some locations 
reaching the micro molar range for example at the synapse. This means that if all the 
labile zinc in the cell were to bind the ATP there would be essentially no change to the 
biologically available ATP-Mg concentration. Zinc interacting with ATP is an unlikely 
site for interaction given the information. The in vitro kinesin ATPase end point assay did 
show that the threshold concentration for zinc inhibition on the kinesin was 12 µM 
(Figure 34B) which is much higher than the one observed for the in situ analysis using 
HeLa cells. This could have been a result of the buffer being used (PIPES) binds zinc and 
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could be causing this to be an artificially high concentration of zinc due to the buffer 
binding up all the free zinc. We switched to a HEPES buffer which does not coordinate 
zinc as PIPES does and performed the same ATP vs zinc concentration curve finding a 
similar IC-50 value (8 µM) (Figure 34C). To confirm the PIPES was not coordinating the 
zinc we performed a zinc binding curve using FluoZin-3 in the HEPES (Figure 34E) or in 
PIPES (Figure 34D) buffer and found the same dissociation constant for both buffers 
~1.5 nM. The IC-50 value may be artificially inflated compared to the in situ value 
partially due to the buffers used for the ATPase end point assay binding zinc up to the 
nano molar concentrations acting as a zinc buffer. Another potential factor inflating the 
IC-50 value of the in vitro assay compared to the in situ work is because the microtubule 
concentrations are different. The in vitro assay uses far higher concentrations of 
microtubules than what is found in the cell and the microtubules in the cell likely already 
have zinc bound to them unlike the artificial microtubules used in the in vitro assay. The 
microtubules used in the in vitro ATPase assay can act as a chelator binding up excess 
zinc preventing the zinc from binding to the specific interaction site that causes the 
observed zinc induced motility inhibition. Microtubules have been shown to bind zinc at 
many locations, up to 60 sites on one alpha-beta tubulin dimer [227]. This effect directed 
our focus to the microtubule as the potential zinc interaction site. This is the only 
component left in the in vitro assay that has not been evaluated. The microtubule would 
make sense as a candidate for zinc interaction with many zinc binding locations and 





Figure 34: Kinesin ATPase Assay. (A) Detection mechanism for inorganic phosphate. 
(B) ATP hydrolysis curve for kinesin in PIPES buffer and HEPES buffer (C). Zinc 
binding curve in PIPES buffer (D) and HEPES buffer (E).  
We expanded our use of the ATPase End Point kinesin kit by analyzing kinesin 
microtubule stimulated ATPase activity. When increasing the microtubule concentration 
with a set zinc concentration the concentration of zinc required to inhibit kinesin motility 
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was increased as the microtubule concentration increased (Figure 35). The equation used 
to plot these curves is a Michaelis-Menton derived equation kobs=[(x(kcat-
kbasal)/((Km+x)+kbasal)]
2 [237]. We used a Michaelis-Menton equation because of how 
exceptionally well it models enzymatic function to monitor enzyme kinetics (motor 
protein). The Km (1/2 Vmax) had a direct relationship with zinc, as the zinc concentration 
increased so did the Km value. The Km value increases with increased zinc concentrations 
which means more substrate (microtubules) are required to result in the same ATPase 
activity for kinesin. This leads to the microtubules being the probable interaction site for 
zinc inhibition since the kinesin concentration remained unchanged and only increased 
microtubules restored motility when zinc was increased supporting the microtubules as a 
site for zinc inhibition. The Kcat (Vmax) had an inverse relationship with increased zinc the 
Kcat value lowered correlating to decreased function of the kinesin. This would match 
what we have observed where increased zinc decreases the function (motility) of the 
motor protein kinesin. Unfortunately the Kbasal could not be confirmed using the assay. 
The Kbasal value would indicate if zinc is altering the unbound microtubule kinesin motor 
mechanochemical cycle clearly exhibiting if zinc is interacting with the microtubules, 
kinesin, or both. The Kbasal values are so low with kinesin nothing could be accurately 
determined from the Kbasal values. The kinesin motility dropped off significantly when 
reaching 30 µM where despite high concentrations of microtubules full kinesin function 
was not restored. This could be a result of the zinc directly acting on the kinesin motor at 
this high of a zinc concentration. 
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From this we were able to ascertain that the zinc inhibition is acting on either the 
microtubules or the motor proteins. Although the microtubules are considered further 
since there would only be one target site for zinc to inhibit as opposed to two sites 
(kinesin & dynein). Also as mentioned kinesin and dynein as vastly different proteins 
which would be unlikely to contain similar zinc binding sites. Another factor that will be 
discussed shortly is the kinesin motor protein has no known zinc binding locations further 
supporting the microtubule as the zinc interaction site. Our work shifted to evaluating 
how zinc interacts with microtubules. 
 
Figure 35: Kinesin Microtubule Stimulated ATPase Activity. Kinesin activity 
increases at higher microtubule concentrations. 
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Table 11: Km Values for Different Zinc Concentrations. 
[Zn2+] Km ([MT] µM) 
0 0.037 
114 pM 0.056 
9.57 nM 0.299 
30 µM 0.116 
 
To focus on the microtubules as a zinc interaction site we expanded our in vitro 
analysis to single molecule tracking of yeast dynein on bovine microtubules. This 
analysis was performed through collaboration with Steven Markus’s lab at CSU. We had 
gone to their lab to see how everything is performed and plan the experimental design to 
evaluate the observed zinc inhibition and provided buffered zinc concentrations. 
This in vitro analysis provided pivotal information on the location where zinc is 
inhibiting motility. The assay allows microtubules to adhere to a glass coverslip and yeast 
dynein is flowed into the chamber with the adhered microtubules. Yeast dynein was used 
for simplicity due to cytoplasmic dynein requiring dynactin a multiplexed protein as well 
as shorter walking distances [238]. Yeast dynein also has very similar structural and 
sequence homology to cytoplasmic dynein. The dynein has a fluorophore bound to the 
protein and the movement can be monitored via TIRFM (total internal reflection 
fluorescence microscopy). Yeast dynein velocity (Figure 36A & B) and displacement 
(Figure 36A & C) were heavily reduced once exceeding 44 nM labile zinc, falling within 
physiological concentrations of labile zinc. This closely matches the observed 
concentrations found in our in situ analysis using HeLa cells. The fraction of active 
motors dropped off to nearly zero once the zinc concentration reached 44 nM (Figure 
36D). The active motors are the motors actively moving along microtubules, this shows 
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that the active motors are no longer there (moving along microtubules) once reaching 44 
nM. The displacement and velocities may still remain high at 44 nM but the number of 
motor proteins moving at these speeds or distances is nearly zero, then once exceeding 
this concentration no motor proteins are active. This puts the concentration of labile zinc 
causing inhibition of dynein walking on microtubules between 10 nM and 44 nM again 
matching what was observed in situ for the IC-50 concentrations. 
Zinc appears to be inhibiting cellular trafficking via two mechanisms, one being the 
ability of dynein to walk on microtubules and two the ability of dynein to land on 
microtubules. The former is shown in the active motors graph (Figure 36D). The active 
motors are the dynein motors walking along microtubules which decreases at higher zinc 
concentrations (>10 nM). The second way zinc appears to be inhibiting motility is by 
blocking dynein from landing on microtubules shown in the landing plots of active 
motors and total motors (Figure 36E & F, respectively). This clearly shows that zinc is 
preventing the dynein from binding to the microtubules once reaching 44 nM 
concentration. This points to the microtubule being the location where zinc is inhibiting 
cellular motility. The IC-50 values were determined using the landing rates of dynein and 
found to be ~6.5 pM, well below physiological cytosolic zinc concentrations (Figure 36G 
& 36H). This value may be artificially low due to low microtubule concentrations used to 
perform these experiments (< 200 nM microtubules) relative to physiological 
concentrations of microtubules (5-10 µM). As shown in the ATPase end point assay 
microtubules can bind excess zinc making the concentration of zinc probably higher than 
what is predicted here in vitro. The zinc inhibition is very potent, where zinc does not 
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need to bind to every tubulin dimer only every 10-20 tubulin dimers to exhibit its 
inhibitory effect on the cellular trafficking. The importance of this assay is in 
demonstrating zinc inhibition is occurring at the microtubule. The zinc appears to be 
preventing the motors from landing on the microtubules and does not affect their speeds, 
supporting the microtubule as being the sole zinc interaction site. This can be observed in 
the average speeds not changing despite increasing the zinc concentrations. Only when 
no motors are able to land on the microtubules does the speed change to zero. The 
number of motors walking on microtubules is diminished greatly by increasing zinc 
concentrations by as little as 0-120 pM zinc (Figure 36E). This effect can also be 
indirectly observed in all the kymographs where the baseline has many more moving 
organelles or motor proteins then the zinc treatment kymographs have significantly less 
organelles or motors on the kymographs. The decreased motility could also be a result of 
a small number of motor protein binding sites still being available on the microtubules 
which allow the motors to bind but then the zinc occupies the next tubulin dimer 
preventing movement effectively stopping the motor proteins that can successfully bind 




Figure 36: In Vitro Analysis of Yeast Dynein on Bovine Microtubules. (A) 
kymograph of dynein at various zinc concentrations. (B) Velocity & displacement (C) of 
yeast dynein on microtubules. (D) Fraction of active dynein motors on microtubules. (E) 
The landing rate of active & total (F) motors onto microtubules. (G) IC-50 of yeast 
dynein landing rate onto microtubules for total dynein motors. Contributed by our 
collaborator Steven Markus from CSU. 
We expanded this work to look at the effect zinc has on yeast microtubules. All the 
previous single molecule work was used bovine microtubules. The same zinc inhibitory 
effect was found when using yeast microtubules. The same trends were found as with the 
bovine microtubules although the landing rates (active motors) were more significantly 
decreased compared to bovine microtubules. The landing rate reached zero at 10 nM zinc 
instead of 44 nM zinc as observed with the bovine microtubules. This also indicates there 
could be species dependent variability in how pronounced zinc inhibits cellular 
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trafficking. The inhibitory effect zinc has on motor proteins landing rate appears to be 
universal across species. After establishing a location for zinc interaction in inhibiting 
cellular trafficking we worked toward identifying the precise zinc binding residues on the 
microtubule. 
We decided the best method to determine the precise location where zinc interacts to 
inhibit cellular trafficking on microtubules was saturation mutagenesis of a specific 
amino acid identified to bind zinc. First we needed sites where zinc could potentially bind 
on microtubules. To determine these sites we first used four different zinc-protein 
binding algorithm programs (Zinc Explorer [239], PredZinc [240], ZincBinder [241] & 
Zinc Machine [242]) and ran the sequence of α tubulin through the algorithms. These 
programs only evaluate cysteine, histidine, glutamate, and aspartate (CHED) as possible 
zinc coordinating amino acids. The algorithms listed off all the CHED proteins from the 
most likely to bind zinc to least likely, these lists were cross referenced to produce the 
most likely candidates for zinc binding sites on α tubulin, refer to Appendix D for listed 
predictions. The identified sites were C20, C25, C305, H309, C376, E284, E411, H393, 
& E417. All of these were regarded as high potential zinc binding amino acid locations 
on α tubulin derived from the zinc binding programs. Additional sites were chosen for 
mutation based on papers citing these as being zinc binding locations while also being 
required for sheet formation of tubulin dimers, H192, D424, & E420 [243]. Zinc can 
form zinc sheets instead of microtubules when tubulin dimers are in the presence of high 
concentrations of zinc, these zinc binding locations were also evaluated as potential sites 
for zinc induced inhibition of cellular trafficking. The zinc algorithms suffer from the 
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same issues molecular modeling programs suffer from as discussed in chapter 1. The 
algorithms are not able to evaluate every aspect that contributes to a zinc binding location 
therefore some are missed. To avoid missing zinc binding sites additional zinc binding 
sites were chosen based off logical deductions. 
Further we reviewed literature to find where the zinc could be binding on the 
microtubules. The first tubulin structures imaged were of zinc “sheets” not the tubes 
which form microtubules using electron microscopy to map the surface of the tubulin. 
These were believed to be the structure of tubulin despite these being completely 
artificial structures formed by micromolar additions of ZnSO2 [227]. Zinc sheets do not 
resemble microtubule structures beyond the sheet structure compared to tube structure. 
The protofilaments form in anti-parallel directions while normal microtubules form 
protofilaments in parallel with all the α tubulin on one end of the microtubule (minus 
end) and all the β tubulin on the opposite end of the microtubule (plus end). These 
original images could not identify a zinc binding location although a later structure 
identified what appears to be a zinc ion in the structure of tubulin dimer [220]. This zinc 
ion appears at the interface between two α tubulin proteins in the antiparallel structure. 
The zinc ion is coordinated through four amino acids two from each α tubulin at the 
interface, H192 and E417; and H283 and E284 refer to Figure 37 below for a 




Figure 37: Depiction of Zinc Binding Site. Shows the antiparallel alpha tubulin with 
the four coordinating zinc amino acids on each alpha tubulin (H192 & E417) (H283 & 
E284). The structures were used from 1JFF from PDB structure determined by [220]. 
Chimera constructed the image. 
Each location was mutated and evaluated first by co-transfection with the mutant α 
tubulin mCherry construct and mito-eGFP. Alpha tubulin mutants where the morphology 
of the microtubules was lost were not used for analysis due to the mutant microtubules 
not forming preventing evaluation of zinc induced inhibition. C20N, C20P, C305F, 
C305L, E411T, E411P, E411S, and E417R mutants all prevented the formation of 
microtubules and were not used for analysis. When monitoring the motility of 
mitochondria in HeLa cells after the addition of zinc we observed there were no 
statistically significant changes between all of the mutants tested, Figure 38A. We 
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deciphered the reason we did not observe any statistically significant change in the 
reduction of inhibition of mitochondrial motility is because endogenous α tubulin was 
competing with the mutant α tubulin diluting the effects the mutant would have on the 
inhibition. 
Our next method to determine a mutant that would alter the inhibition of cellular 
trafficking observed by zinc addition was to transfect the cells with the mutant α tubulin 
mCherry construct and observe the movement of the microtubules not an organelle. The 
microtubules have a lot of movement caused by the pulling of the motor proteins on the 
microtubules hence we can observe decreased landing of motor proteins on the 
microtubules [244, 245]. This eliminated the artifact of motility occurring on the wild 
type microtubules. We compared the microtubule motility across all the mutants 
described in the previous method and found no statistically significant reduction in zinc 
induced inhibition of cellular trafficking, refer to Figure 38B. Up to this point we had 
been performing all experiments at 37 ˚C to closely resemble physiological conditions 
and organellar, motor protein, and microtubule motility is substantially faster at this 
temperature as opposed to room temperature. We deemed this was causing variations in 
our measurements. The issue is buffers, drugs, and the incubation chamber change 
temperature slightly which was causing small shifts in the motility of the observed 
component preventing small error bars and statistical significance. The incubation 
chamber also caused artifacts by moving the image frame when opening and removing 
the incubation chamber lid. To avoid these artifacts we transitioned to imaging 
microtubules at room temperature. 
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The microtubule motility was monitored at room temperature and Figure 38C found 
two mutants that have significant reduction in the zinc induced inhibition, H192N & 
H283T. Both of these sites were not predicted by the different zinc algorithm programs to 
be zinc coordinating sites. Although both of these sites were logically what were 
predicted to be the zinc coordinating amino acids and shown in the crystal structure of the 
zinc sheets to bind zinc. The crystal structure predicted four amino acids would be used 
to coordinate zinc, H192, E417, E284 and H283. The E284 amino acid showed no change 
in the reduction in motility despite being linked in the H283 amino acid coordination of 
zinc which may be because histidine has superior binding to zinc compared to glutamate. 
The E417 position could not be evaluated due to mutations at this position prevented the 
formation of microtubules. This is a helpful indicator this site is particularly important to 
maintain the tubular structures of microtubules. This work supports the zinc binding 
location that is causing the inhibition of motor protein binding to microtubules is between 





Figure 38: Identification of Zinc Interaction Site on Microtubules. (A) The reduction 
in baseline mitochondria motility after addition of 20 µM ZnCl2 and 2.5 µM pyrithione. 
No statistical significance between any of the mutants compared to the wild type 
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reduction in motility. (B) Reduction in Microtubule Motility at 37 ˚C. The reduction in 
baseline microtubule motility after addition of 20 µM ZnCl2 and 2.5 µM pyrithione at 37 
˚C. No statistical significance between any of the mutants compared to the wild type 
reduction in motility. (C) Reduction in Microtubule Motility at Room Temperature. The 
reduction in baseline microtubule motility after addition of 20 µM ZnCl2 and 2.5 µM 
pyrithione at room temperature. Statistical significance was performed using a one way 
ANOVA post hoc Tukey, n=3-6. * represents p < 0.05; ** represents p < 0.01; *** 
represents p < 0.001; **** represents p < 0.0001. 
Mitochondrial motility was analyzed in primary rat hippocampal neurons when 
TRPML1 is overexpressed and activated using a synthetic agonist ML-SA1 with similar 
potency as the endogenous agonist phosphatidylinositol-3,5-bisphosphate [246]. 
Mitochondrial motility was found to be reduced after activation of TRPML1 and 
recovered following treatment with TPA, Figure 39A. TPA was used for two reasons one 
its lower affinity for calcium to ensure that calcium concentrations were not affected and 
two the faster kinetics compared to TPEN [225, 226]. The mitochondrial tracks were 
broken down into components (ranges), using the computer program R [247] with the 
mclust package [248], where the mitochondrial speeds are most commonly found under 
each treatment condition (baseline, MLSA-1, and TPA) refer to Figure 39C-D. There are 
four components for baseline and TPA treatment indicating a fourth higher speed 
category for mitochondria although when treated with MLSA-1 there are significantly 
reduced speeds not reaching this fourth category, refer to Figure 39A & B. The majority 
of mitochondria fall under the first component category for the TPA treatment compared 
to baseline or TPA treatment which aligns with the majority of the mitochondria tracks 
slowing down significantly. TPA was able to restore the motility of the mitochondria 
after zinc release from the lysosomes (Figure 39A & B). We found zinc release from the 




Figure 39: Mitochondrial Motility in Rat Hippocampal Neurons Following Activation 
of TRPML-1. (A) The proportion of mitochondria tracks within each of the components. 
(B) Average speed for each component. (C-D) Parameterized Gaussian mixture model of 
each sample determining the number of components for the system optimizing between 1 
and 9 components for baseline, MLSA-1, and TPA respectively. (F-H) Density graph of 
the number of lysosomes at each speed for baseline, MLSA-1, and TPA respectively. 
N=3. 
4.4 CONCLUSIONS 
We have shown in a top down approach that cellular trafficking in cells is regulated 
by labile zinc from the organelles to the zinc interaction site at microtubules. Zinc was 
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shown to inhibit microtubule based trafficking of organelles and motor proteins. Zinc was 
revealed to bind microtubules resulting in what we presume is a conformational change 
in the motor protein binding domain of the microtubule preventing motor proteins from 
landing or walking on microtubules. We confirmed unequivocally zinc regulates 
microtubule based trafficking in cells through a variety of microscopy and biochemical 
techniques. 
We were able to determine that zinc inhibits cellular trafficking by interacting with 
four amino acid residues on the α tubulin monomer of microtubules. This explains why 
the microtubule cellular based trafficking in inhibited when zinc concentrations are 
increased. The H192 and H283 amino acid residues on α tubulin were confirmed as the 
zinc binding residues where zinc binds to cause the inhibition of cellular trafficking. We 
hypothesize that E283 and E417 also coordinate the zinc ions although E417 mutant 
disrupted the microtubule structure therefore we were unable to evaluate this site through 
this method of analysis. Although the mere fact the mutation disrupted microtubule 
structure indicates this amino acid is essential to properly form tubules. E283 was not 
statistically significant although this may be a result of glutamate not coordinating zinc as 
avidly as histidine. We propose these four amino acids coordinate the zinc ions in the 
microtubule structure [220]. The exact mechanism of how zinc inhibits the microtubule 
cellular based trafficking is hypothesized to be by altering the microtubules structure 
altering the motor protein binding site on α tubulin which prevents the motor proteins 
from landing and walking on the microtubules. This mechanism to prevent motor 
proteins from landing appears to be universal across different organisms with this 
 
164 
occurring in yeast, bovine, human, and rat species. Previous papers have shown that 
higher concentrations of zinc will stabilize microtubules but begin to cause 
conformational changes in the tubulin structure which causes alters the quaternary 
structure of the microtubules [227-229, 249]. The conformational changes are reversible 
with the removal of zinc which explains why the movement of organelles and motor 
proteins can be restored with the removal of zinc. Although longer incubation times with 
zinc appear to have a denaturing or deactivating effect on the tubulin which requires 
longer times after removal of zinc for the protein to return to the native conformation 
[227]. This may explain why there is a time dependent effect of the reversal of high 
concentrations of zinc, the longer the high zinc is incubated the smaller the reversal of the 
motility inhibition. These four residues would explain this conformational change since 
they are distant from the motor protein binding domain of tubulin causing an allosteric 
effect through a conformational change of the tubulin dimer. 
The zinc induced inhibition of cellular trafficking was shown to be within 
physiological concentrations of zinc. The IC-50 for zinc induced inhibition of cellular 
trafficking is in the low nano-molar range, a range which has been reached by zinc 
release from the lysosomal TRPML-1 channel [88]. Activation of the TRPML-1 channel 
uncovered the channels ability to influence organelle motility and the channels role as a 
regulator of cellular trafficking. Prior to this work there has been no evidence to suggest 
that TRPML-1 channel or zinc contribute to cellular trafficking. This finding could 
provide novel therapies in treatments of diseases such as MLIV disease. 
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Increased influx of labile zinc ions has been shown to cause neuronal death under 
ischemic events, [47, 157] where it was previously understood to be caused by 
mitochondrial dysfunction leading to mitochondrial induced apoptosis [4]. Cellular 
apoptosis may not be a result of mitochondrial dysfunction but rather a result of 
preventing cellular trafficking. Another example where the zinc concentration could 
increase is oxidative stress can cause zinc release from zinc binding proteins like 
metallothionien proteins or glutathione increasing the intracellular zinc in localized 
environments [91]. Redox reactions and zinc dynamics could be mechanisms the cell 
uses to modulate cellular trafficking that prior to this finding were unknown. Through the 
advent of superior zinc sensors additional avenues are waiting to be uncovered that 
modulate zinc concentrations to regulate cellular trafficking. Zinc concentrations are 
reported qualitatively and not quantified due to lack of zinc sensors capable to provide 
accurate measurements of zinc dynamics. New zinc sensors have begun to flood the 
research environment allowing these previous roadblocks to be abolished. Zinc biology is 
a rapidly changing field with more and more discoveries of zincs role within the cell 
elevating the importance of zinc. 
Another potential area of study where this finding could become increasingly 
important is the synaptogenesis of developing neurons. Studies have demonstrated zinc is 
connected to synaptogenesis, neuron development, and synaptic plasticity [250]. Zinc 
may help shape neuronal function through modulating cellular trafficking in neurons 
during these critical developmental stages. During this time period the neurons cellular 
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trafficking is even more important leading to regulators such as zinc playing an enormous 
role in synaptogenesis or defects in synaptogenesis such as in Downs syndrome [251]. 
This work has shown that zinc provides a novel regulatory role in cellular trafficking. 
This is enormous due to the cellular trafficking within the cell still being elucidated this 
offers a novel mechanism to slow down, stop, or speed up transport. Cellular transport is 
vital for cell survival, and needs to be regulated to delivery cargo at specific 
spatiotemporal locations. This aspect of the cell regulates exocytosis, endocytosis, energy 
distribution, nutrient delivery, material transport, and many more aspects required to cell 
survival. The fact that cellular trafficking is regulated by zinc provides a universal 
mechanism of regulating cellular transport and places a newfound importance on 
biological zinc. 
While focusing on mitochondrial zinc dynamics and zincs interaction with 
microtubule-based cellular trafficking we stumbled upon a link between mitochondrial 
microtubule-based trafficking being impeded by increased polyamine concentrations. A 
hallmark of Alzheimer’s disease are dysfunctional mitochondria which ultimately 
contribute to cell apoptosis. Polyamines are also elevated in the brains of Alzheimer’s 
disease patients. Many avenues have been explored to determine the exact mechanism or 
critical biomarkers for Alzheimer’s disease with limited success. Some of these avenues 
indicate polyamines as a potential marker or mechanism to treat Alzheimer’s disease. 
Polyamines are aliphatic amines with a positive charge at physiological pH. Polyamines 
have been found to modulate a wide array of cellular functions from gene expression to 
immune response although no investigation has linked polyamines to alter mitochondrial 
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motility. This decreased mitochondrial motility caused by polyamines could be a 
contributing factor to mitochondrial dysfunction. Providing a link to pursue polyamine-
mitochondrial interaction as a potential therapy for Alzheimer’s disease.
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CHAPTER FIVE: MITOCHONDRIAL MOTILITY AFFECTED BY 
POLYAMINES A POTENTIAL MECHANISM UNDERLYING DOWN 
SYNDROME-ALZHEIMER’S DISEASE 
5.1 INTRODUCTION 
Down Syndrome (DS) is a genetic condition where a partial or full extra copy of 
chromosome 21 is expressed resulting in triplication of the amyloid precursor protein 
(APP) gene. Down Syndrome was first described by J. Langdon Down in 1866 [252] and 
later the cause was identified as trisomy of chromosome 21 by Lejeune in 1959 [253]. 
This is the most common chromosome disorder in humans with 1 in 1000 babies born 
each year with Down syndrome [254]. Studies have found that virtually all individuals 
with DS have sufficient neuritic plaques and neurofibrillary tangles to neuropathological 
diagnosis of Alzheimer’s disease (AD) by the age of 40 years old [255, 256]. Increased 
APP results in an increased incidence of AD pathology in individuals with DS [257-259]. 
Senile plaques contain β-Amyloid (Aβ) protein which is a downstream product from a 
precursor protein β-Amyloid precursor peptide (APP) is located on chromosome 21. The 
APP protein is overexpressed in trisomy of chromosome 21 leading to increased Aβ and 
rising the theory that the Aβ plaques could cause AD [260]. Studying the AD pathology 
in DS individuals is a superb platform to study the mechanisms of AD pathology due to 
the increased production of the Aβ peptide [261-263]. 
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AD is currently the most prevalent neurodegenerative disease affecting the human 
population. AD was first described in 1907 by Alois Alzheimer and was the first 
neuropsychological characterization of the disease documented hence bearing his name 
for the disease [264]. Despite being discovered at the turn of the century research into the 
dementia related pathology only accelerated since 1980, over 70 years later. AD accounts 
for more than half of patients with dementia neurological pathologies. The medial 
temporal lobe (MTL) consisting of the hippocampus & entorhinal cortex is the major 
region that deteriorates as the disease progresses [265]. AD is characterized by 
oligomerization of extracellular amyloid-β (Aβ) plaques as well as intracellular 
accumulation of a protein named Tau forming neurofibrillary tangles. These Aβ deposits 
are localized at synapses and are not ubiquitous throughout the brain remaining 
concentrated in the MTL. The plaques and tangles instigate the loss of synapses and 
eventual neuron death ultimately leading to the progressive cognitive decline observed in 
AD patients. Many avenues have been explored to determine the mechanism underlying 
the pathogenesis of AD with partial success. 
Some of the less explored avenues include amino acid catabolism and polyamines, 
which might may underlie the mechanism leading to AD pathology [266-269]. 
Polyamines (PA) are ubiquitously expressed in all tissues of all animals and plants [270] 
and have diverse roles in numerous cellular processes such as gene expression [259], 
immune response, apoptosis, cell division, differentiation, proliferation, DNA and protein 
synthesis, and homeostasis [271, 272]. However, little investigation into polyamines 
effects on AD has been performed. PAs are aliphatic polycation amines at physiological 
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pH associated with a positive charge [273]. The positive charges associated with PAs 
allow them to interact with negatively charged macromolecules such as DNA, RNA, and 
certain amino acids [274]. The most common PAs present in mammalian are putrescin, 
spermidine, and spermine. These polyamines are biosynthesized from the amino acid 
arginine. Cells will begin by using mitochondrial arginase to convert arginine to 
ornithine, which is then decarboxylated by ornithine decarboxylase (ODC) converting the 
amino acid to the PA putrescin. Putrescin requires an amino propyl group that is 
enzymatically synthesized by S-adenosylmethionine (SAM) acting as a substrate to react 
with SAM decarboxylase forming putrescin. Putrescin and the amino propyl group are 
substrates for the enzyme spermidine synthase to generate the polyamine spermidine. 
Another amino propyl group is incorporated by the same mechanism described above 
with spermine synthase to form the final polyamine spermine [275]. Refer to Figure 40 
for PA biogenesis. PAs have been linked to aging and have been postulated to serve a 
role in the progression of AD. 
Increased polyamine concentrations have been found in AD brains. A similar pattern 
has been found in DS related AD brains [266]. We hypothesize that polyamine 
concentrations increase due to increased beta amyloid proteins leading to increased 
oxidative stress, which has been suggested to increase the activate ornithine 
decarboxylase (ODC), the rate liming enzyme in the biosynthesis of polyamines [262]. 
Previous work has found the ODC enzyme function increases, leading to a production of 
higher concentrations of PAs in the brains of AD patients compared to controls [276]. 
These higher PA concentrations are believed to be linked to the activation of the NMDA 
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receptor causing memory loss. This was confirmed in some studies where Aβ was 
injected into mice cerebrospinal fluid increasing PA concentrations and NMDA 
activation resulting in memory deficits which were reversible upon addition of NMDA 
antagonists [277, 278]. These studies suggest that increased PAs facilitate the production 
of Aβ  plaques and cause cognitive decline [275]. We found increased polyamine 
concentrations in our mice DS cell lines, which might underlie the mechanism of the 
decreased mitochondrial motility also observed in the DS cell lines. Furthermore, we 
have shown that the increased concentrations of polyamines decreased mitochondrial 
motility. In addition, we revealed decreased mitochondrial motility in primary cultured 
rat hippocampal neurons when exposed to polyamines. 
Flawed bioenergetics of the cell is a hallmark of neurodegenerative diseases including 
AD implicating mitochondria as a nexus between the disease and the disruption of 
bioenergetics. Mitochondriopathies are diseases where the mitochondria is at the origin of 
the insult for the disease, AD has been classified as a mitochondiropathie. Some of the 
first indicators AD had mitochondrial dysfunction was altered glucose metabolism in the 
brain [279]. A location of mitochondrial dysfunction appears to be in the electron 
transport chain, leading to a production of higher concentrations of reactive oxygen 
species that will cause more damage to the cell [280]. Many of the electron transport 
chain (ETC) enzymes are dysfunctional in AD brains such as cytochrome c oxidase 
[281], pyruvate dehydrogenase complex [282], and the Krebs cycle α‐ ketoglutarate 
dehydrogenase complex [282]. Although it is still debated if the altered bioenergetics 
observed in AD brains is the cause or a consequence of the primary insults leading to the 
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AD pathology, there is a clear connection between AD and dysfunctional mitochondria, 
which contribute to neuronal apoptosis rendering the mitochondria a primary target to 
study in relation to AD and polyamine interactions. 
PA production can be decreased using an FDA approved drug 
Difluoromethylornithine (DFMO) for hyper proliferative (cancer) and infectious disease 
treatments. DFMO is the fluorinated ornithine analog performing the function as a 
suicide inhibitor of ODC preventing PA production [283] (Figure 40). Although all 
eukaryotic cells require PAs, rapidly dividing cells have a higher demand for PAs to 
divide and function at such a high metabolic rate consequently blocking the production of 
PA production prevents rapid division of cells. We can realign the use of DFMO inhibitor 
to inhibit ODC and prevent the production of PA to determine if AD pathologies can be 
improved (Figure 41). We found DFMO restores mitochondrial motility in our DS mouse 
model. A mouse neuronal model a normosomic control cell line was used to establish a 
reference point for polyamines and Aβ aggregation. Mitochondrial motility and 
polyamines have never been linked prior to these results indicating a novel mechanistic 
pathway for the underlying pathology of AD in DS brains. This could set the grounds for 






Figure 40: Biogenesis of Polyamines and Pathway of Difluoromethylornithine 
(DFMO) Inhibition of ODC Enzyme. 
 
Figure 41: Proposed Mechanistic Relationship between Aβ1-42 & Polyamines. 
Putrescine is synthesized from ornithine through a decarboxylation reaction catalyzed by 
ornithine decarboxylase (ODC). Spermidine and spermine are derived from putrescine by 
the addition of either one or two amino propyl groups, respectively. In Down Syndrome 
(DS) the overproduction of Aβ1-42 is hypothesized to upregulate polyamine synthesis by 
increasing expression of the rate-limiting ODC enzyme. In turn, greater intracellular 
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concentrations of polyamines are believed to increase Aβ1-42 aggregation with associated 
decreased mitochondrial motility. 
 
5.2 METHODS 
PRIMARY RAT HIPPOCAMPAL NEURON CULTURE AND 
TRANSFECTION 
All primary neuron culture was prepared and provided by lab mates. Neuron 
transfection was performed according to the methods described in chapter 4. 
PLASMID CONSTRUCTION 
For mammalian expression, the sensor was constructed in the mammalian vector 
pcDNA3.1 by PCR cloning. To construct mito-mCherry, three repeats of the coding 
sequence for the first 29 amino acids of the human cytochrome c oxidase subunit 8a 
(mitochondrial precursor; accession number NP_004065) was utilized for mitochondrial 
matrix targeting and incorporated into pcDNA3.1 vector using HindIII. The mCherry 
fragment was inserted between BamHI and EcoRI sites. 
LAMP1-RFP (Addgene #1817), GCAMP5 (Addgene #: 31788) and CMV mito-
RGEC01 (Addgene #: 46021) were purchased from Addgene. 
H1B & HTK MOUSE CELL LINES CELL CULTURE AND TRANSFECTION 
The H1b and the HTk cells were obtained from Dr. Pablo Caveides, Faculty of 
Medicine, University of Chile, Santiago, Chile. The H1b cells were derived from the 
hippocampus of normal mouse foetus, and the HTk cells were derived from the 
hippocampus of trisomy 16 mouse foetus[284]. Mouse neuron cells (H1b & HTK) were 
maintained in 1:1 ratio of high glucose Dulbecco’s Modified Eagle Medium (DMEM) to 
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Ham’s F-12 medium (Sigma Co.) with 10% inactivated adult bovine serum (ABS), 2.5% 
fetal bovine serum (FBS), 1 g/L bicarbonate, and glucose adjusted to 6 g/L at 37˚C, 5% 
CO2. The cells were split once a week using Trypsin (Invitrogen) to detach the cells. Cell 
media was replaced twice a week. 
Transfection protocol was performed as follows. The cells were split at high density ~ 
150000 cells/ml and added to a 2 ml imaging dish. On day 2 the cells were transfected. 
The transfection protocol follows the same methods described above for the primary rat 
hippocampal cells using lipofectamine 3000. The single difference is differentiation 
media (Neurobasal-B 27 (Gibco, NYSE-TMO), Forskolin (FK) (10 µM), bFGF 100 
ng/mL (ProSpec-Tany) added to the cell culture media described above) will be added 
back to the cells after washing out the lipofectamine from the cell culture media as 
described [285]. Allow the cells to incubate with the differentiation media for 48 hours. 
When difluoromethylornithine (DFMO) was applied, it was added 48 hours after addition 
of the differentiation media in a 5 mM working concentration. All cells were imaged 72 
hours after transfection. 
LIVE CELL MICROSCOPY 
Cells were imaged 48 hours post-transfection, and cells were washed three times with 
the indicated imaging buffer immediately before imaging. All imaging was performed on 
an inverted Nikon/Solamere CSUX1 spinning disc confocal microscope with a 40x 1.4 
NA oil immersion objective. Data was collected using MicroManager software and 




Hanks salt imaging buffer (HHBSS) pH 7.4 was used for imaging buffer. The image 
acquisition was every 2.5 seconds using a 561 nm laser with the laser power set to 5% 
and the exposure time at 50 ms. The imaging was performed at 37 ˚C. The mouse cell 
lines were imaged using the same parameters except the image acquisition was every 10 
seconds. 
For the neuron imaging polyamine concentrations of 1:1000 dilution from 1 M stock 
polyamine concentrations were added to the imaging dishes for a working concentration 
of 1 µM. The polyamines used were putrescin, spermine, and spermidine. 
For all motility imaging the same specifications were used for motility experiments 
described in chapter 4.2 for neurons. The same procedures described in chapter 4.2 for 
motility of HeLa cells was used for mitochondrial motility in H1b and HTk mouse 
neurons. 
DATA ANALYSIS 
Data analysis was performed using Fiji (ImageJ) and Excel spread sheets. The 
construction of graphs and statistical analysis Kaleidagraph (Version 4.5.3, Synergy 
Software) and JMP (JMP®, Version 13.0. SAS Institute Inc.) were used. All t-tests were 
preceded by an f-test to analyze variance equality. T-tests were then performed with 
consideration for the determined variance equality or inequality.  
Image analysis of mitochondrial motility utilized two programs. Imaging of the 
hippocampal normosomic and trisomic mouse cell lines (H1b & HTK respectively) used 
an ImageJ plugin called Mito_Motility to determine the percent change in mitochondrial 
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motility between two frames in an image stack, the plugin was designed by Kurt De Vos, 
et al [235]. Refer to Appendix A for a detailed method.  
Mitochondrial dynamics were observed in rat hippocampal neurons using the ImageJ 
kymograph program Kymolyzer [286] developed in the Schwarz lab. Refer to Appendix 
B for a detailed method. 
POLYAMINE QUANTIFICATION USING MICELLAR ELECTROKINETIC 
CHROMATOGRAPHY WITH LASER INDUCED FLUORESCENCE 
DETECTION (MEKC-LIFD) 
Capillary electrophoresis was used as opposed to other chromatography techniques 
such as high performance liquid chromatography (HPLC) due to its precision in resolving 
elution peaks down to the yoctomolar (10-24) range [287]. Conventional HPLC with mass 
spectrometry are not as reliably in resolving simultaneously the different polyamines. For 
this reason, capillary electrophoresis was used to separate and quantify PA’s in the cell 
lysate samples. Micellar electrokinetic chromatography (MEKC) utilizes the concept of 
capillary electrophoresis (CE) a separation method utilizing sub micro or nanofluidic 
channels, but extends the application to neutral analytes. The major difference between 
MEKC and traditional zone CE is that there is no stationary phase, MEKC utilizes a 
pseudo-stationary phase by using micelles and a surfactant such as SDS. This 
psuedostationary phase allows the neutral analytes being separated to form a partitioning 
between the micelle migration and the electro-osmotic flow (EOF). This makes the 
neutral analytes elute at different times depending on their partitioning between the 
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micelle and the EOF. This method is dependable and utilizes very small volumes of 
solution (nL) to separate out the neutral analytes [288]. 
REAGENTS 
The following chemicals or solutions were used for running samples through MEKC-
LIFD. Fluorescein isothiocyanate Isomer 1 (FITC), sodium carbonate, sodium bicarbonate, 
& putrescine, sodium dodecylsulphate (SDS), acetone, sodium tetraborate, formic acid, 
HPLC grade acetonitrile. All the reagents were prepared using 18Ω ultrapure MiliQ water.  
DERIVATIZATION PROCEDURE 
One milligram of FITC was dissolved in 1 milliliter of acetone. This solution was used 
to chemically bind to the polyamines amine groups, allowing the polyamines to be detected 
through fluorescence of FITC. Identification of the elutant using laser induced fluorescence 
detection is the detection method for this instrument. A 20 mM carbonate buffer at pH 10 
was prepared with 5 ml of 200 mM NaHCO3 and 5 ml of 200 mM Na2CO3 in 90 ml of 18 
Ω ultrapure water. This solution performs two functions one buffering the anionic solution 
to maintain the migration of micelles and EOF toward to the positive cathode and to 
maintain the pH above 9 for FITC to stay bound to the PA’. At a pH below 8 the FITC will 
no longer bind the amine groups. The 1 ml of 20 mM carbonate buffer was mixed with 1 
ml of 1 mg/ml FITC in acetone to obtain a 1.28 mM FITC derivatizing solution (1:1 
mixture). A known amount of this solution was added to standards and samples. The 
solution is light sensitive and was always covered in aluminum foil to prevent bleaching 
of the FITC. The mixture of FITC/Acetone and 20 mM carbonate buffer were reacted with 




The MEKC-LIFD instrument was built in-house with a Glassman High Power Supply 
model PS-MJ30P04400X88 (Glassman High Voltage Inc.), a collinear fluorescence 
detector equipped with a Hamamatsu Photo Multiplier Tube Model H-9306 (Hamamatsu 
Co.) and a Cobolt solid state, 488 nm, continuous wave laser model 0488-06-01-0060-100 
(Cobolt MLD). The signals were collected by a National Instruments data acquisition card, 
model PCI-6221 (National Instruments Co.) in a computer programmed with custom-made 
software both for acquisition and processing. Contributed by Daniel Paredes. 
 SAMPLE TREATMENT 
The cells were lysed by removing the cell culture media and rinsing the cells with -20 
˚C 1X PBS buffer two times. Following rinsing, the cells were lysed with -20 ˚C ethanol. 
The cell lysates were collected and mixed with acetonitrile to precipitate out the proteins 
using 10 µl of each in a 1:1 mixture. The samples were then centrifuged at 375 g for 5 
minutes. The supernatant was kept and reacted with the derivatizing solution described 
earlier in a 1:1 ratio. 10 μl of the supernatant was reacted with 10 μl of the derivatizing 
solution. After allowing the solution to react for a minimum of 16 hours out of light the 
samples and the standards were ready for MEKC analysis. 
RUNNING PROCEDURE 
The samples were hydrodynamically injected by applying a negative pressure of −10 
to -15 psi for 1 second at the cathodic end of a fused silica capillary model TPS 025375, 
polyimide coated, 350 μm external diameter, 25 μm internal diameter and 60 cm long 
(Polymicro Technologies Inc.) while the anodic end of the capillary was immersed into the 
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test solution. The estimated injection volume was 800 pL. The running buffer was 
composed of 40 mM Sodium Borate and 20 mM SDS at pH 9.0 determined from a previous 
study [289]. The SDS will help form the micelles in the running buffer and the pH > 9 
allows the FITC to remain bound to polyamines. The capillary was washed 
hydrodynamically for 6 min with a 1 M sodium hydroxide solution to remove any 
particulates that accumulated in the capillary from previous runs and followed by a run 
with ultrapure water for 6 min, finally the capillary was filled with the running buffer for 
6 min to condition the capillary. The solution takes ~6 minutes to run through the capillary 
with a hydrodynamic pressure of -18 PSI. After injection, the anodic end of the capillary 
was immersed in a reservoir containing the running buffer and equipped with a Platinum-
Iridium electrode while the cathodic end remained in the running buffer reservoir of the 
cathode. A positive, 27 kV were applied at the anode for the electrophoretic separation and 
the data was collected for 30 minutes. 
DATA ANALYSIS 
The data was analyzed using PicoAnalytical software that is capable of filtering a 
moving average digital filter and has both horizontal and vertical displacement 
capabilities for automatic electropherograms alignment. When the Fourier Transformed 
Compton Profile (FTCP) was not well resolved, the software deconvolved the peaks and 
calculated the best fitted Gaussian curve to calculate the area under the curve and 
determine the concentration by correlating with the standard curve of each PA. The 
statistical comparisons were made using Kaleidagraph V 4.5.3 for analysis of variance 
(ANOVA) post hoc Tukey. 
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MITOCHONDRIAL FUNCTION TEST 
The mitochondrial function test was performed using Mitochondrial ToxGloTM Assay 
by Promega. This kit is a cell-based assay that utilizes multiplexed chemistry for analysis 
of mitochondrial dysfunction as a result of testing procedures. Overall the kit will lyse the 
cells and treat the lysate with a combination of luciferin, ATPase inhibitors, protease 
inhibitors, and Ultra-GloTM Luciferase to detect the ATP production of the cells. The 
following procedure was used for analysis of the cells mitochondrial function. 
Mitochondrial function was performed by addition of 20 µl of the 5X Cytotoxicity 
reagent to each well using a multichannel pipette. Shake on an orbital shaker for 1 minute 
at 500 rpm. Add 100 µl of the ATP detection solution to each well using a multichannel 
pipette to ensure close timing with the addition. Mix by using the orbital shaker for 5 
minutes at 500 rpm. Measured the luminescence using a Tecan plate reader with the gain 
set for 90% saturation. 
Following 24 hours of treatment for respective triplicates the mitochondrial function 
was measured again and recorded. 
Hippocampal mouse neuron cell lines were used from Pablo Caveides lab. The 
normosomic (H1b) and trisomic (HTK) cell lines were tested for mitochondrial function. 
The cell lines were split following protocols described for HeLa cell splitting and plated 
at equal concentrations for both cell lines and all the treatment conditions. The treatment 
conditions consisted of controls for each cell line (no treatment), treatment with 10% 
DMSO (Control should kill cells), treatment with DFMO. 50 µl of each cell lines cells 
were plated at 200,000 cells/ml to a 96-well cell culture plate. In between each addition 
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of cells the stock solution of suspended cells was pipetted up and down 3 times to ensure 
an even distribution of cells. Cell clumping can adversely affect the results by having 
variable numbers of cells in each well resulting in mitochondrial function varying 
dramatically due to cell count not function. Cells were allowed to adhere for 24 hours. 
The cell media used to suspend the cells is a 1:1 ratio of high glucose Dulbecco’s 
Modified Eagle Medium (DMEM) to Ham’s F-12 medium (Sigma Co.) with 10% 
inactivated adult bovine serum (ABS), 2.5% fetal bovine serum (FBS), 1 g/L bicarbonate, 
and glucose adjusted to 6 g/L. After 24 hours this media was replaced with the 
differentiation media consisting of the same media as above supplemented with 
Neurobasal-B 27 (Gibco, NYSE-TMO), Forskolin (FK) (10 µM), & bFGF 100 ng/mL 
(ProSpec-Tany). The cells were incubated in differentiation media at 37 ˚C and 5% CO2 
for 48 hours. After 48 hours the treatments were added to the respective wells, three 
replicates were performed for each treatment. At this point prior to treatment 3 replicates 
of each treatment condition (without treatment) were recorded for mitochondrial 
function. 
5.3 RESULTS/DISCUSSION 
Initially to probe PA’s impact on mitochondrial motility, PA’s were increased 
exogenously to healthy primary hippocampal cells to determine if there was an impact on 
mitochondrial motility. PA’s have been shown to be taken into the cell through 
endocytosis [290, 291] allowing PA’s to interact with mitochondria upon exogenous 
application. The PA’s were added into the HHBSS solution used to image the primary rat 
hippocampal neurons and compared to the baseline speed of the mitochondria prior to PA 
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addition. The mitochondrial speeds were monitored in the axons. We found the 
mitochondrial speed decreased after the addition and incubation with spermidine and 
spermine. Putrescin did not statistically reduce the mitochondrial speed although it 
appears that the effect may be mild but still decrease mitochondrial speed. One 
interesting pattern observed was the speed of the mitochondria decreased based on the 
polyamine added with more dramatic inhibition of speed from putrescin to spermidine to 
spermine (Figure 42). The more amino propyl groups are contained in the backbone of 
the PA, the more pronounced the decrease in the mitochondrial motility. This potentially 
link the charge on the PA to the decreased mitochondrial speed. This provides an inverse 
correlation between positive charges and mitochondrial motility. 
 
Figure 42: Primary Cell Culture Rat Hippocampal Neurons Supplemented with 
Polyamines. A-C show baseline mitochondrial motility in total movement length over 10-
minute time periods using the program Kymolyzer compared to the total movement 
length after a 20-minute incubation with polyamines. D-F show the kymographs from the 
mitochondrial motility before polyamine addition (baseline), directly after polyamine 
addition (Putrescin, Spermidine, Spermine respectively), and after a 20-minute incubation 
with each respective polyamine. Experiments were performed in primary cell culture rat 
hippocampal neurons, and imaging was performed along the axons of the hippocampal 
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neurons. N=3 for each PA evaluated. Statistical analysis was performed using two way T-
test, * represents p < 0.05; ** represents p < 0.01; *** represents p < 0.001; **** 
represents p < 0.0001. 
Mitochondrial motility was analyzed using a mouse cell line derived from mouse 
hippocampal fetus neurons developed out of Pablo Caveides lab [284]. These cell lines 
are unique and extraordinarily useful for our purposes due to one cell line being a 
normosomic (derived from wild type mice) cell line (H1b) and one being a trisomic cell 
line (HTK). Despite on being normosomic and the other being trisomic both cell lines are 
from the same species and cell type. The mitochondrial motility of these two cell lines 
(normosomic and trisomic) were compared with each other as shown in Figure 43 below. 
The HTK cell line had lower mitochondrial motility than the H1b cell line. This 
correlates with our findings that DS cell lines have increased polyamine concentrations 
(Figure 44). Even more intriguing we discovered that 24 hour incubation with DFMO, 
which inhibit the synthesis of PA’s rescued mitochondrial motility of HTK above 
baseline, matching the levels of H1b mitochondrial motility. Potentially the reduction in 





Figure 43: Mitochondrial Motility Restoration using DFMO in DS (Trisomic) 
Hippocampal Mouse Neurons. Mitochondrial motility was calculated for control 
normosomic hippocampal mouse neurons and trisomic hippocampal mouse neurons. 
Both were treated with difluoromethylornithine (DFMO) an ornithine decarboxylase 
inhibitor. DFMO improved the mitochondrial motility back to normal levels when 
introduced into the trisomic hippocampal neurons. DFMO decreased mitochondrial 
motility in normosomic hippocampal neurons (not shown). Mitochondrial motility was 
calculated from the program ‘Total_Motility’ described in the methods section every 10 
seconds. Statistical significance was calculated using a t-test, p < 0.0001 ****, n=3. 
Next we wanted to quantify the polyamine concentrations in the mouse neuronal cell 
lines to determine if the mitochondrial motility is decreasing as PA’s increased. We 
analyzed the PA concentration using a capillary electrophoresis in the modality of micelle 
electrokinetic chromatography-laser induced fluorescence detection (MEKC-LIFD). The 
concentrations of Putrescine in the H1b cell line were statistically lower than the HTK 
cell line, indicating the trisomic cells has higher putrescine concentrations than the 
normosomic cell line (Figure 44). Spermidine did not show to be statistically significant 
increased in the HTK as compared to the H1b cell lines, but a trend to be increased was 
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observed (Figure 44B). With increased n counts this might show a statistical significant 
increase. The DFMO lowers the polyamine concentrations in the HTK cell line to the 
levels of the normosomic H1b cell line, Figure 44. In addition we confirmed the link 
between the polyamine concentration and trisomy of chromosome 21 increasing the 
amount of Aβ1-42 produced. HTK cells produced more PA’s as well as Aβ1-42. A finding 
by Dr. Guido Vacano not shown here was the ODC protein concentration was higher in 
HTK cells compared to H1b cells as well as APP and Aβ. The higher production of Aβ1-
42 increased the concentrations of the ODC protein which consequently matched our 
hypothesis to convert ornithine to polyamines. This finding combined with our findings 
support our hypothesis that triplication of the APP gene which induces elevated Aβ leads 
to increased polyamine production slowing down mitochondrial motility. This aligns with 
directly adding the polyamines to the extracellular solution or cell culture media causing 
a significant decrease in the mitochondrial motility. In both scenarios, the PA 




Figure 44: Polyamine Content from Normosomic and Trisomic Hippocampal 
Neurons. Treatment of DS hippocampal neurons with the ODC inhibitor DFMO 
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decreases polyamine concentrations, restoring polyamine concentrations to physiological 
concentrations in the normosomic hippocampal neurons. There is significantly higher 
polyamines in the trisomic cell lines. Statistical significance was performed using a one 
way ANOVA post hoc Tukey, * represents p < 0.05; ** represents p < 0.01; *** 
represents p < 0.001; **** represents p < 0.0001, n=3. Contributed with the help of 
Daniel Paredes. 
At this juncture we wanted to identify the potential mechanism by which polyamines 
might decrease the mitochondrial motility. A similar endeavor was undertaken in Chapter 
4 with identification of the zinc interaction site for zinc induced inhibition of cellular 
trafficking. We explored if PA’s would influence other organelles beyond mitochondrial 
motility. We performed a similar experiment as before with the addition of exogenous 
polyamines to primary rat hippocampal neurons. Although we observed lysosomal 
motility, it was unaffected by incubation with spermine the most potent PA found in this 
work for inhibition of mitochondrial motility observed (Figure 45A). This result confirms 
PA induced inhibition of motility appears to be specific to mitochondria. We further 
investigated this specificity by imaging lysosomes in differentiated and undifferentiated 
HTK and H1b cells using TIRF microscopy imaging performed by Anarkali Mahmood 
(Data not shown). We discovered there was no change in the speed of lysosomes between 
the trisomic and normosomic mouse cell lines. Again this confirms that the PA induced 
inhibition of motility is specific to the mitochondria. Another interesting observation of 
the mouse cell lines is the diffusion (motility), which was higher in the undifferentiated 
cell lines than the differentiated cell lines. This may be caused by differentiated cells 
containing neurites, which limit the diffusion of lysosomes. The central observation 
remains to PA’s affecting specifically mitochondria not lysosomes. We reasoned the 
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mitochondria must have a unique mechanism to interact with PA’s and decrease motility 
unlike other organelles. 
 
Figure 45: Mechanism of How Mitochondrial Motility is Inhibited. (A) There was no 
significant change in the speed of lysosomes in primary rat hippocampal neurons speed 
after incubation with spermine, indicating motor proteins and microtubules are not 
responsible for decreased motility, n=3. (B) The calcium concentrations were not altered 
after incubation with spermine in the mitochondria (Mito-RGEC01)or the cytosol 
(GCAMP5) of HeLa cells, n=3. No statistical significant differences were found between 
any of the measurements. A two way T-Test was used for statistical analysis. 
One possible protein that could link mitochondrial dynamics to PA’s is the Miro/Trak 
complex. This complex is what attaches the mitochondria to the microtubules allowing 
mitochondria to be transported on microtubules. Increased calcium can bind the Miro 
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protein causing the Miro/Trak complex to dissociate from the motor protein preventing 
movement of the mitochondria [23] (Figure 46). Miro regulates the binding of 
mitochondria to these Trak protein complexes which have been shown to be regulated by 
calcium and GTP. There are also various splices of the Miro protein indicating there may 
be multiple molecules that affect the binding of the Miro protein to the Trak protein 
complex potentially PA’s. The EF hands (calcium binding domain) of the Miro protein 
bind the calcium and which then causes the protein complex to dissociate halting 
mitochondrial movement. The exact nature of how the Miro/Track/Kinesin all dissociate 
from the microtubule is still undefined. Similar interactions exist between Drp1, Miro, 
and calcium. When calcium is low, fusion is predominantly occurring between 
mitochondria although when calcium levels rise there appears to be a suppression of 
Drp1 when Miro binds calcium and dissociates from the Miro/Trak protein complex. 
 
Figure 46: Mitochondria Attachment to the Miro/Milton Complex. The mitochondria 
rely on motor/adaptor complex (Miro/Milton) to connect to the motor proteins which are 
connected to the microtubules to move the mitochondria along these microtubules. 
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We suspect the Miro/Trak complex could be the location where PA’s influence the 
mitochondrial motility. Previous studies point to the polyamines altering calcium 
concentrations of cells [292]. We monitored the calcium concentrations in the cytosol and 
mitochondria of HeLa cells upon PA addition and found no significant changes to the 
calcium concentration (Figure 45B). This may be an artifact intrinsic to imaging HeLa 
cells and not neurons given there were no changes in either the mitochondrial or cytosolic 
calcium concentrations. In consequence, we agreed the PA effect on mitochondria 
motility is calcium-independent. Another potential mechanism for decreased 
mitochondrial motility is the decreased mitochondrial function associated with AD 
pathogenesis. 
Studies have shown mitochondrial dysfunction due to dyshomeostasis of polyamine 
concentrations within the cell [293, 294]. Mitochondrial function was quantified by 
measuring the luminescence of cell lysates with a luciferase assay analyzing the ATP 
production of cells. This experiment allowed us to evaluated the mitochondrial health of 
the H1b and HTk cell lines with or without DFMO treatment and found no changes in 
mitochondrial function after treatment with DFMO (Figure 47). Trisomic hippocampal 
neurons (HTK) showed reduced mitochondrial function after 24 hours compared to 
normosomic hippocampal neurons, which showed slightly increased mitochondrial 
function after 24 hours. However, DFMO treatment did not restore the mitochondrial 
function in trisomic hippocampal neurons (Figure 47). DMSO was used as a control 




Figure 47: Mitochondrial Function in Normosomic and Trisomic Mouse Neurons. 
Mouse neurons were differentiated and measured mitochondrial function over 24 hours. 
Normosomic cell lines appear to have no change or a slight increase in mitochondrial 
function while trisomic cell lines show a clear decrease in mitochondrial function. DFMO 
does not restore the mitochondrial motility in the mouse cell lines. N=3, Statistical 
significance was performed using two way T-Test, * represents p < 0.05; ** represents p 
< 0.01; *** represents p < 0.001; **** represents p < 0.0001. Contributed with the help 
of Randall Mazzarino. 
We were unable to ascertain the specific interaction site for polyamines and 
mitochondria that resulted in the decreased mitochondrial motility. Although there is a 
clear inverse correlation between mitochondrial motility and polyamine concentrations. 
5.4 CONCLUSIONS 
We determined a clear inverse correlation between mitochondrial motility and 
polyamine concentrations. This relationship has never been reported in previous 
literature. The increased polyamine concentrations significantly decreases mitochondria 
motility. The effect of PAs in mitochondria motility appears to be specific to 
mitochondria, not affecting lysosome motility (Figure 42, 43, & 45). The polyamine 
concentrations were shown to be significantly increased in the DS cell model. This 
 
193 
suggest that the higher levels of polyamines present in AD patients could be decreasing 
mitochondrial motility causing disproportionate energy distribution throughout the 
neurons. Neurons as described in chapter 4 are more sensitive to improper bioenergetics 
than normal cell types. This decreased mitochondrial motility may contribute to the cell 
apoptosis observed in AD patients MTL neurons. 
The precise interaction site of polyamines and mitochondria have not been 
determined. It appears that the increased polyamines do not affect all microtubule-based 
trafficking since lysosome motility was unaffected by increased polyamine 
concentrations. The mitochondria have a specific Miro-Milton complex that is calcium 
sensitive, binding mitochondria to the motor proteins kinesin and dynein. Previous 
studies indicated that trisomic cell lines had changes in calcium concentrations, which 
could impact the ability of mitochondria to remain attached to the motor proteins. 
Calcium concentrations were unchanged in the cytosol and the mitochondria following 
increased polyamine concentrations. This suggest that Miro-Trak complex is not at the 
core of the action of Pas for decreasing mitochondrial motility. 
Another potential cause for decreased mitochondrial motility is the mitochondria 
becoming unhealthy due to the increase in polyamine concentrations. However, 
mitochondrial function, which was evaluated with a luciferase assay production of ATP 
was found to be decreased in the HTk cell lines as compared to H1b cell, was not restore 
with DFMO treatment. Thus, suggesting the intracellular levels of PAs does not affect 
ATP production. One potential explanation for this is that mammalian cells utilize both 
aerobic and anaerobic (glycolysis) mechanisms to produce ATP. Either of these 
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bioenergetics processes will compensate for the other if one is compromised. What might 
be occurring is the mitochondrial aerobic function is improved after treatment with 
DFMO, although the glycolysis is reduced producing what appears to be no increase in 
ATP production or restoration of mitochondrial function. Although we would need 
further analysis to show this is what is occurring. 
One last potential mechanism how the PAs may be affecting mitochondrial motility is 
electrostatic attractions. The PAs have a positive charge and the mitochondria are more 
negatively charged inside the matrix than the cytosol. This would create an electrostatic 
attraction between the positively charged PA’s and the negatively charged mitochondria. 
The accumulation of positively charged PA’s may be interfering the binding of 
mitochondria to motor proteins. This would explain the specificity for mitochondria since 
other organelles are not negatively charged like mitochondria. Further testing is needed to 
confirm this, although it could be the electrostatics surrounding the mitochondria 
following polyamine solvation preventing the mitochondria from properly attaching to 
motor proteins and moving. It has been found that the polyamines localize around the 
mouth of VDAC channel present a voltage dependent block [295]. This could also cause 
interactions that prevent the mitochondria from properly binding the motor proteins. PAs 
have been linked to formation of the mitochondrial transition pore and release of 
cytochrome c [296, 297]. This could decrease the mitochondrial health potentially 
leading to decreased mitochondrial motility. However, given that a significant reduction 
of mitochondria motility is observed within 20 minutes upon PAs application to the 
hippocampal primary cell culture, strongly suggest that PAs might be affecting the 
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physical interaction of the mitochondria with the microtubules.  This is a plausible 
mechanism warranting further studies.   
There are many mechanisms the cell has to slow down microtubule-based cellular 
trafficking whether through MAP proteins or inhibitors or activators of motor proteins 
which may only be specific for mitochondria. Currently we do not know where the 
polyamines are interacting with the mitochondrial to decrease motility although there is a 
clear link between the polyamine concentration and mitochondrial motility. The 
increased polyamines are connected to the triplication of APP, which result in 
overproduction of Aβ and has been suggested to increase the activity of ODC leading to 
increased synthesis of PAs. This finding provides an additional avenue by which neurons 
might become dysfunctional in Down syndrome associated AD. Reducing polyamine 
concentrations to normal concentrations may offer a novel therapy for treating AD 




CHAPTER SIX: CONCLUSIONS AND FUTURE DIRECTION 
The first project optimized the GZnP sensor developing a vastly improved array of 
zinc sensors. Through sensor optimization multiple new sensors with increased zinc 
sensitivity, faster kinetics, and distinctive binding affinities for zinc were produced. The 
new sensors increased our repertoire of available fluorescent zinc sensors. By expanding 
our available tools to analyze zinc we expanded our ability to study biological zinc. We 
obtained our goal to design zinc sensors that are comparable to currently available 
calcium sensors in sensitivity, kinetics, brightness, and specificity. By optimizing GZnP 
we created zinc sensors that are comparable to currently available calcium sensors such 
as GCaMP and G-GECO sensors. There is still room for further development of this 
sensor platform to enhance the DR, maximum sensor fluorescence, kinetics, and binding 
affinity. In addition a red sensor variant is highly desirable to have multiple zinc probes 
available to simultaneously image without spectral bleed through. In addition red sensors 
are relatively pH insensitive which is advantageous for zinc biology due to many zinc 
stores being acidic such as the endosome & lysosome. 
The second project utilized the optimized zinc probes designed in the first project to 
answer two zinc biology questions. The zinc probes were further modified to ratiometric 
sensors to provide better quantification of zinc concentrations in different subcellular 
compartments. The mitochondrial matrix zinc concentration was confirmed to be nearly 
zero across four different cell types. The second question answered was the 
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mitochondrial matrix is not a storage site for excess zinc, excluding the mitochondria 
from buffering intracellular zinc concentrations. This work clearly shows the 
mitochondria do not store excess zinc when the cell is stressed with high intracellular 
concentrations of zinc. In addition under basal conditions the mitochondrial matrix has 
~zero zinc. Without the enhanced zinc sensors developed in project one, project two 
would have not been possible. Further work can be performed to determine where zinc is 
sequestered during high intracellular zinc stress. The novel zinc sensors provide a perfect 
platform to investigate the zinc dynamics during these events. 
Project three utilized the enhanced zinc probes along with a multitude of other 
techniques to identify zinc as a regulator of cellular trafficking. This is an unprecedented 
connection linking zinc and cellular trafficking together. We performed a top down 
approach demonstrating zinc inhibited cellular trafficking of organelles. Next we 
established zinc inhibited the movement of both motor proteins kinesin and dynein. 
Finally we discovered zinc interacts with microtubules to prevent the landing of motor 
proteins on the microtubule preventing microtubule-based trafficking when zinc 
concentrations increase. We identified the amino acid residues responsible for the zinc 
interaction as H192 and H283 on the α-tubulin monomer of microtubules. This was the 
first study connecting zinc to cellular trafficking. Future studies can determine the 
processes zinc induced inhibition of cellular trafficking affects. One such process may be 
synaptogenesis for neuronal development. Although any process where zinc 
concentrations are found to be dynamic can be investigated to potentially control cellular 
trafficking. The improved zinc sensors can resolve additional zinc pathways and further 
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investigation can reveal if there is a link between the novel zinc pathways and cellular 
trafficking. 
Project four found the trafficking of mitochondria is correlated to polyamine 
concentrations. We discovered there is an inverse relationship between polyamines and 
mitochondrial motility. We were unable to identify the specific site linking polyamines 
and mitochondria to each other although we eliminated many prospects. During this 
project we established a pristine link between PA’s and mitochondrial motility in AD. 
This link provides a new avenue to explore for AD therapies. Future studies can aim to 
identify how PA’s alter the mitochondrial motility and then aim to design treatments for 
AD using this novel pathway. 
Overall this work advanced zinc cell biology by developing improved zinc sensors, 
answering zinc biology questions, and discovering new relationships between zinc and 
biology. In addition novel connections were found for the most common 
neurodegenerative disease of our time AD, linking PA’s and mitochondrial motility. With 
all of these developments and discoveries more questions than answers were unearthed 
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APPENDIX A: QUANTIFICATION OF ZINC CONCENTRATION IN 
CYTOSOL, MITOCHONDRIAL MATRIX, AND IMS 
This is a detailed procedure for the image analysis of the fluorescent GZnP2 probe 
with a mCherry fluorophore attached to measure zinc concentrations in the cell cytosol, 
mitochondrial matrix, and IMS. 
Imaging analysis was performed by Fiji (Image J) [147]. Open an image stack of 
mCherry-GZnP2 in Fiji. 
 
Split the image stacks of the GZnP2 and mCherry sensor signals using the “Image” 




Both image stacks (green and red channel) were aligned to account for thermal and 
mechanical drift in the xy directions using the Stackreg plugin with the Rigid Body 
method in Fiji. This prevented any drift of the cell affecting the intensity of the signal 
being misinterpreted as changes in zinc concentrations. Note running the Stackreg will 
convert the color to black and grey on grey scale for the images. 
Next an ImageJ plugin called “Time Series Analyzer” was used to measure the 
intensity of the fluorescent signal in each channel over time. Regions of interest (ROI) 
were chosen over the cells in the imaging frame as well as one for the background to 




For the quantitative analysis, image stacks for both GZnP2 and mCherry were 
background corrected by generating a region of interest (ROI) on a blank area of the 
imaged area and subtracting the fluorescence intensity of each channel from the 
respective channel, e.g. IGZnP2(cell) – IGZnP2(background), and ImCherry(cell) – 
ImCherry(background). The “Time Series Analyzer” program was run and the intensities 
collected for both GZnP2 and mCherry for each respective cell for the duration of the 




Each cell was background corrected for both the mCherry and GZnP2 channel. The 
background corrected GZnP2 and mCherry images are used to calculate the 
normalization ratio (R, i.e. GZnP2/mCherry) to eliminate any drift in the z plane from 
being misinterpreted as changes in the zinc concentration. The calibration of the sensors 




The baseline mCherry-GZnP2 ratio (R), minimal ratio achieved using 100 µM TPEN 
(Rmin), and maximal ratio (Rmax) obtained using zinc saturation (Zn-PTO) were used to 
quantify cytosolic zinc concentration using the equation [Zn2+] = Kd [(R – Rmin) / (Rmax – 
R)]1/n (Kd & n values were specific to the region being quantified, pH = 8 for 
mitochondrial matrix and pH = 7.4 for the cytosol and IMS and characterized in vitro).  
All in situ sensor calibrations were performed at RT. The same methods were used to 
calculate the zinc concentrations in the mitochondrial matrix and IMS, the ROI were 
drawn using the freehand tool to capture all the mitochondria for a single cell. Statistical 
analysis was performed using the t-test in KaleidaGraph program. The error bars 
represent the standard error of the mean. 
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APPENDIX B: QUANTIFICATION OF CELLULAR TRAFFICKING 
MEASURING MOTILITY IN KYMOGRAPHS OF NEURONS 
Motility in neurons was measured using kymographs due to the nature of neurites 
allowing the motility to be funneled down a straight line. Kymograph analysis provides a 
wealth of information from speeds, to velocities (directionality), movement lengths, 
number of moving particles, or any derivation therein. Motility analysis for neurites was 
performed using ImageJ [147] and an ImageJ plugin “Kymolyzer” developed by the 
Schwarz lab [224]. Prior to running the program all image stacks were separated 
according to treatment (baseline, TPEN, etc.). This is accomplished by clicking the 
“Image” tab then the “Stacks” dropdown menu then “Tools” and click on “Slice Keeper”. 
Put the first to last image slice for each treatment of the full image stack and make sure it 
is slicing every single frame not every other which the default is. The reason we must cut 
the full image stack into the respective treatments is the Kymolyzer program can only run 
for the entire image stack it processes and provide averages which would not indicate 
changes between different treatments. Each stack was aligned using the ImageJ plugin 
“Stackreg” with the transformation “Rigid Body” to correct for xy drift. After being 
aligned the stacks were run through the Kymolyzer plugin. Prior to imaging the soma of 
the neurons is identified for the directionality of the neurite motility (retrograde and 
anterograde). 
1. Run step 1 of kymolyzer: Plugins>Macros>Kymolyzer>Step1_MakeKymograph 
a. Select the image stacks for a treatment that has been prealigned. 
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i. If it is a dual channel image stack, the macro will ask the user to select any one 
channel, which has the moving particles that are to be traced. The total time length of the 
image stack will be required to calculate the kymograph and the data derived from the 
kymograph. 
 
b. The macro will then give a maximum projection image of that channel and ask to 
user to trace a line to make the kymograph. At this point you can change the thickness of 
the traced line that will be the average of the intensities to ultimately make the 
kymograph by double clicking on the segmented line option. I change the thickness to be 
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just wide enough to cover the neurite width any wider and the line average is majority 
background and the particles fade especially with dimmer organelles such as lysosome. 
 
i. At this stage the user can ask the macro to open up a file where drawing the line 
will be easier (such as the GFP channel) 
c. Macro will then make the kymograph and ask the user to change the brightness and 





d. Step 1 is finished! 
  
2. Run step 2 of kymolyzer: Plugins>Macros>Kymolyzer>Step2_Track 
a. A folder selection window will open up as soon the step 2 is run.  
i. Select the folder with the name of the image 
b. Macro will open up the kymograph and ask the user the following: 
i. Puncta Start Count:  
1. At the start of each image this number should be 1 
2. If, for some reason the step 2 has to be restarted with some particles being already 
tracked in that image, then change the puncta start count to whatever number of particles 





ii. Show box size: This is the size of the box used to display the tracked particle. Start 
with show box size as 5 and adjust as necessary 
iii. After the setting the puncta start count and show box size press OK to start the 
tracking 
c. During the tracking process you can do the following at any point of the image: 
i. Shift+LeftClick : adds points on a track 
ii. Cntrl+leftClick: finishes the track 





1. It is advisable not to use the Alt+LeftClick function to begin with. Only use it 
once you know what to depict as stationary and what as moving (after going 
through the step 3 atleast once). 
iv. After the tracking of each puncta, a movie will popup showing how well the 
puncta was tracked. Press OK if you are satisfied with the tracking. 
v. Then go on the next puncta, by clicking “Yes” in the “For another track” dialog 
vi. After the final puncta, click “No” on the same dialog box 
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3. Run step 3 of kymolyzer: Plugins>Macros>Kymolyzer>Step3_Measure 
a. A folder selection window will open up as soon the step 3 is run.  
i. Select the folder with the name of the image 
b. After folder selection, a window will pop-up asking for the image parameters: 
i. Pixel Scale in um/pixel: length of each pixel in micro after maginification. This 
information can be determined from the microscope specifications. 
ii. Timescale (s): Time gap between two frames 
The kymograph width and height should not be changed these should auto populate 
with the correct values after the macro reads the metadata. 
iii. Kymograph width (in pixels): generally the length of the line selection made 
iv. Kymograph height (in pixels): generally, total number of frames in the movie. 
c. After setting the scale parameters, the following two options have to be selected: 
i. Calculate step (every 1 time points): Each track is divided into segments.  This 
value defines the number of frames to skip in between recording the position of each 
particle, to divide the tracks (for example, in a movie with a 100 time points, a value of 5 
will divide the track into 20 segments).  
ii. Lower limit of velocity: lowest velocity of a particle at any segment below which, 
it is considered as stationary. I set this to zero. 
d. The best way to decide the values is to track two test particles, one that is 
stationary and one that is motile. Then set the frame step gap and lowest velocity limit to 
the lowest possible values such that the stationary particle is indeed recorded to be 
stationary while movement is detected for the motile particle 
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e. The raw data for all the particles in a kymograph can be found in the following 
excel file: …pathTofolderWithImageName/RawPunctaFiles/Summary.xls 
ii. Open up this file and check the tab “Move %” to see whether the stationary particle 
is indeed recorded to be stationary. 
iii. If not repeat the third step by increasing the lower velocity limit or the frame skip 
gap. 
f. This value should be changed in between different samples of the same experiment. 
All the raw data can be pulled from the excel file labeled “summary”. 
NON-NEURONAL CELL MITOCHONDRIAL MOTILITY CALCULATION 
This protocol outlines in detail how to determine mitochondrial motility in cells other 
than neurons where kymographs cannot be performed. The program being used is an 
ImageJ plugin called “Total_Motility” developed by the Kurt De Vos lab[235]. This 
plugin works by measuring the difference in mitochondrial area between two frames and 
dividing this value by the total area of mitochondria. This will offer a percent movement 
of mitochondria per a frame. This program works well at identifying oblong shapes 
which typically works well for mitochondrial morphology. 
Open the image stack with the mitochondria tagged channel. Image stacks were 
aligned using the ImageJ plugin “Stackreg” with the transformation “Rigid Body” 
correcting for drift in the xy direction. The image stack was cropped to choose a single 
cells mitochondria using the free hand tool. When cropping cut out any areas of the cell 
that are out of focus, later when thresholding the image faded areas are difficult for the 




Threshold the image by clicking on “Image” then click the dropdown menu “Adjust” 
then click on “Threshold”. The image stack was thresholded using the default threshold 
method AKA “Isodata_IJ” method. Click the option “Dark Background” then click 
“Apply”. A new prompt dialogue box will pop up, do not calculate the threshold for each 
image use the initial calculation to have a fair comparison between all images. Leave the 




Following thresholding the image stack noise was reduced using the median filter 
“Despeckle” an ImageJ plugin under the “Process” tab then the “Noise” dropdown menu. 
This removes speckling from the thresholding. Then the image stack was run through the 
Total_Motility plugin showing the thresholded image, the difference between two frames, 




NON-NEURONAL CELLS LYSOSOME, ENDOSOME, AND VAMP2 
MOTILITY 
This will detail the protocol used to analyze lysosome, endosome, and VAMP2 vesicle 
motility in non-neuronal cells. The “Total_Motility” plugin works but is optimized for 
oblong shapes which these organelles are sphereical and a better system was developed to 
track their motility. The image stack is loaded into Fiji, for this example LAMP1-
mCherry (lysosome) in HeLa cells will be used. Prior to running the program all image 
stacks were separated according to treatment (baseline, TPEN, etc.). This is accomplished 
by clicking the “Image” tab then the “Stacks” dropdown menu then “Tools” and click on 
 
232 
“Slice Keeper”. Put the first to last image slice for each treatment of the full image stack 
and make sure it is slicing every single frame not every other which the default is. The 
reason we must cut the full image stack into the respective treatments is the particle 
tracking program can only run for the entire image stack it processes and provide 
averages which would not indicate changes between different treatments. Image stacks 
were aligned using the ImageJ plugin “Stackreg” with the transformation “Rigid Body” 
correcting for drift in the xy direction. The image stack was cropped to choose a single 
cells mitochondria using the free hand tool.  
 
The image stacks noise was cleaned up using the Gaussian filtering in Fourier space 
ImageJ plugin “Bandpass Filter” located under the tab “Process” then the dropdown 
menu “FFT”. The limits for the size of the structures of interest were adjusted to 10-2 
pixels correlating to 2.14-.43 µm in size approximately the size of lysosomes. This value 
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will be adjusted depending on the particle size you are analyzing. Uncheck the two boxes 
labeled “Autoscale after filtering” and “Saturate Image when Autoscaling” and check the 
box “Process Entire Image Stack”. This plugin will filter out any objects falling outside 
the size specifications you choose eliminating background noise significantly. 
 
The background noise was reduced further using the ImageJ plugin “Background 
Subtract” based on the rolling ball algorithm [298] located under the “Process” tab. 
Change the size of the “rolling ball” to 3 pixels in diameter. This plugin works in essence 
by imagining wherever a rolling ball could roll of a certain size will be designated 
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background wherever the ball cannot travel is considered the object of interest. Adjust 
accordingly for specific objects being analyzed. 
 
Threshold the image by clicking on “Image” then click the dropdown menu “Adjust” 
then click on “Threshold”. The image stack was thresholded using the “Moments” 
method. Click the option “Dark Background” then click “Apply”. A new prompt dialogue 
box will pop up, do not calculate the threshold for each image use the initial calculation 
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to have a fair comparison between all images. Leave the box checked for “Black 
Background”. 
 
Following thresholding the image stack noise was reduced using the median filter 
“Despeckle” an ImageJ plugin under the “Process” tab then the “Noise” dropdown menu. 




The “Particle Tracker 2D/3D” plugin was then used to track the particles speeds under 
the “Plugins” tab and the “Mosaic” dropdown menu. This will bring up a prompt box if 
the image is 3D, for all the image stacks performed for this work none were 3D so click 
“No”. Another prompt dialogue box will populate requesting the particle detection 
specifications. Set the “Radius” to 3 the “Cutoff” to 0 and the “Per/Abs” to 0.7. The 
remaining default settings were used. The particle linking specifications can be changed 
based on particular data sets although it was left as 2 for the link range and a 
displacement of 10 and Brownian motion. This will run through all the images in the 
stack which may take a while. A results dialogue box will populate. Click the tab “All 
MSS/MSD to Table” this will bring up a dialogue box asking you to change the “Frame 
Interval” to something other than zero, click “ok”. Change only the pixel width and 
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height according to the microscope specifications for the magnification that was used and 
the fram interval to the acquisition times between two frames. The results will then be 




APPENDIX C: ANALYSIS OF COMPONENTS USING “R” 
Begin by loading the computer software program R. This computer software can be 
downloaded for free at http://cran.r-pro ject.org/ 
Once the program is downloaded the package “mclust” must be installed into the 
computer. This is the program that will calculate the components of the system using a 
mixed Gaussian function. This can be installed by clicking the “Packages” tab then 
clicking the “Install Package(s)…” tab from the drop down menu. Find the package 
“mclust” and install. Once installed into the computer the software R needs to load the 
software everytime you start the software by clicking on the tab “Packages” then “Load 
Packages” from the drop down menu. Once this is performed you are ready to begin 
analyzing data. 
The data from the software program “Kymolyzer” needs to be loaded into the R 
program. R can only read text files not excel files. Therefore before loading the files 
derived from Kymolyzer convert the files to a .txt file. Then load these into R by 
inputting the command “dataset <- scan (file.choose())”. Which will bring up a prompt 




Once the data has been read by R it will say “Read X items” 
Now we will determine how many “components” your univariate data set has. In 
order to do this we will use the “densityMclust” function from the mclust package 
previously installed. Input the following command into R: “dataset_model <- 
densityMclust(dataset, G=1:9, modelNames=NULL, prior=NULL, control=emControl(), 
initialization=NULL, warn=FALSE)” 
We will also need the parameters for the output which can be retrieved with the 
command: “dataset_model$parameters” 




The density mclust function will by default analyze the dataset between 1 and 9 
components (G), with either constant variances or different variances. The parameters 
were left at the default settings with 9 possible components for the dataset and leaving the 
variances for the optimal fit. modelNames=NULL will analyze both E (constant 
variances) and V (different variances), and finds the ‘best’ overall fit. 
Description of the returned values: 
1. attr(,"modelName") 
[1] “V” 
If you inputted modelNames=NULL, then this value means that the best model it 




[1] 0.3123456 0.3023054 0.1966528 0.1886961 
In the case of a 4-component data set (illustrated here), four values are returned 
describing the proportion (“pro”) of each (in this case, ~31%, ~30%, ~19%, and ~18% 
for the 1st, 2nd, 3rd, and 4th components, respectively). 
2. attr(,"parameters")$mean   
           1                       2                    3                    4  
0.0009198442 0.0038618539 0.0117697282 0.1934740257 
In the case of a 4-component data set, here are the 4 means (0.0009, 0.0038, 0.011, 
and .193 µm/s) for each components speed. 
4. attr(,"parameters")$variance$sigmasq 
[1] 2.433642e-07 1.427590e-06 1.459027e-05 2.308891e-02 
These are the variances values or sigma squared. To obtain the standard deviations, 
square root these values. 
These values provide all the components the proportions of each component as well 
as the average speed for each component. Although graphical representations of the 
dataset are nice to confirm what the program calculated. Input the command: 
plot((dataset_model), xlim=c(0,0.01)) 
The xlim command will adjust the x-axis which can be changed to best view the 
plots. 
to plot the density mclust function. Three plots are possible BIC for the best 
component determined from 1 to 9, density function for a plot of the density of 




The BIC plot provides the best interpretation of the calculated components. Basically 
where the highest BIC value lies is the highest correlation for the dataset for that many 
components. Input the command “1” to retrieve the BIC plot. In the case of this set it is 




To retrieve the density plot input the command “2”. These plots you can see where 
the components were calculated through the peaks. In this case there are 4 optimal 
components and there are 4 peaks in the dataset. 
 




APPENDIX D: PREDICTION RESULTS FROM ZINC ALGORITHM 
PROGRAMS 







C 4 1.5 
H 8 1.5 
C 20 0.4 
C 25 0.4 
H 28 1.9 
E 55 0.2 
H 61 0.3 
H 88 0.5 
H 107 1 
C 129 0.9 
H 192 0.4 
H 197 0.3 
C 200 0.6 
C 213 0.7 
H 266 0.2 
H 283 0.3 
C 295 0.8 
C 305 1.5 
C 315 0.5 
C 316 0.7 
C 347 0.6 
C 376 1.2 
 





E3 0.208647 NO 
C4 0.261433 NO 
H8 0.321097 NO 
C20 0.455949 YES   
 
245 
E22 0.233913 NO 
C25 0.457186 YES   
E27 0.269017 NO 
H28 0.334304 NO 
D33 0.209778 NO 
D39 0.105601 NO 
D46 0.147903 NO 
D47 0.178926 NO 
E55 0.194402 NO 
H61 0.179375 NO 
D69 0.242295 NO 
E71 0.251222 NO 
D76 0.259463 NO 
E77 0.154559 NO 
H88 0.299331 NO 
E90 0.135963 NO 
E97 0.182321 NO 
D98 0.244097 NO 
H107 0.273298 NO 
E113 0.205133 NO 
D116 0.337126 NO 
D120 0.270236 NO 
D127 0.164639 NO 
C129 0.477733 YES   
H139 0.263905 NO 
E155 0.199757 NO 
D160 0.261336 NO 
E168 0.151069 NO 
E183 0.220488 NO 
H192 0.401923 YES   
E196 0.169668 NO 
H197 0.289239 NO 
D199 0.209252 NO 
C200 0.305752 NO 
D205 0.238154 NO 
E207 0.25779 NO 
D211 0.167909 NO 
C213 0.4737 YES   
D218 0.18771 NO 
 
246 
E220 0.158318 NO 
D245 0.132508 NO 
D251 0.197715 NO 
E254 0.198189 NO 
H266 0.361645 NO 
E279 0.119179 NO 
H283 0.324007 NO 
E284 0.270458 NO 
E290 0.154876 NO 
C295 0.34321 NO 
E297 0.200272 NO 
C305 0.548478 
YES  High 
Confidence 
D306 0.217402 NO 
H309 0.211275 NO 
C315 0.309683 NO 
C316 0.467673 YES   
D322 0.229953 NO 
D327 0.172654 NO 
D345 0.241314 NO 
C347 0.407846 YES   
D367 0.170978 NO 
C376 0.445165 YES   
E386 0.173775 NO 
D392 0.159043 NO 
H393 0.18585 NO 
D396 0.167768 NO 
H406 0.418916 YES   
E411 0.211676 NO 
E414 0.219363 NO 
E415 0.196619 NO 
E417 0.17415 NO 
E420 0.201976 NO 
E423 0.143774 NO 
D424 0.216997 NO 
E429 0.228211 NO 
D431 0.304683 NO 
E433 0.187322 NO 
E434 0.257806 NO 
 
247 
D438 0.197459 NO 
E441 0.208392 NO 
E443 0.209271 NO 
E445 0.13483 NO 
E446 0.140095 NO 
E447 0.166035 NO 
E449 0.119469 NO 
E450 0.139383 NO 
 




GLU 411 0.137 
GLU 55 0.119 
ASP 98 0.113 
GLU 71 0.025 
GLU 450 0.024 
ASP 392 0.019 
GLU 183 0.016 
GLU 155 0.016 
GLU 434 0.014 
GLU 449 0.012 
GLU 290 0.011 
ASP 396 0.011 
ASP 205 0.011 
ASP 218 0.01 
GLU 113 0.009 
GLU 429 0.008 
GLU 97 0.008 
GLU 207 0.008 
GLU 445 0.007 
GLU 22 0.007 
HIS 28 0.007 
GLU 443 0.006 
GLU 284 0.006 
GLU 3 0.005 
GLU 90 0.005 
 
248 
GLU 417 0.005 
CYS 25 0.005 
GLU 414 0.004 
ASP 120 0.004 
ASP 69 0.004 
CYS 316 0.004 
HIS 283 0.004 
GLU 297 0.004 
GLU 386 0.003 
GLU 77 0.003 
HIS 88 0.003 
CYS 305 0.003 
ASP 431 0.003 
GLU 279 0.002 
GLU 196 0.002 
CYS 315 0.002 
HIS 197 0.002 
GLU 254 0.002 
ASP 322 0.002 
CYS 213 0.002 
HIS 139 0.002 
GLU 168 0.002 
GLU 423 0.002 
CYS 295 0.001 
ASP 199 0.001 
GLU 415 0.001 
ASP 438 0.001 
GLU 447 0.001 
GLU 27 0.001 
ASP 46 0.001 
HIS 192 0.001 
CYS 129 0.001 
ASP 345 0.001 
HIS 8 0.001 
HIS 266 0.001 
CYS 347 0.001 
GLU 441 0.001 
ASP 211 0.001 
 
249 
ASP 251 0.001 
GLU 420 0.001 
HIS 393 0.001 
HIS 406 0.001 
ASP 33 0.001 
ASP 306 0.001 
GLU 433 0.001 
CYS 20 0.001 
ASP 116 0.001 
ASP 160 0.001 
HIS 107 0 
GLU 220 0 
CYS 376 0 
CYS 200 0 
HIS 309 0 
ASP 424 0 
GLU 446 0 
ASP 47 0 
ASP 367 0 
ASP 39 0 
HIS 61 0 
ASP 76 0 
ASP 127 0 
ASP 245 0 
CYS 4 0 
ASP 327 0 
 
 
